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ABSTRACT 
Thyroid hormones are important regulators of fetal growth and maturation, although their 
mechanism of action and interactions with other hormones are unclear. The overall aim of the 
project was to elucidate the effects of hypothyroidism on the growth and development of the 
sheep fetus in late gestation. Specifically, the project investigated the extent to which the 
changes in fetal growth induced by thyroid hormone deficiency were mediated by changes in 
pancreatic islet development and insulin signalling in fetal tissues. In nineteen twin-bearing 
pregnant ewes at 105-110 days of gestation (dGA; term~145dGA) and under general 
anaesthesia, one fetus was thyroidectomised, while the other was sham-operated. At either 
129 or 143dGA, umbilical blood samples and a variety of fetal tissues were collected after 
euthanasia. 
Hypothyroidism in utero did not affect fetal bodyweight but impaired skeletal growth and led 
to disproportionate patterns of organ growth. A 30-40% increase in pancreatic β-cell mass was 
observed in the thyroid deficient fetuses, compared to sham controls, and this was associated 
with increased plasma insulin and leptin concentrations. In studies using isolated fetal ovine 
pancreatic islets, β-cell proliferation in vitro was inhibited by T3 in a dose-dependent manner 
but was stimulated by the highest dose of insulin. Pancreatic β-cell proliferation was inhibited 
at low, and stimulated at high, leptin concentrations. Perirenal adipose tissue was enlarged in 
the hypothyroid fetuses due to an increase in the proportion of unilocular adipocytes, 
characteristic of white adipose tissue. The greater relative unilocular adipocyte mass was 
caused by hyperplasia in association with upregulation of the insulin signalling pathway. 
Kidneys of hypothyroid fetuses had no apparent changes in glomerular or tubular structure, 
but a greater water content may have accounted for the increased kidney mass seen in the 
thyroid deficient fetuses, compared to sham controls. No changes in insulin signalling or 
sodium transporter expression were seen in the kidneys of the hypothyroid fetuses.  
This research demonstrates that the thyroid hormones are required in the ovine fetus during 
late gestation for the normal development of the endocrine pancreas, adipose tissue and 
kidney. Alterations in organ development in response to hypothyroidism may have short and 
long term consequences for carbohydrate metabolism, obesity and renal function.  
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1. INTRODUCTION
1.1 Fetal growth and maturation
Late gestation is a critical period for the control of fetal growth, development and
maturation. A multitude of factors regulate fetal growth including maternal nutrition,
placental function and the supply of nutrients and oxygen. Changes in the environment
in utero can lead to permanent changes in the structure of organs, such as the kidney
and heart, and in the activity of key metabolic pathways in fetal tissues. In experimental
animals, restricting nutrient supply or oxygen availability leads to intrauterine growth
restriction (IUGR) and impairments of cardiovascular, metabolic and endocrine function
in the short and longer term (Sferruzzi-Perri et al., 2013).
In humans, growth restricted infants have significantly higher rates of morbidity and
mortality in the neonatal period compared to those of average size, and are at greater
risk of developing diseases such as diabetes, obesity and heart disease in adulthood
(Barker et al., 1989; Hales & Barker, 2001). Homeostatic adaptations to perturbations in
utero are mediated, in part, by hormones produced by the fetus. Hormones have the
ability to control the fate of nutrients delivered to the fetus and therefore have an
important role in matching nutrient supply to fetal growth and metabolism. During the
perinatal period, hormones are also important in the stimulation of maturation
processes in the fetus, which are necessary for survival after birth.
The thyroid hormones are responsible for growth and maturation in many fetal organs
during late gestation, such as the heart, lungs, brain and muscle (Ansari et al., 2000;
Lanham et al., 2011; Chattergoon et al., 2012a). There is limited knowledge however, on
the role thyroid hormones on the growth and maturation of organs such as the
pancreas, adipose tissue and kidney. Additionally, insulin is a potent growth factor in the
fetus and the insulin signalling pathway has been proposed to be an important growth
stimulus in utero, but their interactions with the thyroid hormones in late gestation are
unknown.
1.2 Thyroid hormones
Thyroid hormones, thyroxine (T4) and triiodothyronine (T3), are tyrosine-based lipid-
soluble hormones produced by the follicular cells of the thyroid gland. Thyroxine is
synthesised entirely in the follicular cells, and is a pro-hormone for active T3. The
biological activity of the thyroid hormones is determined primarily by the intracellular
concentration of T3 available to bind to its nuclear receptor. This, in turn, depends on a)
circulating concentrations of T3 and T4, b) the presence of transporters regulating the
cellular uptake of thyroid hormones and c) the activities of the deiodinase enzymes that
metabolise thyroid hormones to more or less active substances (Forhead & Fowden,
2014).
1.2.1 The hypothalamic-pituitary-thyroid (HPT) axis
The paraventricular nucleus of the hypothalamus maintains the circulating levels of the
thyroid hormones by the production of thyrotropin-releasing hormone (TRH); TRH, in
turn, stimulates thyrotrophs in the anterior pituitary gland to produce thyroid
stimulating hormone (TSH). Pituitary TSH stimulates the thyroid gland to produce T4 and
T3. A large proportion of the T3 in circulation is derived from deiodination of T4 in
peripheral organs by the actions of deiodinase enzymes (Senese et al., 2014). In sheep
and primates, the HPT undergoes maturation in utero, compared to rodents, in which
the majority of maturation occurs postnatally (Kapoor et al., 2006).
Pituitary TSH is detectable in the human fetus at 8 to 10 weeks of gestation (where term
is 40 weeks) and the circulating concentration remains low until around 18 weeks of
gestation when it increases rapidly (Blackburn, 2003a; Kapoor et al., 2006). In sheep
fetuses, TSH can be detected from 50 days of gestation (dGA; term ~145dGA) and also
increases towards term (Fisher & Polk, 1989). Plasma T4 levels are low at mid-gestation
and gradually increase and plateau towards full term (Figure 1.1). Plasma T3 levels,
however, remain low until a surge just before birth as the conversion from T4 to T3
increases (Polk et al., 1989; Blackburn, 2003a; Hillman et al., 2012).
1.2.2 Thyroid hormone transport
The active sites of deiodinase and thyroid hormone receptors are intracellular and for
thyroid hormone metabolism and action to take place, the hormone must be
transported into the cell. Thyroid hormone is transported into the cell by membrane
transporters such as monocarboxylate transporters 8 and 10 (MCT8, MCT10), organic
anion transporters (OATP) and L-type amino acid transporters (Visser et al., 2008;
Loubière et al., 2010). The membrane transporter MCT8 is specific to thyroid hormones,
and in MCT8-deficient mice, thyroid hormone levels in the brain are markedly decreased
(Trajkovic et al., 2007).
Figure 1.1. Development of thyroid function in the human and sheep fetus. Fetal serum
levels of thyroid stimulating hormone (TSH), thyroxine (T4), triiodothyronine (T3) and
reverse T3 (rT3) are shown relative to the fraction of thyroid system maturation and
show similarities between the species. Adapted from Fisher and Polk. (1989).
Placental transfer of thyroid hormones can contribute to thyroid hormone levels in fetal
circulation, depending on species. In humans, cellular uptake of T3 and T4 by the
placenta is critical for thyroid hormone action, within the organ itself and for thyroid
hormone transport to the fetus (Loubière et al., 2010). In the human placenta, mRNA
and protein expression of MCT8 and MCT10 are present from 6 weeks of gestation and
increase with gestation from 15 weeks onwards (Loubière et al., 2010). Intrauterine
growth restriction of the human fetus is associated with a reduction in MCT8 and MCT10
protein in the placenta, thus compromising thyroid hormone transport to the fetus
(Loubière et al., 2010).
Little is known about the developmental expression of thyroid hormone transporters in
fetal life. At 30 weeks of gestation, MCT8 mutation in the human fetus leads to
deficiencies in brain maturation, myelination and expression of neuronal proteins
(López-Espíndola et al., 2014). It has recently been identified that MCT8 can interact
with MCT10 to regulate fetal thyroid hormone availability, as mouse models of genetic
knockouts for both transporters have a less severe phenotype than MCT8 knockout
alone and have normal serum T4 levels (Müller et al., 2014).
1.2.3 Thyroid hormone metabolism
Deiodinase enzymes are important in the regulation of cellular T3 levels. Once T4 enters
the cell, it can be deiodinated by the activities of type I 5’-deiodinase (D1) and type II 5’-
deiodinase (D2) into the active form of T3. Inactivation of T4 to reverse T3 (rT3), and of
T3 to T2, is mediated by type III 5’-deiodinase (D3), as illustrated by Figure 1.2 (Gereben
et al., 2008; Brent, 2012).
In the fetus, the deiodinases regulate thyroid hormone metabolism during development
in a tissue specific manner (Gereben et al., 2008). The conversion of T4 to T3 by D1 in
the fetal liver is the major source of circulating T3 and D1 is also found present in other
tissues, such as the kidney and pituitary (Polk, 1995). The brain and brown adipose tissue
primarily express D2, where it is responsible for the generation of local concentrations
of T3. The inactivating deiodinase D3 is highly expressed in the uterus and placenta
where it has a key role in regulating placental transfer of thyroid hormones and limiting
exposure of the fetus to maternal T3 and T4 (Forhead & Fowden, 2014).
As well as deiodination, sulphation of the hydroxyl group is another important pathway
of metabolism for the thyroid hormones (Figure 1.3), especially in the fetus (Visser,
1994). Sulphation by the enzyme sulphotransferase facilitates the inactivation of T3 and
T4 and occurs rapidly in the fetal liver (Visser et al., 1990). Sulphotransferases are widely
expressed before birth and have previously been localised in human fetal tissue such as
the kidney, small intestine, testis and the lung (Hume & Coughtrie, 1994; Parker et al.,
1994; Hume et al., 1996; Richard et al., 2001; Stanley et al., 2005). The levels of
expression are equivalent to or higher than that seen in the adult, indicating that they
have a significant role in thyroid hormone metabolism before birth (Stanley et al., 2005).
Figure 1.2. Thyroid hormone transport and cellular metabolism. T3 and T4 are transported into
the cell cytoplasm. T4 is deiodinated to T3 or rT3 by the deiodinase enzymes. When bound to
its receptor, T3 regulates transcription of genes in the nucleus via the thyroid hormone-
response element (TRE). Transportation of T3 via the integrin receptor on the cell surface
promotes trafficking of the receptor into the nucleus by activation of phosphatidylinositide 3-
kinase (PI3K) and T4 activates the mitogen-activated protein kinases (MAPK) pathway.
In the sheep fetus, the sulphated forms of T3 (T3S) and T4 (T4S) in circulation peak
towards the end of term; 80% of T4 produced by the fetal thyroid is sulphated,
suggesting that they are major metabolites during development (Wu et al., 1992; Polk
et al., 1994). In comparison, T4S is undetectable in in adult sheep (Wu et al., 1993)
Although the sulphated forms of the thyroid hormones are biologically inactive, they are
a potential source of active thyroid hormones as desulphation by sulphatase can occur
in a variety of tissues, such as the liver and placenta (Kester et al., 2002). The sulphated
form of T3 has a longer half-life than the non-sulphated form and is therefore an
important source of T3, especially during hypothyroidism. Following thyroidectomy in
the sheep fetus, serum concentrations of T4S are decreased, but T3S remain unchanged
for at least 2 weeks (Wu et al., 1993).
1.2.4 Thyroid hormone receptors
Triiodothyronine binds to thyroid hormone receptors (TR), which belong to a
et
al., 2013). The TR isoforms are expressed in a temporal and tissue-specific manner in
adults and during development. In adult brain, white adipose tissue and heart atria,
Figure 1.3. The enzymes, sulphotransferases, inactivate T4 and T3 by sulphation of the
hydroxyl group present in their molecular structures.
heart ventricles (Mullur et al., 2014).
is seen across several species including Xenopus, chickens, rodents, sheep and humans
(Mullur et al., 2014). The different patterns of expression of these receptor isoforms
influence thyroid hormone activity. Previous studies have identified that abnormalities
in the TR can cause changes in circulating thyroid hormone concentrations. For instance,
hypothyroidism (Saltó et al., 2001).
The thyroid receptors have the ability to exert genomic and non-genomic actions in the
cell. In the genomic action, the receptors act as T3 inducible transcription factors (Cheng
et al., 2010; Chi et al., 2013). The TR are ligand-dependent receptors that regulate gene
expression by binding to specific thyroid hormone-response elements (TRE; Figure 1.2)
present in the regulatory region of target genes (Cao et al., 2005). Efficient binding to
DNA occurs with the common partner, the retinoid X receptor (RXR), to form
heterodimers and the transcriptional activity of TRs is mediated by various co-repressors
and co-activators (Brent, 2012).
Non-genomic actions of thyroid hormones do not involve direct transcriptional
as a cell surface receptor to mediate the actions of the thyroid hormone, as shown in
Figure 1.2 (Bergh et al., 2005). Through the integrin receptor, T3 and T4 stimulate the
mitogen-activated protein kinase (MAPK) signalling cascade which initiates cell
proliferation and angiogenesis (Cheng et al., 2010). The integrin receptor can also
activate phosphatidylinositide 3-kinase (PI3K), which initiates trafficking of intracellular
et al., 2010). The
activation of MAPK and PI3K suggests that the thyroid hormones have the potential to
initiate cross-talk through several cellular signalling pathways. Non-genomic actions of
thyroid hormones have only been examined in vitro using adult fibroblasts and tumour
cell lines and it is not known if this form of thyroid action is cell-specific or occurs in fetal
tissues (Bergh et al., 2005; Lin et al., 2009).
There is limited knowledge on the expression of the thyroid hormone receptors in the
fetus. In the liver and brain of fetal sheep, there is a progressive increase in T3 nuclear
receptor binding from 80dGA towards term when thyroid hormone receptor binding
reaches a plateau over the perinatal period (Polk et al., 1989). In thyroidectomised
sheep fetuses at 129dGA, the reduction of thyroid hormones has no effect on receptor
binding in either the brain or liver. The same pattern of hepatic expression of TR has
been identified in fetal pigs (Duchamp et al., 1994). Compared to the fetal liver, skeletal
muscle, however, shows a much higher binding affinity for T3 at 80dGA (term 115dGA),
indicating that fetal muscle can potentially respond to thyroid hormones earlier in
development (Duchamp et al., 1994). In the fetal rat, TR mRNA is not seen until 14dGA,
where term is ~22dGA (Perez-Castillo et al., 1985). In rodent tissues, TR are present
before activation of the HPT axis, suggesting that the receptors may be bound and
activated by maternal thyroid hormones. There is a progressive increase in receptor
mRNA and protein in the heart and liver towards term, whereas expression in the lung
and brain is maintained throughout gestation. Thyroid hormone receptor mRNA in all
organs examined increases into neonatal life and peaks at postnatal day 6, especially in
the neonatal brain (Perez-Castillo et al., 1985). The different expression patterns of TR
indicates that there may be organ-specific development of thyroid hormone activity in
the fetus (Polk et al., 1989).
1.3 Thyroid hormones and fetal growth
In the fetus, thyroid hormones play a key role in regulating growth and metabolism in a
variety of developing organs and physiological systems (Brent, 2000; Brent, 2012). In
normal human pregnancy, there are significant associations between cord blood
concentrations of T4 and birth weight, head circumference and skin fold thickness
(Shields et al., 2011) and in human neonates affected by IUGR, serum concentrations of
T3 and T4 are reduced (Kilby et al., 1998). Additionally, deficiency of thyroid hormones
in utero impairs growth in fetal sheep (Fowden & Silver, 1995). In the sheep fetus,
thyroidectomy has been shown to reduce bodyweight and limb and crown-rump lengths
in late gestation compared to intact fetuses (Lanham et al., 2011). The same study also
found that the mechanical properties of the bones were also affected, as the trabecular
bone of the metatarsals in hypothyroid fetuses were stronger, yet more brittle,
compared to sham controls. It was suggested that hypothyroidism delays bone
development by impairing bone deposition (Lanham et al., 2011). Similar skeletal
abnormalities have been demonstrated in a neonatal mouse model of hypothyroidism
(Bassett et al., 2008).
Abnormal growth patterns induced by fetal hypothyroidism may compromise the fetus
in its preparation for extrauterine life and thyroid hormones are important not only in
the control of overall body growth, but also in tissue-specific development (Forhead &
Fowden, 2014). The transporters MCT8 and MCT10, as well as the deiodinases D2 and
D3, are expressed in skeletal muscle of both human and rodent fetuses (Visser et al.,
2008) and it has previously been established that T3 stimulates muscle growth by
increasing the number and diameter of muscle fibres in utero (Yu et al., 2000; Lee et al.,
lower muscle weight associated with decreased fibre number and size (Yu et al., 2000).
Thyroidectomy in fetal sheep results in decreased contractile force generated by skeletal
muscle (Finkelstein et al., 1991), and the normal development of fast and slow muscle
fibre types is impaired by pharmacological hypothyroidism in neonatal rats (Butler-
Browne et al., 1984).
Organs such as the heart, kidney and brain are also thyroid hormone sensitive before
birth. In the sheep fetus, thyroidectomy results in decreased relative heart and lung
mass; this is due to decreased cardiomyocyte number in the fetal heart and hypotrophy
associated with smaller air spaces in the fetal lungs (Erenberg et al., 1974; van Tuyl et
al., 2004; Chattergoon et al., 2012a). The brain is also significantly reduced in
hypothyroid fetal sheep in late gestation, but is relatively spared compared to other
organs. Hypothyroid fetal sheep have an upregulation of D2 in the brain indicating that
the brain can enhance local T3 production when needed (Polk et al., 1988). In fetal rats
born to hypothyroid dams, absolute weights of the kidney and liver are decreased, while
the absolute and relative brain mass is increased (Shibutani et al., 2009). These changes
in organ mass are seen to persist in adulthood (Shibutani et al., 2009).
Thyroid hormones are able to influence other endocrine systems involved in fetal
development. Hypothyroidism has been shown to change the availability of hormones
and growth factors in utero including growth hormone and the insulin-like growth
factors, also known as the IGFs (Forhead et al., 1998; Johnson et al., 2007; Carey et al.,
2008). Thyroidectomy in fetal sheep impairs the normal ontogenic expression of growth
hormone receptor and insulin-like growth factor-I (IGF-I) mRNA expression in the liver
and skeletal muscle (Forhead et al., 2000; Forhead et al., 2002). Pharmacological
hypothyroidism in the neonatal mouse also leads to reductions in circulating and liver
mRNA levels of IGF-I compared to controls (Ramos et al., 1998). Additionally, oxygen
consumption in hypothyroid sheep fetuses is reduced by 20-45% (Fowden & Silver,
1995), thus indicating fetuses generate less energy by oxidative phosphorylation. The
decrease in oxygen consumption is restored to normal levels after administration of T4,
indicating a positive correlation between thyroid state and umbilical oxygen uptake.
1.3.1 Thyroid hormones and fetal maturation
Near term, there is also a surge in plasma cortisol concentrations from the fetal adrenal
gland, which is responsible for stimulating aspects of fetal maturation, including the
prepartum increase in circulating T3 (Hillman et al., 2012). The increase in plasma T3
concentrations near term is due to the influence of rising D1 and D2 activities in
peripheral tissues, stimulated by cortisol (Forhead et al., 2006; Chattergoon et al., 2014)
and removal of the adrenal gland in utero abolishes the prepartum rise in both cortisol
and T3 (Forhead et al., 2006). The rise in circulating T3 levels has been shown to be
responsible for mediating some of the maturational effects of cortisol near term
(Forhead & Fowden, 2014).
The maturational surge in plasma T3 late in gestation coincides with acceleration of
alveolar septation, a period of pulmonary remodelling to increase the blood-gas
interface (Massaro & Massaro, 2002). This has been demonstrated in fetal mice by
administration of glucocorticoids, which causes a rise in circulating T3 and results in early
fetal lung maturation (Ansari et al., 2000). In the hypothyroid mouse neonate, the lungs
have altered air spaces with less alveolar septae and reduced surfactant content,
indicating that there are impairments in structural and functional maturation (deMello
et al., 1994; van Tuyl et al., 2004).
Thyroid hormones are known to be essential in cardiomyocyte maturation as the
increase in circulating T3 concentrations towards term promotes a switch from cell
proliferation to differentiation (Chattergoon et al., 2012a). In fetal sheep, T3 stimulates
up-regulation of cell cycle suppressors and increases the population of differentiated
binucleated cells (Chattergoon et al., 2012b). Consequently, thyroidectomy in the fetal
sheep leads to a decrease in the proportion of terminally differentiated cardiomyocytes
(Segar et al., 2012). In fetal rats and mice, T3 has been shown to be necessary for the
upregulation of the cardiac insulin-sensitive glucose transporter type-4 (GLUT4) towards
et al.,
1994; van Tuyl et al., 2004).
Thyroid hormones also have an important role in preparing the fetus for hepatic
gluconeogenesis and endogenous glucose production at birth (Forhead & Fowden,
2014). In the liver and kidney of fetal sheep, thyroidectomy suppresses the normal
increase in the gluconeogenic enzymes, phosphoenol-pyruvate carboxykinase (PEPCK)
and glucose-6-phosphatase (Forhead et al., 2003). Fetal thyroidectomy in sheep has also
been shown to abolish the normal rise in hepatic glycogen content, which provides an
important source of glucose for metabolism before and after birth (Forhead et al., 2009).
1.3.2 Hypothyroidism in the fetal sheep
No animal model can truly emulate human development in utero; however, the sheep
has been used extensively in studies of fetal growth and development. The sheep is a
precocious species, meaning that its young are well developed in comparison to rodent
offspring. Because of this, the sheep fetus has many commonalities with the human
fetus. The degree of maturity of the new born lamb suggest that this species may be
more dependent on the presence of the thyroid hormones than species which give birth
to less developed young, such as mice (Hopkins & Thorburn, 1972). Studies in fetal sheep
have shown that a functional thyroid gland is present from as early as 70dGA which is
able to incorporate iodine and produce measurable circulating amounts of the thyroid
hormones. This is a similar time frame to thyroid gland development in the human.
The transfer of thyroid hormones from mother to fetus via the placenta varies between
human and sheep. The human placenta is permeable to thyroid hormones and a variety
of thyroid hormone transporters are expressed throughout development (Loubière et
al., 2010). Once the fetus is able to produce its own thyroid hormones (around 12 weeks
of gestation), maternal T4 makes only a modest contribution to the circulating pool
(Morreale de Escobar et al., 1990). Placental transfer of thyroid hormones becomes
particularly important in disorders such as fetal hypothyroidism. Congenital
hypothyroidism affects approximately 1 in 3000 human births a year in the UK and can
cause severe mental and physical retardation if untreated (LaFranchi, 2011). The most
common cause of congenital hypothyroidism is thyroid dysgenesis, where the thyroid
gland fails to develop normally (LaFranchi, 2011). The gland may be ectopic and develop
away from the normal position, or the gland may be completely absent. Human fetuses
with congenital hypothyroidism have reduced cord concentrations of T4 which are 20-
50% of normal values (Vulsma et al., 1989), indicating that the fetus can acquire
substantial amounts of thyroid hormones when there is a steep gradient in hormone
concentrations. Because of placental transfer of thyroid hormones, human neonates
with hypothyroidism tend to have little evidence of the condition at birth (Vulsma et al.,
1989); however, few studies have examined tissue development in the neonate with
congenital hypothyroidism.
The ovine placenta appears to be impermeable to thyroid hormones, at least at 108dGA
(Hopkins & Thorburn, 1972), meaning that the transfer of thyroid hormone from mother
to fetus is restricted. The ovine fetus is therefore completely dependent on its own
thyroid gland for appropriate thyroid hormone secretions during development (Hopkins
& Thorburn, 1972).
1.4 Insulin signalling
is an important growth promoting hormone before birth and there is a positive
correlation between plasma insulin concentrations in utero and growth rates in the
sheep fetus in late gestation (115 dGA onwards; Fowden et al., 1989).
The insulin signalling pathway is a key metabolic pathway which involves numerous
intracellular proteins, growth factors and transcription factors in a complex, interacting
network. The pathway is conserved across a range of species (Rhodes & White, 2002).
Downstream targets of the pathway stimulate cell growth and differentiation and also
increase the uptake of glucose by stimulating the translocation of GLUT4 from
intracellular storage to the cell surface, as illustrated in Figure 1.4 (Saltiel & Kahn, 2001).
Serial muscle biopsies in fetal sheep show an increase in insulin signalling proteins when
stimulated with a hyperinsulinaemic clamp, thus providing evidence that the insulin
pathway is well-developed in the sheep fetus during late gestation (Anderson et al.,
2004).
1.4.1 The insulin receptor
The insulin receptor (InsR) belongs to a subfamily of tyrosine kinase receptors. It is a
tyrosine kinase activity, which is essential for insulin action within the cell. When insulin
this in turn leads to tyrosine phosphorylation of other protein substrates (Figure 1.4),
known as insulin receptor substrates, or IRS (Rhodes & White, 2002).
The IRS proteins play an important role in regulating downstream effects in the insulin
signalling cascade and are linked to the PI3K pathway which is responsible for the
majority of the metabolic actions of insulin, and the MAPK pathway which regulates
gene expression (Taniguchi et al., 2006). Removal of the Irs2 gene in adult mice induces
a diabetic phenotype in which mice have increased insulin resistance and a reduction of
et al., 1998; Cantley et al., 2007). Deletion of this
gene also has an impact on other organs during development, such as the kidney, where
Irs2 knock out causes a reduction in kidney size in fetal mice (Carew et al., 2010).
1.4.2 Downstream proteins
Binding of IRS to the insulin receptor leads to conformational changes that reduce kinase
inhibition leading to recruitment of PI3K (Taniguchi et al., 2006). The role of PI3K is to
convert phosphatidylinositol-4,5-bisphosphate (PIP2) into phosphatidylinositol-3,4,5-
Figure 1.4. A simplified diagram of the insulin signalling pathway. The binding of insulin to its
(IRS). This leads to the recruitment of PI3K which, in turn, converts PIP2 to PIP3 at the cell
membrane. An increase in PIP3 at the membrane activates PDK and Akt to enhance
phosphorylation of mTOR and, eventually, S6 kinase. Akt also stimulates the translocation of
GLUT4 to the membrane. IGFR: IGF receptor, IR: insulin receptor, PI3K: phosphatidylinositide
3-kinase, PIP3: phosphatidylinositol-3,4,5-trisphosphate, PDK: phosphoinositide-dependent
kinase, Akt: protein kinase B, GLUT4: glucose transporter type 4, mTOR: mammalian target of
rapamycin, S6K: S6 kinase. Adapted from McCurdy and Klemm (2013).
trisphosphate (PIP3) and to increase the levels of PIP3 at the membrane to stimulate
signalling proteins, protein kinase B (Akt) and phosphoinositide-dependent kinase (PDK),
as shown in Figure 1.4 (McCurdy & Klemm, 2013). Protein kinase B stimulates the
translocation of the glucose transporter, GLUT4, to the plasma membrane. Insulin is able
to promote GLUT4 translocation in a dose-dependent manner and translocation is
suppressed when the Akt gene is deleted in an adipocyte cell line (Tsuchiya et al., 2014).
All eukaryotes express Akt where it exists in 3 different isoforms, Akt1, Akt2 and Akt3,
of which only Akt1 and Akt2 are expressed in all tissue types (Brazil et al., 2004). The
roles of Akt1 and Akt2 are isoform-specific; isoform-specific knock-out mouse models
have revealed that Akt1 regulates cell proliferation and Akt2 is important in glucose and
lipid metabolism (Manning & Cantley, 2007).
Activation of PI3K also leads to the phosphorylation of mammalian target of rapamycin
(mTOR) which regulates proteins such as S6 kinase (S6K) to promote protein synthesis
and growth. The kinase mTOR is the core of two distinct complexes, mTORC1 and
mTORC2. Each complex is defined by associated proteins, Raptor in mTORC1 and Rictor
and Sin1 in mTORC2 (Liu et al., 2013). It is known that mTORC1 promotes cellular
metabolism and is an important regulator of cell growth (Huang & Fingar, 2014),
however the role of mTORC2 in the insulin signalling pathway is less well defined.
1.5 Insulin-like growth factors
The insulin-like growth factors, IGF-I and IGF-II, are important in the control of fetal
growth, and are ubiquitously expressed in all tissues and circulation in relatively high
concentrations before birth (Kawai & Rosen, 2010; Bloomfield et al., 2013). Binding of
IGF-I to the cell surface receptor, IGF type 1 receptor (IGF-IR), triggers the activation of
intracellular kinases such as PI3K (Figure 1.4) in the same manner as insulin in the same
pathway (Burks & White, 2001; Lai et al., 2004).
The expression of IGF-I and IGF-II in utero varies with gestational age and nutritional
state in a tissue-specific manner (Fowden & Forhead, 2009). In humans and rodent
fetuses, tissue expression of IGF-II mRNA is more abundant than IGF-I mRNA in mid
gestation and then decreases towards term (Delhanty & Han, 1993; Fowden, 2003).
Serum levels of IGF-II however, are 3-10 fold higher than IGF-I during late gestation in
human, sheep and rodents (Fowden, 2003). Abundance of IGF mRNA also differs
between fetal sheep tissues, as IGF-I mRNA is highest in abundance in the liver and
skeletal muscle and IGF-II mRNA is highly expressed in the lung and kidney (Delhanty &
Han, 1993).
Insulin-like growth factor-I is more responsive to stimuli than IGF-II and rises with
increasing fetal concentrations of glucose, induced by maternal nutritional state
(Fowden & Forhead, 2009). In the fetal sheep, plasma concentrations of IGF-I also rise
with increasing oxygen availability and are reduced in hypothyroidism (Mesiano et al.,
1987; Iwamoto et al., 1992). Compared to IGF-I, IGF-II gene expression is relatively
unresponsive to nutritional stimuli and is posited to be an important regulator of whole
body growth before birth. Disruption of IGF-II in mice by gene targeting produces growth
restricted offspring (DeChiara et al., 1990). Conversely, the relative weights of the heart,
kidney, brain and liver are increased in a transgenic mouse model of IGF-II
overexpression (Petrik et al., 1999). Taken together, previous studies suggest that IGF-II
acts as a constitutive growth factor for intrauterine growth, while IGF-I regulates fetal
growth in relation to the nutrient and oxygen supply.
The activity of the IGFs is regulated by their binding proteins (IGFBP), which can inhibit
or potentiate depending on subtype of binding protein and their targets (Duan & Xu,
2005). They function as carrier proteins for IGFs in the circulation and regulate
physiological concentrations at the tissue level. In the human and sheep fetus, IGFBP-3
is the most abundant IGFBP in serum, followed by IGFBP-2, suggesting that these are
important in IGF modulation during development (Lord et al., 1991; Delhanty & Han,
1993). The expression of the IGFBPs during development has also been shown to be
tissue-specific: for example, IGFBP-2 expression declines in the muscle, heart and lung
at 75dGA but continues in the kidney and adrenal until post natal life (Delhanty & Han,
1993).
As studies on experimental hypothyroidism in utero have shown growth retardation, it
can be postulated that growth mechanisms are altered by changes in insulin and/or IGF
signalling. These alterations may affect important downstream signalling proteins which
are essential for growth and maturation in the fetus. Interactions between thyroid
hormones and insulin, and the development of the pancreas, have not been investigated
previously before birth.
1.6 Pancreatic islets of Langerhans
The islets of Langerhans of the pancreas comprise of distinct cell types which secrete
different hormones. It is estimated that adult humans have approximately 2 million
islets, which make up about 2% of the pancreas by weight (Kulkarni, 2004). Insulin is
polypeptide-producing PP cells. Somatostatin is an inhibitory paracrine hormone which
suppresses the secretion of insulin and glucagon, while pancreatic polypeptide is
secreted in response to food intake and regulates exocrine pancreatic secretion (Wang
et al.
maintaining an optimal range of blood glucose levels in adult life and for normal growth
and development in the fetus.
1.6.1 Endocrine islet cell development
Embryonic development of the pancreas is a complex process, as pancreatic cells with
profoundly different functions arise from the same progenitor cells. Therefore, specific
transcription of genes for cell specification and maturation (Conrad et al., 2014). The
pancreas originates from the dorsal and ventral region of the distal foregut endoderm
at 4 weeks of gestation and 24dGA in the human and sheep, respectively, and at 10dGA
in the mouse (Cole et al., 2009; Jennings et al., 2015). Development of the pancreatic
bud is due to inhibition of expression of the gene sonic hedgehog, which normally
suppresses the key transcription factor pancreatic duodenal homeobox factor, also
known as PDX1 (Pan & Wright, 2011). In the human embryo by 30dGA, there is a marked
expression of PDX1 and GATA binding protein 4 (GATA4) in the ventral and dorsal buds,
which are necessary for pancreatic growth. Previous studies have shown that mice with
a global loss of Pdx1 lack a pancreas and die at birth (Offield et al., 1996). Later in
embryogenesis, the transcription factors, forkhead box O1 (FOXO1), NK2 homeobox-2
(NKX2-2) and NK6 homeobox-1 (NKX6-1), are all expressed and are vital in maintaining
During the embryonic period, the pancreas undergoes extensive expansion of
proliferative progenitor cells and the transcription factor neurogenin 3 (NGN3) is
required for the commitment of progenitor cells to an endocrine fate (Figure 1.5).
Pancreatic expression of NGN3 increases at the end of the embryonic period (~7 weeks)
5 weeks before term (Salisbury et al., 2014). This suggests that human pancreatic
et al., 2015).
The transcription factors v-maf avian musculoaponeurotic fibrosarcoma oncogene
MAFB expression marks the start of insulin transcription, followed shortly by expression
of MAFA (van der Meulen & Huising, 2015). Mice lacking MafA in the pancreas have
altered islet morphology and impaired insulin secretion, indicating that it is an important
et al., 2014).
aristaless-related homeobox gene (Wilcox et al., 2013). In the embryonic mouse
pancreas, Arx
overexpression of Arx et
al. et
al.
(PAX6) and forkhead box A2 (FOXA2; Figure 1.5) are essential for glucagon production
and secretion (Gosmain et al., 2011; Heddad Masson et al., 2014; van der Meulen &
Huising, 2015)
Figure 1.5.
regulation by transcription factors.
1.6.2 Fetal islet growth and development
In the normal developing human fetus, small clusters of endocrine cells multiply around
25% of gestation (10 weeks) and the islet structure matures in the third trimester
(Fowden & Hill, 2001). This is a similar time frame to that found in the ovine fetus, where
primitive islets are formed by 33dGA or 23% of gestation (Green et al., 2010). In the
rodent however, islets do not form until 78% of gestation (Jensen 2000). For most of
weeks of gestation. Detection of pancreatic insulin occurs at around 10 weeks of
gestation (Reddy & Elliott, 1988; Fowden & Hill, 2001). In the ovine fetus at 40-45dGA,
insulin is the predominant hormone expressed in the endocrine cell population of the
pancreas (Reddy et al., 1988).
insulin secretion in parallel with cell number (Fowden & Hill, 2001). In contrast, in
rodents, endocrine cells are mitotically quiescent until just before term (Green et al.,
however, during the last 8 weeks of gestation and in the first 8 weeks of postnatal life,
there is a wave of apoptosis in pancreatic islets during which new cells are generated by
neogenesis. This is known as the period of remodelling (Kassem et al., 2000). The same
period of remodelling is also seen in rodents, and takes place at 2-3 weeks of postnatal
age around the time of weaning (Hill et al., 2000). The mechanisms controlling islet
apoptosis are undefined but in rodents, it is associated with a decrease in circulating
IGF-II levels (Hill et al., 2000).
show appropriate responses to fluctuations in blood glucose in utero (Otonkoski et al.,
secretion, in response to insulin demand. This may be achieved by altering secretory
humans, the percentage of pancreatic islets is correlated to birth weight and in small-
for-gestational age neonates, the percentage of islets is halved to 2% of pancreatic tissue
(van Assche & Aerts, 1979; Fowden & Hill, 2001). This suggests that adverse conditions
in utero may affect fetal pancreatic development.
Beta cell development has been shown to be controlled and affected by intrauterine
availability of growth factors and hormones (Figure 1.6). The fetal pancreas expresses
both IGF-I and IGF-II, which have mitogenic actions. In mice, genetic manipulation of
IGFs and their receptors leads to changes in pancreatic islet mass (Fowden & Hill, 2001).
(Figure 1.6), increased islet areas and reduced endocrine cell apoptosis (Petrik et al.,
1999). Mice deficient for the igfr1 and irs2 genes in a double knock out model show a
et al.
cell specific knockout of igfr1
associated with hyperinsulinaemia and glucose intolerance (Kulkarni et al., 2002). This
Figure 1.6.
a balance between replication, growth and apoptosis. Transcription factors such as PDX1,
Disruption of the IRS proteins has been shown to affect the growth and development of
the pancreas. Loss of Irs2
type controls (Withers et al., 1998). Subsequent immunohistochemical labelling for IRS2
revealed its localisation to the ductal epithelium, the site of islet neogenesis, indicating
that IRS2 may play an important role in proliferation (Withers et al., 1998; 1999).
Recently, it has been postulated that IRS2 may have more of a maintenance role in the
adult pancreas. Analysis of mice with pancreas-specific loss of Irs2
cell mass was no different to that of control mice at 2 weeks of age. By 12 weeks of age
however, the Irs2 et al., 2007).
Mice deficient for the S6K protein, an endpoint of the insulin pathway, have low
circulating insulin and are glucose intolerant; this was found to be due to a reduction in
similar to that seen in chronic type 2 diabetes (Pende et al., 2000).
Glucocorticoids are stress hormones produced by the adrenal gland which are
responsible for mobilising glucose into the circulation (Fransson et al., 2013), and appear
et al., 2011).
with glucocorticoid receptor gene knockout (Gesina et al., 2006). At an earlier embryonic
fractions were similar to that in normal mice, suggesting that there is a specific time at
which the pancreas becomes glucocorticoid sensitive (Gesina et al., 2006).
Additionally, the hormone leptin, secreted by adipocytes, has previously been found to
fetal and adult rat islets, and also in cultured insulinoma cells in vitro (Kieffer et al., 1996;
Islam et al., 1997; Kulkarni et al., 1997). Addition of leptin to isolated fetal rat islets has
in vitro (Islam et al., 2000). In contrast to
mice with a pancreas-specific knockout of the leptin receptor (Covey et al., 2006;
Morioka et al.
be established.
There is limited knowledge on the effects of thyroid hormones on development of
thyroid hormones by D3 near term is required for normal maturation of the pancreas
(Medina et al., 2011). There may be specific temporal changes in thyroid hormone
activity locally that regulate pancreas development before birth. Neonatal rats which
are hypothyroid and growth retarded due to maternal hypothyroidism have been shown
to have reduced insulin secretion and impaired glucose tolerance (Karbalaei et al.,
cell mass between normal and hypothyroid rats (Karbalaei et al., 2014).
The majority of these previous studies are limited in the use of rodents as an
experimental model. It is possible that humans and larger mammals may have a
different developmental pattern in the pancreas as they are a precocial species i.e. they
are more physiologically mature at birth. Limesand et al. (2005) studied an ovine model
of IUGR and found that pancreatic islet size and insulin content are lower in growth
restricted fetuses compared to controls. However, this study used growth restricted
fetuses generated by elevating the environmental temperature of the ewe. Although
increasing maternal temperature can reduce the plasma concentrations of cortisol and
thyroid hormones in the fetus, it is not sufficient to induce fetal hypothyroidism (Wallace
et al., 2005). The effect of hypothyroidism on fetal islet development in a precocious
animal model remains unknown.
1.7 Adipose tissue growth and development
Insulin secretion in utero is essential for normal growth and development of the fetus,
especially in tissues highly sensitive to insulin such as adipose tissue. Adipose tissue is
an endocrine organ composed predominantly of adipocytes. The main physiological role
of adipose is to store glucose in the form of triglycerides for future energy expenditure,
and in the fetus, adequate adipose tissue growth is required for thermoregulation as a
newborn. In addition to energy storage, adipose is important for secretion of a variety
of active peptides, known as adipokines, which can act in both a paracrine and endocrine
manner (Kershaw & Flier, 2004). Leptin is one such hormone secreted by adipose tissue
which has an important role in energy homeostasis by serving as metabolic signal of
energy sufficiency to the hypothalamus and other tissues (Ahima & Flier, 2000).
In mammals, adipose tissue is distributed unevenly throughout the body. Subcutaneous
adipose is found under the skin, primarily in thighs and in the trunk. Visceral adipose,
however, includes the mesenteric, pericardial and perirenal (Sarr et al., 2012). Visceral
adipose depots have been shown to correlate with the development of insulin
resistance, while subcutaneous does not (Bjorndal et al., 2011). For large precocious
mammals, the majority of fat deposition occurs in the final third of gestation; in the fetal
sheep, at least 80% of adipose tissue is perirenal, which is located around the kidneys
(Symonds et al., 2003). Additionally, perirenal adipose tissue is known to contain both
white and brown adipocytes (Symonds et al., 2012). Perirenal adipose tissue (PAT) is
therefore a useful tissue to examine how insulin signalling and thyroid hormone regulate
growth.
1.7.1 Adipose development in utero
Adipose tissue first appears in human fetuses at 16 weeks of gestation (Poissonnet et
al., 1983) and in the sheep fetus at around 80dGA (Symonds et al., 2012). In mammals,
adipocyte differentiation is controlled by a network of transcription factors (Poissonnet
et al., 1983). The gene zinc finger protein-423 (ZFP423; Figure 1.7) has been identified
as an essential determinant of pre-adipocyte commitment from mesenchymal precursor
cells and is required for normal adipogenesis (Gupta et al., 2010). Downstream of
ZFP423, the transcription factors Kruppel-like factors 4, 5 and 6 (KLF4-6), sterol
regulatory element-binding transcription factor 1 (SREBP-1) and CCAAT-enhancer-
(Stephens, 2012).
et al.,
adipocyte fatty acid binding protein, lipoprotein lipase, GLUT4 and PEPCK (Leonardini et
al., 2009). Pre-adipocytes can differentiate into mature adipocytes throughout life, thus
enabling hyperplastic expansion when increased lipid storage is needed. In situations of
overnutrition, adipocytes can also become hypertrophic (Coelho et al., 2013).
There are two different types of adipocytes, white and brown. White adipocytes make
up white adipose tissue (WAT) and are leptin immunoreceptive; around 90% of their
volume consists of a single large lipid droplet and the nucleus is pushed to the edge of
the cell. These white adipocytes are termed unilocular or UL (Cinti, 2012). In brown
adipose tissue (BAT), the adipocytes contain several smaller lipid droplets (multilocular,
Figure 1.7. Diagram showing adipocyte differentiation and its regulation by transcription factors.
The transcription factor ZFP423 determines mesenchymal precursor cells to a pre-adipocyte cell
C/EBP: CCAAT-enhancer-binding proteins, SREBP-1: sterol regulatory element-binding
ML) and are characterised by a large number of mitochondria (Clarke et al., 1997;
Symonds et al.
differentiation and maturation, they arise from different origins (Figure 1.8). It has been
shown that brown adipocytes originate from myogenic factor-5 (Myf5) expressing
precursor cells, while white adipocytes arise from Myf5-negative mesenchymal
precursor cells (Seale et al., 2008; Sarjeant & Stephens, 2012).
Figure 1.8. Diagram showing brown and white adipocyte differentiation and the
transformation of white into brown-like beige cells. Brown adipocytes are thought to derive
from Myf5 expressing mesenchymal precursor cells. The transcription factor PRDM16 has
been shown to regulate brown adipocyte development and can “brown” white adipocytes to
myogenic factor 5, PRDM16: positive regulatory domain containing-16.
The transcription factor, positive regulatory domain containing-16 (PRDM16), has been
shown to control development of brown adipocytes, and is responsible for the
“browning” of some white adipocytes to form beige cells, as shown in Figure 1.8
(Sarjeant & Stephens, 2012; Harms & Seale, 2013). Beige cells can be found within WAT
in both human and rodents in adult life, and development of these cells from white
(Seale et al., 2008; Harms & Seale, 2013).
1.7.2 Hormonal control of fetal adipose growth
As gestation progresses, total adipose mass in the fetus continues to increase towards
term and it comprises of both white and brown adipocytes (Clarke et al., 1997; Symonds
et al., 2003). In the sheep fetus during mid-gestation, adipose tissue is largely composed
of WAT which is laid down first and when the fetus begins to mature in late gestation,
the BAT becomes more dominant (Devaskar & Anthony, 2002). By 30 days of post-natal
life, the multilocular BAT has declined, and the fat is mainly composed of unilocular WAT
(Symonds et al., 2012).
Insulin is a potent growth factor in fetal adipose tissue. Insulin and IGF-I receptors have
been identified in relatively large quantities in brown adipocytes isolated from fetal rats
and binding of the hormones to their receptors occurs with high affinity (Teruel et al.,
1996). Mice with an adipose-specific deletion of InsR, have decreased body weight and
fat mass indicating that insulin is essential in adipose development (Bluher et al., 2002).
The effects of insulin on fetal adiposity can be seen in pregnant women who are
hyperglycaemic with gestational diabetes and who give birth to large-for-gestational age
babies (Kamana et al., 2015). These babies are macrosomic as hyperglycaemia in utero
stimulates fetal insulin secretion which, in turn, promotes somatic, especially adipose
tissue, growth (Stevens et al., 1990). In a model of IUGR in fetal sheep induced by
placental restriction, plasma insulin concentrations are reduced and this is correlated
with a decrease in fetal PAT mass (Duffield et al., 2008).
The hormone leptin is synthesised and secreted by white adipocytes (Forhead &
Fowden, 2009). It has previously been shown in fetal sheep that adiposity correlates
with plasma leptin concentrations (Mühlhäusler et al., 2002), leading to speculation that
leptin itself has a role in the maintenance of fat mass before birth. Administration of
leptin to sheep fetuses in late gestation had no effect on overall PAT mass, but reduced
the proportion of UL adipocytes and increased the proportion of ML cells (Yuen et al.,
2003). This suggests that leptin has an important role in regulating the balance of UL and
ML adipocyte types.
There are limited reports concerning the effects of thyroid hormones on adipose growth
in utero
brown adipocytes, and during differentiation, the binding capacity of T3 to either TR
have lower body weight than wild-type mice which is associated with decreased WAT
mass, suggesting that thyroid hormones play a role in white adipocyte differentiation,
et al., 2007).
1.7.3 Hormonal control of fetal adipose function
One major function of fetal WAT is the production of leptin and it has previously been
reported that this process can be regulated by insulin. Insulin infusion in fetal sheep
increases leptin mRNA in WAT, demonstrating that insulin can stimulate production of
leptin (Devaskar & Anthony, 2002). This has also been reported in vitro in isolated rat
adipocytes, where insulin stimulates an 80% increase in the secretion of leptin (Barr et
al., 1997). In fetuses of well-fed ewes, plasma insulin concentrations are increased and
this is correlated with plasma leptin concentrations (Mühlhäusler et al., 2002). Insulin
promotes the synthesis of lipids through lipogenesis by an increase in transcription of
the genes encoding acetyl-CoA carboxylase and fatty acid synthase (Kersten, 2001).
These lipogenic genes are regulated by SREBP-1, which is stimulated by factors
downstream of insulin and PI3K in the insulin signalling pathway (Saltiel & Kahn, 2001).
Insulin also promotes the storage of glucose in adipocytes by stimulating the
translocation of GLUT4 to cell membranes via the insulin signalling pathway (Saltiel &
Kahn, 2001).
In the fetus, BAT is essential for thermoregulation after birth as it expresses the unique
uncoupling protein, UCP1, which promotes the rapid generation of heat (Mostyn et al.,
2003; Cinti, 2012; Symonds et al., 2012; Pope et al., 2014). Uncoupling proteins are
mitochondrial inner membrane proteins which can increase the permeability of the
mitochondrial membrane allowing protons to return to the mitochondrial matrix. Heat
is generated by uncoupling oxidative phosphorylation from ATP production in the
respiratory chain. This process is known as non-shivering thermogenesis (Nedergaard et
al., 2001). It has previously been postulated that thyroid hormones stimulate the
appearance of BAT and UCP1 in the fetus near term. Polk et al. (1987) showed that
thyroidectomy in the sheep fetus results in hypothermia in the new born lamb and in a
decrease in plasma free fatty acids, which are normally released in association with BAT
thermogenesis. Additionally, it has been identified that there is a peak in D2 mRNA
expression in fetal PAT close to term, which provides a site for local T3 production and
activity (Clarke et al., 1997; Pope et al., 2014). Consequently, transgenic mice with D2
deletion have severe defects in thermogenesis due to a reduction in UCP1 of 50% (Hall
et al., 2010). In fetal rat adipocytes in culture, Guerra et al. (1996) demonstrated that
the presence of T3 in media significantly increased UCP1 mRNA levels and that this was
due to increased gene transcription. Consistent with this finding, Rabelo et al. (1995)
identified, in a brown fat cell line, that T3 stimulates the UCP gene by acting on up-
stream TREs positioned on the gene.
The abundance of UCP1 in fetal adipose tissue is also closely related to the elevation in
circulating cortisol before birth and a functional adrenal gland is essential for the
developmental increase in PAT UCP1 expression (Mostyn et al., 2003). In fetal sheep,
UCP1 protein expression in PAT is positively correlated with both plasma T3 and cortisol
(Mostyn et al., 2003). Therefore, the extent to which cortisol alone, or in parallel with
T3, affects BAT development in late gestation remains to be determined.
1.8 Renal growth and development
The prepartum rise in T3 may also influence the growth and maturation of the fetal
kidneys as it has previously been shown in the sheep fetus that hypothyroidism in utero
increases relative kidney mass (Chattergoon et al., 2012a). The main role of the adult
kidney is to maintain electrolyte and water balance and to excrete waste through
nephrons. In the fetus, fluid homeostasis is maintained primarily by the placenta.
However, the fetus starts to produce urine early on in gestation which is the main
component of amniotic fluid (Guron & Friberg, 2000).
1.8.1 Kidney growth in utero
The kidney is derived from three embryonic structures: the pronephros and
mesonephros, which appear early in gestation and then regress, and the metanephros,
which will differentiate into the kidney (Guron & Friberg, 2000). In humans,
development of the kidneys begins early in gestation, at around 4 weeks, with the final
number of nephrons formed by 36 weeks (Blackburn, 2003b). In the ovine fetus, the
pattern of renal development is similar to that of humans, as nephrogenesis ends at
around 130dGA, when the number of nephrons will persist into adulthood (Gimonet et
al., 1998; Wintour et al., 2003; Figueroa et al., 2005). Rodents differ from this pattern of
development in that nephrogenesis begins at mid-gestation and continues until 10 days
after birth (Guron & Friberg, 2000).
Several experimental studies have reported that growth restriction in utero results in
reduced nephron number (Zimanyi et al., 2000; Mitchell et al., 2004). In twin sheep
fetuses, which are an example of natural in utero growth restriction, both the relative
kidney mass and total nephron number are lower than that seen in single fetuses
(Mitchell et al., 2004; MacLaughlin et al., 2010). In a model of IUGR induced in fetal
sheep by placental embolism nephron number was unchanged, although relative kidney
mass was reduced in late gestation (Mitchell et al., 2004). Intrauterine growth restriction
due to twinning reduces nephron endowment, whereas IUGR in late gestation does not,
indicating that the timing of growth restriction in gestation contributes to renal
development.
1.8.2 Hormonal control of fetal renal growth
Regulation of fetal renal growth may be influenced by several hormonal factors,
including insulin. In the fetal mouse kidney, InsR protein and mRNA are present in the
whole metanephros from 13dGA (~60% gestation) until birth, when InsR expression
declines in newborns (Liu et al., 1997). Additionally, metanephros isolated from fetal
mice respond to insulin in culture in a dose-dependent manner and exhibit hyperplasia
and hypertrophy (Liu et al., 1997), suggesting that insulin has a potential role in
nephrogenesis. Insulin-like growth-factor I has also been implicated as a potent growth
stimulus in the developing kidney (Marsh et al., 2001). In the sheep fetus, there is a
positive relationship between renal IGF-I mRNA abundance and relative kidney weight
(Lok et al., 1996; Marsh et al., 2001; MacLaughlin et al., 2010), and intravenous infusion
of IGF-I causes a substantial increase in kidney mass (Lok et al., 1996; Marsh et al., 2001).
Changes in the insulin-IGF signalling pathway have been demonstrated to affect kidney
mass. In a transgenic mouse model of renal Irs2 deletion, neonatal kidneys are reduced
in size and remain smaller in aged mice compared to same age controls (Carew et al.,
2010). Quantification of the glomeruli number indicated no change in glomeruli density,
suggesting that there is an overall reduction in kidney size affecting all of the
components of the organ. It may be hypothesized that the insulin pathway may not be
required for nephrogenesis specifically, but may be important for overall organ growth
(Carew et al., 2010).
Leptin has also been implicated in the control of growth in the developing kidney.
Neonatal rats treated with a leptin antagonist have decreased kidney mass but an
increased number of glomeruli, however, these appeared to be smaller and more
immature compared to those in control animals (Attig et al., 2011). Leptin, therefore,
may have a role in nephron branching and glomerular maturation.
The renin-angiotensin system (RAS) is an important regulator of nephrogenesis
(Blackburn, 2003b). Angiotensin II is the main effector of the RAS system and in humans
and sheep, angiotensin II exerts its effects via two main receptors (Chen et al., 2004),
type 1 and 2 (AT1R and AT2R). Changes in the fetal RAS at specific time points during
gestation can program changes in the developing kidney. For example, fetal sheep
infused with a AT1R antagonist have reduced kidney weights (Forhead et al., 2011) and
human neonates exposed to inhibitors of the RAS cascade during gestation demonstrate
renal dysplasia (Cooper et al., 2006).
The activity of the renal RAS increases developmentally towards term alongside plasma
cortisol and T3 concentrations and in the sheep fetus, renal activities of D1 increase, and
D3 decrease, towards term (Polk et al., 1988; Forhead et al., 2006), suggesting that
thyroid hormone exposure and action increase in the fetal kidneys during late gestation.
Experimental thyroidectomy in the fetal sheep leads to a decrease in renin mRNA, total
renin and AT1R mRNA in the kidney and these changes are normalised when thyroid
hormone replacement is administered (Chen et al., 2005b; 2007). Indeed, it has been
identified in vitro that the 5’ flanking DNA sequence in the promoter of the renin gene
contains a TRE (Kobori et al., 2001). Although the effects of fetal hypothyroidism on the
renal RAS have been examined, the consequence of thyroid hormone deficiency for the
structure of the developing kidney remains unknown.
1.8.3 Hormonal control of fetal renal function
Renal sodium (Na+) reabsorption requires coordinated expression of apical and
basolateral channels in the tubules (Figure 1.9). The epithelial Na+ channel (ENaC) and
the sodium/potassium ATPase (Na+/K+ ATPase) in the kidney contribute to the
regulation of body salt and water homeostasis and blood pressure (Bhalla & Hallows,
the rate limiting step in assembly of the whole ENaC complex (Bhalla & Hallows, 2008).
In the fetal rat, ENaC transcripts are expressed primarily in the apical plasma membrane
of the distal tubules and the collecting ducts of the kidney, and increase in abundance
in the final 3-4 days of gestation (Watanabe et al., 1999). Several endocrine factors may
be responsible for this developmental increase in ENaC towards the end of term.
The Na+/K+
subunit (Horowitz et al., 1990). The pump plays a vital role in renal reabsorption by
transporting Na+ out of the cell and K+ into the cell against their concentration gradients
in an ATP dependent manner (Figure 1.9) and establishes a sodium gradient for a variety
of secondary active transport systems (Féraille et al., 1999).
Glucocorticoids are known to have an influence on renal ion transporters in utero.
Glucocorticoid receptor mRNA is expressed from 80dGA in the renal cortex of fetal
sheep and continues to increase towards term, when it decreases post-natally (Keller-
Wood et al., 2008). Fetuses born to ewes treated with dexamethasone or cortisol have
increased renal mRNA expression of ENaC and Na+/K+ ATPase compared to controls in
late gestation (Moritz et al., 2011). As the thyroid hormones also increase in the
circulation towards term in parallel with cortisol, and in response to glucocorticoid
treatment, they may also have a role in increasing ENaC expression to prepare the fetus
for neonatal life.
Another hormone which may regulate ENaC is insulin. In an epithelial cell line, it has
been shown that ENaC expression is upregulated by the serine-threonine kinase, under
Figure 1.9. Diagram showing sodium reabsorption in a renal tubule cell. Epithelial sodium
channels (ENaC) facilitate Na
the distal nephron. At the basal membrane the Na+/K+ ATPase pump transports Na+ out
of the cell and K+ into the cell against their concentration gradients in an ATP dependent
manner.
stimulation of PI3K through the insulin signalling pathway (Wang et al., 2001).
Furthermore, chronic hyperinsulinaemia in vivo in rats increases ENaC trafficking to the
apical membrane (Song et al., 2006). Previously, angiotensin II has also been shown to
regulate ENaC. In adult rats infused with an AT1R blocker, decreases in ENaC mRNA and
protein abundance are observed in the proximal tubules. This decrease was reversed
after an infusion of angiotensin II (Beutler et al., 2003). As the thyroid hormones have
previously been reported to regulate the fetal renal RAS (Chen et al., 2005b; Chen et al.,
2007), it may be possible that hypothyroidism can alter the expression of the ENaC and
therefore affect Na+ and water reabsorption in the developing kidney.
It has been well established that the thyroid hormones regulate the Na+/K+ ATPase pump
in adult life. Previous experimental studies have shown increased Na+/K+ ATPase mRNA
abundance in the kidney of hypothyroid rats injected with T3 (McDonough et al., 1988).
Further to this, in adult rat kidney cortex, hypothyroidism did not change the mRNA
(Horowitz et al.
subunit (Feng et al., 1993). Interestingly, when the protein levels of each subunit were
et
al., 1990). This suggests that the thyroid hormones can also act post-transcriptionally to
regulate the pump.
Insulin has also been implicated in the regulation of Na+/K+ ATPase. In the isolated
tyrosine residue (Féraille et al., 1999). The insulin receptor stimulates tyrosine
phosphorylation after insulin binding, making the insulin receptor a candidate for
phosphorylation of the Na+/K+ +
channels and transporters focuses on adult physiology, it may be plausible that the same
processes occur in utero. The maturation of the transporters may be influenced by both
insulin and the thyroid hormones, in addition to cortisol. Thus, there is potential for
thyroid hormone deficiency to alter the expression patterns of the ENaC and Na+/K+
ATPase directly and indirectly through the insulin signalling pathway.
1.9 AIMS
The thyroid hormones are responsible for growth and maturation in many fetal organs,
such as the heart, lungs, brain and muscle. There is limited knowledge however, on the
role of T3 and T4 in the growth and development of other important metabolic organs,
namely the pancreas, adipose tissue and kidney. Furthermore, insulin signalling has
been proposed to be an important regulatory pathway in tissue growth and
development in utero, but their interactions with the thyroid hormones in late gestation
are unknown.
The overall aim of the project is to elucidate the effects of hypothyroidism on the growth
and development of the sheep fetus in late gestation. The specific objectives are to
identify the effects of thyroid hormone deficiency in utero on (1) the development of
fetal pancreatic islets and (2) insulin signalling pathways in the sheep fetus, in particular
in adipose tissue and the kidneys.
The hypothesis is that growth retardation in the hypothyroid sheep fetus is a result of a
downregulation of cellular markers of the insulin signalling cascade in fetal tissues
(Figure 1.10).
Figure 1.10. It is proposed that thyroid hormone deficiency in utero leads to decreased
downregulation of components of the insulin signalling cascade in fetal tissues such as
adipose and kidney, thus compromising fetal growth.
2. MATERIALS ANDMETHODS
2.1 Sheep husbandry
All surgical and experimental procedures were carried out in accordance with UK Home
Office legislation and the Animals (Scientific Procedures) Act 1986. Unless where stated
otherwise, 38 twin Welsh mountain sheep fetuses were used in this study, 15 were
female and 23 were male. The nineteen pregnant ewes were maintained with 200g/day
concentrates, hay and water ad libitum with access to a salt block. For 18-24 hours
before surgery, food was withheld from ewes, with access to water still available.
2.1.1. Surgical procedures
All surgical procedures were carried out under halothane anaesthesia with positive
pressure ventilation (1.5% halothane in O2-N2O). At 105-110 dGA, where term is 145 ± 2
days, in each ewe, one twin fetus underwent a sham operation in which the thyroid
gland was exposed (sham), and the other twin underwent a thyroidectomy (TX), as
described by Hopkins and Thorburn (1972). The scheme of work is outlined in Table 2.1.
The fetal head was delivered through an incision in the uterus and fetal membranes. The
fetal thyroid gland was removed through an incision from the laryngeal cartilage to
approximately the 10th tracheal ring. The gland was dissected from surrounding
connective tissue using a cautery probe. Prophylactic antibiotics were administered to
the fetus and the ewe at surgery, and to the ewe for three days after.
2.1.2 Post mortem procedures
At either 129 or 143dGA, the fetuses were delivered by Caesarean section under general
anaesthesia (20mg/kg maternal body weight sodium pentobarbitone I.V.). At delivery,
10ml blood samples were collected by venepuncture of the umbilical artery into EDTA-
containing tubes and spun at 1000g for 5 minutes at 4°C. The plasma was stored at -
20°C. The fetuses were weighed and biometric assessment was carried out (detailed in
Section 3.2). The absence of the thyroid gland was confirmed in the TX fetuses. Various
tissues were collected from the fetuses after the administration of a lethal dose of
barbiturate (200 mg/kg body weight sodium pentobarbitone). Tissues were weighed
and either fixed in 4% formalin or frozen in liquid nitrogen and stored at -80°C.
Table 2.1. Number and gestational ages of fetuses in each experimental group
of the study
Treatment group Age at surgery (dGA) Age at collection
(dGA)
Number of fetuses
(male:female)
Sham 105-110 129 9 (5:4)
105-110 143 9 (6:3)
TX 105-110 129 10 (6:4)
105-110 143 10 (6:4)
2.2 Hormone measurements
2.2.1 T3 and T4
Plasma T3 concentrations were measured using a radioimmunoassay (RIA) kit with
rabbit monoclonal anti-T3 serum (MP Biomedicals, Loughborough, UK) validated for
sheep plasma (Fowden & Silver, 1995). The RIA is a competition based assay in which
radioactively labelled and unlabelled T3 antigens compete for binding sites on antibody
coated tubes. As the amount of unlabelled antigen increases in the plasma samples,
more of it can bind to the antibodies and so displaces the labelled variant. Therefore the
level of radioactivity bound is inversely related to the plasma T3 concentration. After
incubation, the unbound and bound fractions are separated and the radioactivity of the
coated tubes is quantified. The RIA uses the radioactive isotope iodine-125 (125I; 10μCi
in total) in phosphate buffer as the tracer solution.
All plasma samples were analysed in duplicate alongside a charcoal-stripped fetal
plasma sample (plasma stripped of hormones). Standards and samples (100μl) were
added to the coated polypropylene tubes followed by the addition of 1ml tracer solution
and mixed well. All the tubes were left to incubate for one hour in a water bath at 37°C.
After incubation, all tubes were decanted and emptied of their contents and were
washed with distilled water (dH2O). After blotting dry, the radioactivity was counted for
one minute using a gamma counter (Hewlett Packard, Bracknell, UK). Concentration of
T3 was determined by interpolation from the standard curve and the concentration of
the stripped plasma was deducted from all the results. All samples were measured in
one RIA kit and the intra-assay coefficient variation was 2.86% (n=10). The minimum
level of detection was 0.067ng/ml.
Plasma T4 concentrations were measured using a RIA kit with mouse monoclonal anti-
T4 serum (MP Biomedicals) validated for sheep plasma (Fowden & Silver, 1995). All
plasma samples were analysed in duplicate alongside charcoal-stripped fetal plasma.
Standards and samples (25μl) were added to the coated polypropylene tubes followed
by the addition of 1ml tracer solution (125I; 9μCi in total) and mixed well. All the tubes
were left to incubate at room temperature for one hour. After incubation, the contents
of the tubes were decanted and blotted dry. After blotting, the radioactivity was
counted for 0.5 minutes using a gamma counter. The concentration of T4 was
determined by interpolation from the standard curve and the concentration of the
stripped plasma deducted from each reading. All samples were analysed in the same kit
and the intra-assay coefficient variation was calculated to be 5.35% (n=10). The
minimum level of detection was 7.6ng/ml.
2.2.2 Insulin
Plasma insulin concentrations were determined using an ovine specific enzyme-linked
immunosorbent assay (ELISA; Mercodia, Uppsala, Sweden). The ELISA uses a direct
sandwich technique in which insulin in the plasma reacts with peroxidase conjugated
mouse monoclonal anti-insulin antibodies that coat the wells of a plate. This bound
conjugate is detected by a reaction with 3,3’-5,5’-tetramethylbenzidine (TMB), which is
light sensitive. The reaction is stopped by the addition of acid, providing a colorimetric
endpoint to be read spectrophotometrically. The intensity of the colour change is
directly proportional to the concentration of plasma insulin.
Enzyme conjugate solution and buffer solution were diluted in dH2O to produce working
solutions. Duplicates of ovine standards (0-3.0μg/L) and samples (25μl) were transferred
into a 96-well plate coated with anti-insulin antibodies. Enzyme conjugate was added
and the plate shaken at 1.6g for 2 hours at room temperature. A series of five washes
was carried out using wash buffer avoiding prolonged soaking of the wells. Substrate
TMB was added to each well and incubated at room temperature for 15 minutes. To
stop the reaction, 0.5M sulphuric acid was added. The optical density was read at an
absorbance of 450nm on a plate reader (Biorad, Hemel Hempstead, UK). Plasma insulin
concentration was calculated from regression of the standard curve. All samples were
measured in one kit and the intra-assay coefficient of variation was 9.3% (n=10). The
minimum level of detection was 25ng/L.
2.2.3 Cortisol
Plasma cortisol concentrations were determined using an ELISA kit for human serum (IBL
International, Hamburg, Germany). The cortisol ELISA is based on the competition
principle. An unknown concentration of cortisol present in the plasma and a fixed
amount of enzyme labelled cortisol compete for the binding sites of rabbit polyclonal
anti-cortisol antibodies that coat the wells of the plate. The enzyme substrate contains
cortisol conjugated with horseradish peroxidase (HRP). After the substrate reaction, the
intensity of the developed colour is inversely proportional to the amount of cortisol in
the sample. The range of cortisol concentrations in the fetal plasma was at the low end
of the standard curve and so the plasma samples were concentrated before the assay.
Ethanol (1.5ml) was added to 100μl plasma sample, mixed and left to incubate for 30
minutes at room temperature. Samples were centrifuged for 15 minutes at 850g at 4°C.
Supernatant was transferred into Eppendorf tubes and dried down using a Speedvac
vacuum concentrator (Thermo Scientific, Loughborough, UK) for 50 minutes. The dried
residue was resuspended in 25μl assay buffer from the kit and incubated at 4°C
overnight.
Duplicates of standards and samples (20μl) were transferred into the antibody-coated
96-well plate with the addition of enzyme conjugate. The plate was mixed for 10 seconds
and incubated at room temperature for 1 hour. The plate was washed three times with
wash buffer. TMB substrate was added to each well and gently shaken. A stop solution
of 0.5M sulphuric acid was added and after 30 minutes the optical density read at
450nm. Plasma concentrations were calculated by interpolation of the standard curve,
and multiplied by 0.5 to account for the concentration of the original sample. Two
control standards of known concentrations were run in duplicate and the final
concentrations were in the accepted ranges. All samples were measured in one kit and
the intra-assay coefficient of variation was 8.6% (n=5). The minimum level of detection
was 2.46ng/ml.
2.2.4 Leptin
Plasma concentrations of leptin, IGF-I and IGF-II were measured by RIA by Dr Dominique
Blache at the School of Animal Biology, University of Western Australia.
Plasma concentrations of leptin were determined by RIA using antibodies raised against
biologically active recombinant bovine/ovine leptin raised in emu (Greenwood et al.,
1963; Blache et al., 2000). Triplicates of standards (bovine/ovine leptin) and duplicates
of unknown samples were analysed by the addition of emu polyclonal anti-bovine/ovine
leptin (1:500) and normal emu serum (1:500). Following incubation overnight at 4°C,
125I-bovine/ovine leptin (4.5μCi total) was added and samples were incubated for 48
hours at 4°C. For precipitation of the antibody-antigen complex, sheep anti-emu
immunoglobulin G (IgG; 1:12) was added to the samples, followed by further incubation
for 48 hours at 4°C. Following the addition of 0.01M phosphate buffered saline (PBS)
and 3% polyethylene glycol, the samples were spun at 2000g for 30 minutes. This was
to improve the stability of the pellet. The supernatant was decanted and pellets left to
dry. Radioactivity was counted on a gamma counter and the minimum level of detection
was 0.09ng/ml. The intra-assay coefficient of variation was 5.7%.
2.2.5 IGF-I and IGF-II
Plasma concentrations of IGF-I and IGF-II were determined by RIA as described by
Forhead et al. (2011). To avoid interference by the IGF binding proteins, IGFs were
extracted by the acid-ethanol cryoprecipitation method developed by Breier et al.
(1991). Plasma samples were mixed with acid-ethanol, containing 87.5% ethanol and
12.5% 2M hydrochloric acid to a ratio of 1:4 and incubated for 30 minutes at room
temperature. Samples were spun at 3000g for 30 minutes at 4°C to obtain a pellet of
precipitated IGF protein. A second precipitation was obtained by decanting the
supernatant and neutralising with 0.855M Tris base at a ratio of 5:2. Samples were
stored at -20°C for 1 hour and then immediately centrifuged at 3000g at 4°C for 30
minutes.
Antibodies (rabbit polyclonal anti-human IGF-I, provided by the National Hormone and
Peptide Program, National Institute of Diabetes, Torrance, CA, USA, 1:15000; rabbit
polyclonal anti-human IGF-II, GroPep, Adelaide, Australia, 1:5000) were added to diluted
(1 in 10) samples and left to incubate at 4°C overnight. Tracer solution containing the
radioactively labelled IGF (125I, 5.4μCi total) and secondary antibody (donkey polyclonal
anti-rabbit IgG in normal rabbit serum, University of Western Australia, 1:20) was added,
and samples were incubated overnight at 4°C. A 6% polyethylene glycol buffer was
added to the samples and these were centrifuged at 1500g for 30 minutes at 4°C. The
supernatant was precipitated and the radioactivity of the precipitate was determined
respectively.
2.3 Histology
2.3.1 Wax embedding
Tissues were fixed in 4% formalin for 48 hours and rinsed in water before dehydration
through a series of graded industrial methylated spirits (IMS; 75, 90 and 100%). Tissues
were cleared in xylene and impregnated with paraffin wax. The samples were
transferred to a tissue embedding processor where the specimens were embedded in a
fresh paraffin wax block and left to solidify.
2.3.2 Sectioning
Paraffin wax blocks were sectioned on a semi-automated rotary microtome (Leica
Biosystems, Milton Keynes, UK). Sections were cut to the desired thickness using HP35
coated microtome blade (Thermo Scientific). Cut sections were gently placed onto dH2O
at 50°C to float and then manoeuvred onto a poly-l-lysine coated glass slide (Polysine,
VWR International, Litterworth, UK). The slide was left to dry on a heat block at 37°C.
2.3.3 Haematoxylin and eosin (H&E) staining
Haematoxylin is a basic dye and binds to acidic components in cells such as nuclear DNA
and stains them blue in colour. Eosin is an acidic dye; it binds to basic structures such as
cell cytoplasm and membranes, thus staining them pink.
Slides were de-waxed by submerging in xylene for 10 minutes followed by rehydration
through decreasing grades of IMS (100, 95, 70 and 50%) and finally dH2O. Slides were
immersed in Mayer’s haematoxylin (Sigma, Poole, UK) for 3 minutes, rinsed in dH2O and
differentiated in acid alcohol (containing hydrochloric acid in 70% IMS) to remove
background staining. To blue the nuclei, the sections were immersed in Scotts tap water
(containing sodium bicarbonate and magnesium sulphate) for 5 to 10 minutes. Slides
were rinsed again in dH2O, before staining in eosin (Sigma) for 1 minute. They were
washed briefly, no longer than one minute, in dH2O and dehydrated through increasing
concentrations of IMS (70, 95, 100%) and finally cleared in xylene. Slides were
permanently mounted using a mixture of distyrene, a plasticiser, dissolved in toluene-
xylene (DPX; Sigma) and coverslips. Sections were scanned using a NanoZoomer digital
slide scanner (Hamamatsu Photonics, Welwyn, UK) to create digital images for analysis.
2.4 Immunohistochemistry
Immunohistochemistry is a method which identifies protein distribution in tissues of
interest. It provides a visual observation to complement protein assays such as ELISA
and molecular biology techniques. Immunolabelling the protein of interest is achieved
with antibodies that target the protein in the tissue section. The antibody-antigen
interaction is often visualised by the addition of an enzyme which conjugates to the
antibody. Binding of the enzyme to a substrate produces a coloured precipitate at the
cellular location of the protein.
2.4.1 Blocking
Sections were de-waxed in xylene for 10 minutes followed by rehydration through
decreasing percentages of IMS (100, 95, 70, 50%) and finally dH2O. Endogenous
peroxidase in the section was blocked by incubation in 3% hydrogen peroxidase (Sigma)
for 15 minutes. Sections were rinsed in running water and washed in PBS.
2.4.2 Antigen retrieval
When required, antigen retrieval was conducted after de-waxing and rehydration to
unmask antigens from formaldehyde bonds. In the presence of a high salt buffer, such
as citrate, cross-linkages between formalin and protein can be disrupted and broken
down by heating to temperatures of around 100°C. Heat retrieval was used with a 10mM
citrate buffer for the anti-proliferating cell nuclear antigen (PCNA) antibody. The slides
were placed in a pressure cooker and heated in a microwave at pressure for 2 minutes
(850W). Sections were left to cool and washed in PBS.
2.4.3 Antibodies
After peroxidase blocking and antigen retrieval (if required), all tissue sections were
drawn around with a hydrophobic pen to provide a barrier. To minimise non-specific
antibody binding, approximately 150μl of blocking solution (5% horse or goat serum in
2% bovine serum albumin (BSA) in PBS) was added to each section and incubated in a
humidified chamber for 1 hour at 4°C. The blocking serum used depended on which
species the primary antibody was raised. After rinsing in PBS, the sections were
incubated for either 1 hour at 37°C or overnight at 4°C with primary antibody diluted in
blocking serum. Blocking solution was used as a negative control. A biotinylated
secondary antibody (horse serum and mouse anti-IgG or goat serum and rabbit anti-IgG)
was added to create a secondary complex with the primary antibody and left to incubate
at room temperature for 1 hour and then washed in PBS.
2.4.4 Detection
Using the Vectastain Elite ABC kit (Vector Labs, Peterborough, UK), the ABC reagent
containing avidin solution and biotinylated HRP was added to each slide and incubated
for 30 minutes at room temperature, followed by washes in PBS.
The chromogen diaminobenzidene (DAB, SigmaFast DAB tablets, Sigma) is a peroxidase
substrate and was prepared by dissolving one DAB tablet and one urea hydrogen
peroxide tablet in 5ml of dH2O to provide a substrate solution containing 0.7mg/ml DAB,
2.0mg/ml hydrogen peroxide and 60mM Tris buffer. Substrate solution was added to
each slide for 1 minute to produce a brown colour change to localise the protein of
interest. To counterstain, the slides were incubated in pre-heated methyl green (Vector
Labs) at 60°C in an oven for 3 minutes. They were washed briefly in dH2O, for no longer
than one minute, and dehydrated through increasing concentrations of IMS (70, 90 and
100%) and finally cleared in xylene. Slides were permanently mounted using DPX and
coverslips. Sections were scanned using a NanoZoomer digital slide scanner to create
digital images for analysis.
2.5 Western blotting
2.5.1 Tissue homogenisation
To quantify various proteins in fetal tissues using western blotting, each tissue of
interest was first homogenised physically and chemically to break down tissue and cells.
Homogenisation buffer was prepared on ice and contained final concentrations of
20mM Tris-base, 1mM ethylene glycol tetraacetic acid, 0.01% Triton-X 100, 1mM
50mM sodium fluoride and a cocktail of protease inhibitors (Complete Mini, Roche,
Burgess Hill, UK). Frozen tissue was weighed at 100mg and homogenised in lysing matrix
tubes (MP Biomedicals) containing 1.4mm ceramic beads with 1ml of cold
homogenisation buffer using a handheld rotary homogeniser (SuperFastPrep-1, MP
Biomedicals) for 20 seconds at 400g. The samples were centrifuged at 14000g for 10
minutes at 4°C. Supernatant was transferred to fresh tubes and the extracted protein
lysate was stored at -80°C.
2.5.2 Protein assay
To determine the concentration of protein lysate, a bicinchoninic acid (BCA) protein
assay kit was used (Sigma). The assay relies on the formation of a copper (II) ion (Cu2+)-
protein complex under alkaline conditions, following the reduction of Cu2+ to Cu+. The
amount of reduction is proportional to the amount of protein present and can be
monitored by a colour change as BCA forms a purple-blue complex with Cu1+ in alkaline
environments. The BCA working solution was prepared by mixing 50 parts reagent A,
containing BCA, sodium carbonate, sodium tartrate and sodium bicarbonate, with 1 part
reagent B, containing 4% (w/v) Cu2+ sulphate pentahydrate. Five standards were
prepared from dilutions of 1mg/ml of BSA protein standard (0, 50, 100, 150, 200μg/ml).
Standards and samples (25μl) were run in duplicate on a 96-well plate. To the samples,
200μl BCA working solution was added and the plate was incubated for 30 minutes at
room temperature. The plate was read in a spectrophotometer at an absorbance of
490nm and a standard curve produced from which the protein concentrations of the
samples could be interpolated.
2.5.3 SDS-PAGE
The quantification of specific proteins was determined using sodium dodecyl sulphate
polyacrylamide gel electrophoresis (SDS-PAGE). Sodium dodecyl sulphate is an anionic
detergent which is used to denature proteins. Secondary and tertiary structures of
proteins are denatured by SDS, which confers its negative charge to the now linear
protein. This negative charge is proportionate to the length of the polypeptide. All
samples acquire a uniform charge so electrophoretic movement should depend entirely
on molecular size and the negatively charged protein samples are run through a
polyacrylamide gel towards the anode. The speed with which they travel is inversely
related to their size.
Protein lysates of known concentration were diluted to a concentrations of either 3 or
4μg/μl in a final volume of 25μl to give 75 or 100μg of protein per well. NuPage LDS
loading buffer (2% lithium dodecyl sulphate, 141mM Tris Base, 10% glycerol, 0.51mM
EDTA, 0.22mM Coomassie blue, 0.175mM phenol red; Thermo Scientific) was added to
each sample. To reduce the protein in the lysates, 2% fresh 100mM dithiothreitol (DTT;
Sigma) was added to each sample directly before heating at 70°C for 10 minutes.
Samples were loaded into a 7.5% pre-cast polyacrylamide gel (Biorad) alongside 5μl
molecular marker (Prism Ultra Protein Ladder 10-245 kDa, Abcam, Cambridge, UK). The
gel was run at 100V for 10 minutes to stack the proteins and then at 150V for 45 minutes
until the samples had run through the length of the gel.
2.5.4 Membrane transfer
After separation, the proteins were transferred to a microporous membrane for
immunoblotting. Using the application of an electric current, the proteins were
transferred to the membrane in the same pattern that they were separated by SDS-
PAGE. Transfer of the proteins to a polyvinylidene fluoride microporous membrane
(Immobilon P 0.45μm, Millipore, Sigma) was achieved using the Pierce G2 Fast Blotter
(Thermo Scientific). The gel and membrane were stacked between two layers of filter
paper soaked in high salt transfer buffer (Pierce 1-Step Transfer buffer, Thermo
Scientific). The stack was placed in the blotter and sandwiched between two plates
which were subjected to 11V, 1.3A for 7 minutes.
2.5.5 Ponceau S staining and blocking
Ponceau S staining of total protein was used as a loading control as described by
Romero-Calvo et al. (2010). After transfer, the membrane was washed in dH2O before
staining in Ponceau S (Sigma) for 8 minutes. The membrane was briefly washed in dH2O
and an image of the blot was captured using an imager (ChemiDoc, Biorad). The stain
was washed away using dH2O and the membrane was incubated in an appropriate
concentration of blocking buffer, consisting of non-fat dried milk (Marvel, Birmingham,
UK) or BSA (Sigma) in Tris-buffered saline with 20% Tween (TBST) for 1 hour at room
temperature on a roller.
2.5.6 Incubation with antibodies
After blocking, the membrane was incubated overnight at 4°C with the appropriate
primary antibody. The membrane was washed with TBST three times for 3 minutes. An
enhanced chemiluminescence (ECL) donkey anti-rabbit or sheep anti-mouse IgG HRP-
linked secondary antibody (GE Healthcare, Amersham, UK) at an appropriate dilution in
blocking buffer was incubated with the membrane for 1 hour at room temperature. The
secondary antibody used depended on the species from which the primary antibody was
raised. The membrane was washed again in TBST. Detection occurred after the
application of ECL substrate (Clarity Western ECL Substrate, Biorad) to the membrane
for 1 minute, which omitted light upon its reaction with the antibody complex forming
a visible band. The membrane was exposed in an imager (ChemiDoc, Biorad) and the
length of time of exposure differed between antibodies and tissues analysed.
Densitometry on the protein bands was carried out using Image Lab software (Biorad).
All of the samples were analysed across four gels which were run and transferred
together, to minimise variation. A single control sample was run on each of the gels and
the results of this control sample were used to standardise the values obtained from all
of the membranes. After densitometry and normalisation to total protein, the results
were standardised to the mean of the sham group at 129dGA. Results are therefore
expressed as fold changes in arbitrary units (au).
2.6 Statistical analysis
All values are expressed as mean ± standard error of the mean (SEM) unless otherwise
indicated. Statistical comparison between two groups was assessed by Students
unpaired t-test. When analysing groups with more than one factor, comparisons were
assessed using a two or three-way analysis of variance test (ANOVA), using treatment,
age and/or sex as factors, followed by the Tukey post hoc test (Sigmastat 3.5, Systat
Software, Chicago, USA). Correlations were assessed using linear regression. In all cases,
significance was accepted at P<0.05. Normality of data was assessed using the
Kolmogorov-Smirnov test prior to each statistical comparison (Sigmastat 3.5). If data
presented as non-normal, it was transformed into log10 and a normal distribution.
For the ovine studies in vivo, to achieve 80% power at the 5% significant level, a sample
size of 7 would be required to find a mean difference in plasma insulin concentrations
of 1.31ng/ml, assuming a standard deviation of 0.81ng/ml (Holleran & Ramakrishnan,
2003; Rosner & Rosner, 2010). This sample size determination is based on a t-test and a
standard deviation from previous studies examining the effects of dexamethasone
treatment on fetal glucogenic capacity (Franko et al., 2007). An additional two fetuses
were added to the cohort to account for fetal loss.
3 EFFECTS OF HYPOTHYROIDISM ON FETAL GROWTH AND PANCREATIC
ISLET DEVELOPMENT
3.1 Introduction
Thyroid hormones have an important role in fetal growth and maturation in utero.
Reduced fetal thyroid hormones concentrations have previously been reported in IUGR
in human and guinea pig models (Jones et al., 1984; Kilby et al., 1998). Hypothyroidism
in utero in humans and sheep can induce low birth weight and reduced body lengths
(Hopkins & Thorburn, 1972; LaFranchi, 2011). Fowden and Silver (1995) reported that
thyroidectomy in the sheep fetus in late gestation led to decreases in body weight and
crown-rump length. It has also been shown that thyroid hormones are important not
only in the control of overall body growth, but also in tissue-specific development.
Developmental abnormalities in the hypothyroid sheep fetus are seen in multiple
systems such as the skeletal system, the kidneys, and the heart (Finkelstein et al., 1991;
Lanham et al., 2011; Chattergoon et al., 2012a).
The actions of thyroid hormones on fetal growth and development may be direct and/or
indirect as thyroid hormones are able to influence other endocrine systems.
Thyroidectomy has previously been shown to change the availability of hormones and
growth factors in utero, such as leptin and the IGFs (Ramos et al., 1998; Iglesias et al.,
2001; Ramos et al., 2001; O'Connor et al., 2007). Insulin is a potent growth hormone in
the fetus (Taniguchi et al., 2006; Bloomfield et al., 2013), however, the role of the
islets of Langerhans before birth remains unknown.
The aims of the study were therefore to identify the effects of hypothyroidism induced
by fetal thyroidectomy on (1) the circulating concentrations of insulin, cortisol, leptin
fetal pancreas. Delivery of fetuses and collection of tissues took place at either 129 or
143dGA, to ascertain the effects of hypothyroidism over the period of the normal surge
in plasma T3 close to term. It was hypothesised that thyroid hormone deficiency in the
sheep fetus during late gestation causes growth retardation due to a decrease in
3.2 Methods
3.2.1 Animals
All animals, treatments and post mortem procedures are described in Section 2.1. Four
treatment groups were analysed: TX at 129dGA (n=9), sham at 129dGA (n=9), TX at
143dGA (n=10) and sham at 143dGA (n=10). After the collection of 10ml blood from the
umbilical artery into tubes containing EDTA, samples were centrifuged for 5 minutes at
1000g at 4°C. Plasma from the samples was extracted and aliquots stored at -20°C.
After the administration of a lethal dose of barbiturate (Section 2.1.2), each fetus was
weighed, the sex noted and measurements of fetal biometry performed, including
measurements of crown-rump length, abdominal circumference, limb lengths and organ
weights. Limbs were divided into hind leg and front leg regions. From the organ weights,
the percentage mass relative to the body weight of the fetus was calculated (organ mass
divided by fetal body weight and expressed as a percentage). The fetal pancreas was
collected and immersed in 4% formalin for wax embedding (Section 2.3.1).
3.2.2 Plasma hormone concentrations
Concentrations of T3, T4, insulin, cortisol, IGFs and leptin were measured in the plasma
aliquots. Plasma insulin, cortisol, T3 and T4 concentrations were determined by ELISA
and RIA using kits validated for ovine serum (Section 2.2). Plasma concentrations of IGF-
I, IGF-II and leptin were measured using RIA by Dr Dominique Blache, School of Animal
Biology, University of Western Australia as described in Section 2.2.
3.2.3 Pancreas stereology
Exhaustive pancreas sectioning
Wax embedded pancreases were sectioned using a rotary microtome according to the
methods described by Bock et al. (2003, 2005). To determine stereologically the fetal
thickness of 5μm.
With a random start between 1 and 100, every 100th section was sampled. The random
number read from a random number table was 84, and therefore sections 84, 184, 284,
384 etc. were sampled. The first section was counted from when the tissue was first hit
by the microtome blade. At least 10 evenly-spaced sections were required from each
pancreas. As every section was 5μm thick, it was calculated that there was a distance of
500μm between the sections (Figure 3.1). Cut sections were gently placed into a warm
water bath and then manoeuvred onto a poly-l-lysine coated glass slides (Section 2.3.2).
The slides were left to dry on a warm heat block.
Figure 3.1. A schematic diagram of exhaustive sectioning used in pancreas stereology. The
sections were collected from number 84 at intervals of 100 sections which equates to a
distance of 500μm apart.
Immunohistochemistry
Immunohistochemistry was used to localise insulin and glucagon containing cells as
described in detail in Section 2.4. Preliminary trials showed that an antigen retrieval step
was not required for either insulin or glucagon labelling. The blocking solution consisted
of 5% horse serum in 2% BSA in PBS.
Following blocking, sections were incubated with either a mouse monoclonal anti-
insulin antibody (1:1000 whole serum; Sigma) or a mouse monoclonal anti-glucagon
antibody (1: 1000 whole serum; Sigma) for one hour at 37°C. The blocking solution was
used on one section as a negative control. The secondary antibody consisted of a mouse
anti-IgG antibody in a vehicle solution containing horse serum in PBS (Section 2.4.3). The
method of detection is described in Section 2.4.4.
method used to estimate volume (Gundersen & Jensen, 1987; Howard & Reed, 2010).
Analysis was conducted using NewCAST stereological software (Visiopharm, Hoersholm,
Denmark). Using meander sampling, the immunolabelled pancreas was investigated
using systematic uniform random sampling (SURS). Starting at a random position within
the region of interest, the software generated fields of view at fixed step lengths in x
and y directions. The magnification at analysis was x200.
point overlaid a brown coloured cell. Simultaneously, the pancreatic tissue (exocrine and
endocrine tissue) was counted when one of four yellow-circled points overlaid the tissue
(Figure 3.2). Adipose tissue, blood vessels, lymph nodes and connective tissue were
counted alongside exocrine and endocrine pancreatic tissue as total tissue by the other
sub-set of purple-circled points. Over the whole section, approximately 9% of the tissue
was sampled and assessed. The sections were analysed blind to the treatment group.
est) were
calculated by the Cavalieri principle (Equation 3.1):
Vol =
×
divided by the volume of total tissue to obtain the percentage of the pancreas occupied
by each islet cell. The absolute and relative islet cell masses were calculated using the
following formula:
Figure 3.2.
insulin or glucagon. Total tissue is counted when the pink circled ‘+’ overlay pancreatic,
fat or connective tissue, and pancreatic tissue (exocrine and endocrine) is counted
when underneath yellow circled ‘+’.
Equation 3.1.
Relative islet cell mass = ( )
From the results obtained, a power analysis test (Holleran & Ramakrishnan, 2003)
after sampling a total of 240 animals (n=60 in each group).
Stereological statistics
Because of the unbiased nature of the Cavalieri principle, the coefficient of variation
(CV) uses a predictive formula that accounts for the systematic nature of sampling. The
CV is a function of two independent factors.
1. Noise effect: This is the point counting variance and represents the independent
variance of each estimate (Pi). It reports the variance of point counting and indicates
how much the overall estimate would change if the counting grid was placed
differently on the section.
CV = 0.0724 × × n × P
Where P = sum of points, n = number of sections (sample size), = the shape
coefficient. The shape coefficient takes into account the complexity of the shape of
the section and is assigned a number (Gundersen & Jensen, 1987). It can be
estimated from a nomograph or, in calculated terms, it is the boundary length (B)
divided by the square root of the sampling area (A; Howard & Reed, 2010).
2. Variance of
the number of sections. It computes the variance under SURS (Gundersen et al.,
Equation 3.3.
Equation 3.2.
1999). The more variable a structure is in the direction of sectioning, the more
sections are required to accurately measure volume.
Var = (3 ( ) ) ÷ 240
A = P × P
B = P × P
C = P × P
Where, Pi = number of points per section. Therefore, P = the sum of the point
counts from all sections in one animal. Thus, the overall CV is calculated as:
Total Variance of P = CV + Var
) =
Therefore, more sections and more counts result in less variability. Approximately 150-
200 points over 8 sections is usually enough to produce a CV of less than 3%. All of the
samples had a CV of less than 3%.
3.2.4 Statistical analysis
All values are expressed as mean ± standard error of the mean (SEM) unless otherwise
indicated. Initially, statistical significance for comparisons between the groups was
assessed using a three-way ANOVA, using treatment, gestational age and sex as factors,
followed by the Tukey post hoc test. As there was no effect of sex in any results,
statistical significance was assessed by two-way ANOVA using treatment and gestational
age as factors, followed by the Tukey test. Correlations were assessed using linear
regression. For comparison between two groups, a Student’s unpaired t-test was used.
In all cases, significance was accepted at P<0.05.
Equation 3.4.
Equation 3.5.
3.3 Results
3.3.1 Plasma hormone concentrations
T4 and T3
In the TX fetuses, plasma T4 and T3 concentrations decreased to below, or close to, the
limit of assay detection (T3, 0.067ng/ml; T4, 7.6ng/ml) at both 129dGA and 143dGA
(Figure 3.3A-B). In both cases, these were significantly lower than the sham controls
(P<0.05). In the sham fetuses, plasma concentrations of T3 at 143dGA were significantly
greater than those at 129dGA (Figure 3.3B), indicative of the normal pre-partum surge.
Insulin
The TX fetuses had significantly higher plasma insulin concentrations than the sham
fetuses at both 129dGA (sham 30.1 ± 9.4ng/L vs TX 129.4 ± 31.3ng/L, P<0.05) and at
143dGA (sham 55.7 ± 12.0ng/L vs TX 167.9 ± 19.3ng/L, P<0.05, Figure 3.3C). There was
no effect of gestational age on plasma insulin concentrations in either treatment group.
Cortisol
Plasma cortisol concentrations were significantly higher in the fetuses studied at
143dGA (sham 54.9 ± 12.7ng/ml; TX 28.7 ± 3.9ng/ml) compared with the fetuses at
129dGA (sham 12.6 ± 3.1ng/ml; TX 9.8 ± 1.5ng/ml, P<0.05, Figure 3.3D). At 143dGA, the
TX fetuses tended to have lower cortisol levels compared to sham controls (P=0.06,
Figure 3.3D). When data from the fetuses at 143dGA were analysed alone by Student’s
t-test, plasma cortisol concentrations in the TX fetuses were significantly lower than
those in the sham controls (P<0.01).
Leptin, IGF-I and IGF-II
Plasma concentrations of leptin were significantly greater in the TX fetuses compared to
the sham fetuses at both 129dGA (sham 517 ± 32pg/ml vs TX 983 ± 58pg/ml, P<0.05)
and 143dGA (sham 669 ± 47pg/ml vs TX 1046 ± 79pg/ml, Figure 3.4A). There was no
effect of gestational age on plasma leptin concentrations in either treatment group.
Neither gestational age nor thyroidectomy altered the umbilical plasma concentrations
of IGF-I or IGF-II at delivery (Figure 3.4B, C).
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Figure 3.4. Mean ± SEM plasma concentrations of (A) leptin (B) IGF-I and (C) IGF-II in sham
and TX fetuses at 129dGA and 143dGA. * Significantly different from sham fetuses at the
same dGA, 2-way ANOVA, P<0.05. n = 9-10 in each group.
3.3.2 Fetal morphometry and organ weights
Fetal body weight, crown-rump length and abdominal circumference remained
unaltered by fetal thyroidectomy at both 129 and 143dGA. In the sham and TX fetuses,
there was a significant increase in these parameters at 143dGA compared to the
younger fetuses at 129dGA (P<0.05 in all cases; Table 3.1).
In the skeletal system, all of the limb bones that were measured displayed growth
retardation in the TX fetuses at 143dGA in comparison to the sham controls (P<0.05 in
all cases; Table 3.1). At 129dGA, three of the six bones measured were significantly
growth retarded in the TX fetuses compared to controls. The mass (relative to fetal body
weight) of the biceps femoris was significantly enlarged in the TX fetuses compared to
controls at 143dGA (P<0.05; Table 3.1). The relative mass of the soleus and
semitendinosus remained unchanged in the TX fetus at both 129 and 143dGA, and there
was no effect of gestational age on these muscle weights in either treatment group.
The lungs, heart, stomach and small intestine were growth retarded in the TX fetuses
compared to sham fetuses at both gestational ages studied (P<0.05 in all cases; Table
3.2). The relative mass of the perirenal adipose tissue and the pituitary gland, however,
were significantly enlarged in the TX fetuses at both 129 and 143dGA (P<0.001).
Additionally, the relative mass of the kidneys was significantly increased in the TX fetus
at 143dGA (P<0.01). There were no changes in the relative mass of the pancreas, liver,
testes, ovaries or adrenal gland with treatment or gestational age (Table 3.2). No thyroid
gland was found in the TX fetuses.
Table 3.1. Mean ± SEM measurements of biometry and components of the
musculoskeletal system in sham and TX sheep fetuses at post mortem.
Body measurements
129 dGA 143 dGA
Sham (n=9) TX (n=9) Sham (n=10) TX (n=10)
Body Weight (kg) 2.61 ± 0.20 2.49 ± 0.20 3.58 ± 0.23† 3.13 ± 0.13†
Crown Rump Length (cm) 43.6 ± 1.1 42.1 ± 1.0 48.3 ± 1.1† 45.7 ± 0.7†
Abdominal Circumference (cm) 30.8 ± 0.9 29.6 ± 1.2 34.9 ± 0.9† 33.5 ± 0.7†
Hind Limb Femur (cm) 9.8 ± 0.4 8.9 ± 0.3 11.3 ± 0.4† 10.2 ± 0.3†*
Hind Limb Tibia (cm) 12.8 ± 0.5 11.8 ± 0.3 14.8 ± 0.4† 13.7 ± 0.2†*
Hind Limb Metatarsal (cm) 15.1 ± 0.5 13.3 ± 0.4* 17.0 ± 0.5† 15.0 ± 0.3†*
Front Limb Humerus (cm) 8.4 ± 0.2 7.8 ± 0.2 9.6 ± 0.3† 8.5 ± 0.3*
Front Limb Radius (cm) 10.4 ± 0.2 9.4 ± 0.2* 11.7 ± 0.3† 10.7 ± 0.2†*
Front Limb Metacarpal (cm) 12.7 ± 0.4 11.2 ± 0.3* 14.6 ± 0.3† 12.6 ± 0.3†*
Absolute skeletal muscle weight (g)
Semitendinosus 3.90 ± 0.35 3.77 ± 0.34 5.45 ± 0.42† 5.34 ± 0.28†
Biceps Femoris 11.55 ± 0.84 11.80 ± 0.87 14.80 ± 1.29† 14.63 ± 0.84†
Soleus 1.67 ± 0.13 1.60 ± 0.14 2.29 ± 0.22† 2.08 ± 0.12†
Skeletal muscle weight relative to body weight (%)
Semitendinosus 0.149 ± 0.008 0.151 ±0.006 0.151 ± 0.005 0.171 ± 0.007
Biceps Femoris 0.444 ± 0.012 0.476 ±0.011 0.410 ± 0.017 0.467 ± 0.015*
Soleus 0.064 ± 0.002 0.064 ±0.002 0.064 ± 0.004 0.066 ± 0.002
different from sham fetuses at the same dGA, 2-way ANOVA, P<0.05.
Table 3.2. Mean ± SEM organ weights in sham and TX sheep fetuses at post
mortem.
Absolute organ
weights (g)
129 dGA 143 dGA
Sham (n=9) TX (n=9) Sham (n=10) TX (n=10)
Heart 16.4 ± 1.2 12.2 ± 0.8* 21.9 ± 1.6† 16.4 ± 0.8*†
Lungs 73.1 ± 4.8 58.3 ± 4.6 93.2 ± 9.42† 71.59 ± 5.6*
Liver 72.0 ± 7.7 69.2 ± 7.6 78.7 ± 5.7 90.3 ± 5.4†
Kidneys 15.4 ± 0.8 16.8 ± 1.5 18.7 ± 1.6 19.7 ± 1.3
Pancreas 2.2 ± 0.2 2.3 ± 0.2 2.9 ± 0.2† 2.8 ± 0.2
Empty stomach 20.5 ± 1.9 17.6 ± 1.2 28.9 ± 1.6† 21.5 ± 0.9*
Small intestine 48.6 ± 6.4 34.5 ± 3.5 83.9 ± 6.4† 42.7 ± 3.2*
Perirenal adipose 9.9 ± 0.6 12.7 ± 1.4 10.9 ± 1.1 14.7 ± 1.1*
Brain 42 ± 1.0 41 ± 1.0 49 ± 1.0† 44 ± 2.0
Pituitary (mg) 86 ± 6 123 ± 11.0* 96 ± 9.0 148 ± 11.0*
Adrenals (mg) 304 ± 20 305 ± 40 417 ± 42 372 ± 21
Testes (mg) 834 ± 48 (n=5) 915 ± 116 (n=6) 1175 ± 106 (n=6) 1058 ± 102(n=6)
Ovaries (mg) 52 ± 6 (n=4) 52 ± 10 (n=3) 69 ± 6 (n=4) 80 ± 8 (n=4)
Thyroids (mg) 514 ± 47 NP 606 ± 72 NP
Organ weights relative to body mass (%)
Heart 0.633 ± 0.03 0.520 ± 0.01* 0.612 ± 0.02 0.527 ± 0.02*
Lungs 2.86 ± 0.18 2.36 ± 0.08* 2.55 ± 0.12 2.29 ± 0.15*
Liver 2.85 ± 0.36 2.73 ± 0.17 2.20 ± 0.07 2.94 ± 0.22
Kidneys 0.603 ± 0.03 0.682 ± 0.04 0.525 ± 0.03 0.628 ± 0.03*
Pancreas 0.086 ± 0.005 0.093 ± 0.005 0.081 ± 0.005 0.089 ± 0.004
Empty stomach 0.81 ± 0.04 0.72 ± 0.02* 0.82 ± 0.02 0.69 ± 0.03*
Small intestine 2.00 ± 0.19 1.35 ± 0.07* 2.34 ± 0.07† 1.36 ± 0.08*
Perirenal adipose 0.39 ± 0.03 0.52 ± 0.05* 0.31 ± 0.03 0.48 ± 0.04*
Brain 1.68 ± 0.12 1.72 ± 0.14 1.44 ± 0.09 1.42 ± 0.05†
Pituitary 0.003 ± 0.001 0.005 ± 0.001* 0.003 ± 0.001 0.005 ± 0.001*
Adrenals 0.012 ± 0.001 0.012 ± 0.001 0.011 ± 0.001 0.011 ± 0.001
Testes 0.031 ± 0.002
(n= 5)
0.036 ± 0.003
(n=6)
0.032 ± 0.001
(n= 6)
0.034 ± 0.003
(n=6)
Ovaries 0.0035 ± 0.0003
(n=4)
0.0025 ± 0.0005
(n=3)
0.0020 ± 0.0001
(n=4)
0.0025 ± 0.0002
(n=4)
Thyroids 0.020 ± 0.001 NP 0.017 ± 0.001 NP
different from sham fetuses at the same dGA, 2-way ANOVA, P<0.05. NP = not present.
3.3.3 Pancreatic islet mass
Immunohistochemistry was successful in labelling pancreatic insulin and glucagon-
containing cells. Insulin was localised mainly in large islets of the pancreas in sham and
TX fetuses at both 129 and 143dGA with some labelling in smaller clusters of cells spread
throughout the tissue (Figure 3.5A, C, E, G). Glucagon, however, was more sparse
compared to insulin in both sham and TX fetuses and was localised in islets alongside
insulin or within exocrine tissue, especially around ducts and blood vessels (Figure 3.5B,
D, F, H).
fetuses compared to the sham controls at 129dGA only (sham 1.8 ± 0.1% vs TX 3.1 ±
0.4%, P<0.05). There was no difference in percentage volume in pancreatic tissue
between sham and TX fetuses at 143dGA (sham 1.7 ± 0.3 vs TX 2.3 ± 0.2%). The volume
143dGA (Figure 3.6A). There was no effect of gestational age on either parameter.
When adjusted for pancreas mass, there was no effect of thyroidectomy or gestational
143dGA (sham 41.4 ± 6.8mg vs TX 44.2 ± 4.1mg, Figure 3.6B). Additionally, when
gestational age (129dGA: sham 12.6 ± 1.9mg/kg vs TX 15.1 ± 2.3mg/kg; 143dGA: sham
11.7 ± 0.9mg/kg vs TX 14.5 ± 1.4mg/kg, Figure 3.6C). Gestational age had no effect on
Figure 3.5. Sections of pancreas labelled with insulin and glucagon (brown) in sham and TX
fetuses at 129 and 143dGA. Insulin and glucagon in a sham fetus (A, B) and TX fetus (C, D) at
129dGA. Insulin and glucagon in a sham (E, F) and TX fetus (G, H) at 143dGA. Scale bar 250μm.
Figure 3.6.
group.
-cell mass
at both 129 (sham 6.0 ± 0.5% vs TX 10.4 ± 0.8%, P<0.05) and 143dGA (sham 6.7 ± 0.8%
vs TX 11.0 ± 1.0%, P
tissue was increased at 129dGA in TX fetuses compared to sham controls (sham 3.6 ±
0.4% vs TX 6.2 ± 0.5%, P
cell volume in pancreatic or total tissue.
at both 129 (sham 92.3 ± 24.1mg vs TX 144.6 ± 23.5mg) and 143dGA (sham 143.9 ±
20.9mg vs TX 183.4 ± 26.8mg, P=0.08, Figure 3.7B). In the sham fetuses at 143dGA, there
at 129dGA (P<0.05, Figure 3.7B). This effect of gestational age was not evident in the TX
fetuses.
When adjusted for pancreas mass and fetal body weight, it was identified that the
controls at both 129 (sham 35.0 ± 7.6mg/kg vs TX 55.4 ± 5.9mg/kg, P<0.05) and 143dGA
(sham 39.7 ± 3.7mg/kg vs TX 58.3 ± 6.9mg/kg, P<0.05) by 40% and 30% respectively
treatment group. Plasma insulin concentrations in the sham and TX fetuses were
2=0.25, n=36, P<0.005, Figure
of cortisol or leptin.
Figure 3.7
fetuses at the same dGA, P P=0.08. †
Significantly different from fetuses in the same treatment group at 129dGA, 2-way ANOVA,
P<0.05. n = 9-10 fetuses in each group.
3.4 Discussion
This study has shown for the first time, and contrary to the original hypothesis, that
cell mass and a concomitant rise in circulating insulin concentration in utero. These
changes were also associated with normal bodyweight but impaired skeletal growth and
disproportionate organ growth patterns.
3.4.1 Plasma hormones in hypothyroidism
Plasma T3 and T4 concentrations in the TX fetuses were at or below assay detection,
and significantly lower than those in the sham controls at both 129 and 143dGA.
Towards term, the normal rise in plasma T3 seen in the sham fetuses was abolished in
the TX fetuses. This demonstrates that the experimental model is effective and that the
fetuses which underwent thyroidectomy were hypothyroid.
Figure 3.8. The positive correlation between plasma insulin concentrations and
2 = 0.25, P
Residual thyroid hormone levels in the circulation of the TX fetus may be due to ectopic
thyroid tissue or fragments of thyroid regrowth not identified at post-mortem. However,
detectable thyroid hormone may have arisen from metabolism of the sulphated forms
of the thyroid hormones (Wu et al., 1993; Polk et al., 1994). Significant amounts of the
sulphated forms have been characterised in the sheep fetus, in which levels peak in the
circulation at around 130dGA. Wu et al. (1993) identified in TX sheep fetuses that, while
the circulating concentrations of sulphated T4 and rT3 decreased, plasma levels of
sulphated T3 were maintained for 2 weeks post thyroidectomy.
Plasma cortisol concentrations in the TX fetus were within the normal range and
followed the same developmental pattern as that seen in the sham controls. Towards
term, an increase in plasma cortisol concentration was observed in both groups of
fetuses. However, cortisol levels tended to be lower in the TX fetuses compared to the
sham fetuses at 143dGA. Since the prepartum cortisol surge is the trigger for the onset
of parturition in sheep, the tendency for TX fetuses to have a lower cortisol
concentration at 143dGA may contribute to the prolonged gestation length reported
previously in the hypothyroid fetus (approximately 7 days longer; Hopkins & Thorburn,
1972). The TX fetuses therefore may not have been exposed to as much cortisol as their
sham counterparts in the last few days before tissue collection. The delay in the
prepartum cortisol surge may contribute to the immaturity in fetal organ systems
associated with hypothyroidism near term (Forhead & Fowden, 2014).
Plasma insulin concentrations were significantly higher in the hypothyroid fetus at both
129 and 143dGA. A previous study in the sheep fetus during late gestation did not
identify any effect of hypothyroidism on plasma insulin concentrations (Fowden & Silver,
1995). However the study of Fowden and Silver did not use twin fetuses as the control
group and the insulin ELISA used was less sensitive and did not use species-specific
antibodies. The current study is the first report of higher plasma insulin concentration
in the TX sheep fetus and suggests that some of the tissue-specific changes in organ
growth may be mediated by changes in insulin signalling. An increase in plasma insulin
concentration has been reported previously in the TX neonatal mouse and was
associated with a reduction in body weight (Ramos et al., 1998). Determination of
plasma glucagon concentrations was attempted with a glucagon ELISA (Mercodia),
however the plasma samples were not collected in the correct preservative and the
levels of glucagon measured were highly variable and unreliable.
Thyroidectomy in the sheep fetus increased plasma leptin concentrations at both 129
and 143dGA. This finding has been reported previously in hypothyroid fetal sheep, in
association with an increase in adipose leptin mRNA (O'Connor et al., 2007). It can be
postulated, therefore, that the increase in plasma leptin may be due to both the greater
relative mass and secretory capacity of the perirenal adipose tissue. The increase in
plasma insulin may also be responsible for the increase in plasma leptin concentrations.
Mühlhäusler et al., (2007) showed an increase in adipose leptin gene expression in
fetuses of over-nourished ewes and that this correlates to plasma insulin in utero.
Similarly, adipose leptin mRNA and plasma leptin concentrations increase in fetal sheep
directly infused with insulin (Devaskar & Anthony, 2002).
It was surprising that there were no changes in the plasma concentrations of IGF-I or
IGF-II in the TX fetuses. In the adult human, plasma IGF-I and IGF-II decrease in
hypothyroid patients and the levels of plasma IGF-I positively correlate with plasma T3
(Miell et al., 1993). Hypothyroid neonatal mice and rats have decreased circulating IGF-
I concentration compared to controls (Ramos et al., 1998; Johnson et al., 2007; Chang
et al., 2014) and thyroidectomy in the neonatal mouse results in abolition of the normal
decrease in plasma IGF-II that is seen in the controls with age (Ramos et al., 1998). In
fetal sheep and pigs, plasma IGF-I levels are reduced by hypothyroidism, and can be
restored after thyroid hormone treatment (Mesiano et al., 1987; Latimer et al., 1993).
In the sheep fetus during late gestation, thyroidectomy decreases IGF-I mRNA
abundance in skeletal muscle, but increases IGF-II mRNA levels in the liver, which may
contribute to stable IGF levels in the circulation overall (Forhead et al., 1998; 2002).
Changes in plasma IGF levels may not have been seen in this study due to the timing of
thyroidectomy and the collection of blood samples. In addition, circulating and tissue
IGF binding proteins were not measured, which may influence tissue levels of these
growth factors.
3.4.2 Musculoskeletal system in the hypothyroid fetus
This study aimed to elucidate the effects of thyroidectomy on the biometry and overall
body growth of the sheep fetus. Previous studies have shown that thyroidectomy in the
sheep fetus alters the growth of organs, and bone and skeletal muscle development
(Lanham et al., 2011; Chattergoon et al., 2012a; Forhead & Fowden, 2014). The growth
retardation observed in fore-limb and hind-limb bones is consistent with a previous
study by Lanham et al. (2011), in which hypothyroid fetal sheep had reduced limb
lengths in association with decreased plasma levels of the non-collagenous protein
osteocalcin, a marker of bone deposition. Mouse fetuses with a genetic TSH receptor
knockout also demonstrate reduced limb lengths (Bassett et al., 2008). More recently,
chondrocytes, which leads to delayed ossification of bone (Desjardin et al., 2014). This
suggested that T3 plays a critical role in chondrocyte proliferation and maturation to
promote skeletal growth.
Interestingly, although the bones of the TX fetus were growth retarded, only the relative
mass of the biceps femoris was altered by thyroidectomy and this was enlarged at
143dGA relative to sham controls. This is inconsistent with previous data that showed
hypothyroidism in fetal sheep reduces myofibre size (Finkelstein et al., 1991). The
enlargement of the biceps skeletal muscle in the older fetuses may be due to changes in
local IGF synthesis. In fetal sheep during late gestation, there is an ontogenic decrease
in IGF-I mRNA in skeletal muscle towards term, which is abolished in hypothyroid fetuses
(Forhead et al., 2002). Additionally, the increase in mass of the biceps skeletal muscle
may be due to alterations in GLUT4. Neonatal mice which are hypothyroid have
increased protein levels of GLUT4 in skeletal muscle, which may indicate increased
insulin signalling and glucose uptake and could therefore contribute to the growth of
the muscle (Ramos et al., 2001).
3.4.3 Changes in organ mass in the hypothyroid fetus
As expected, fetal thyroidectomy affected the growth of several organs. The heart and
the lungs of the hypothyroid sheep fetus were smaller in comparison to sham controls
at both 129 and 143dGA. These findings confirm those from previous studies (Erenberg
et al., 1974; Chattergoon et al., 2012a). In fetal sheep, thyroidectomy suppresses the
normal maturational response to adrenaline in late gestation to promote lung liquid
reabsorption (Barker et al., 1988; 1990). In the fetal lungs, the prepartum surge in
plasma T3 is also known to promote alveolar septation (Massaro & Massaro, 2002). In
hypothyroid neonatal mice, the lungs display smaller air spaces and have reduced
surfactant content, indicating that there are impairments in structural and biochemical
maturation (deMello et al., 1994).
Segar et al. (2012) previously identified that thyroidectomy in fetal sheep leads to a
decrease in the proportion of terminally differentiated cardiomyocytes, without any
change in heart mass. This may be because, in their study, the fetal sheep were only
hypothyroid for one week and thyroidectomy took place later in gestation at 129dGA.
The decrease in heart mass found in the present study is more consistent with that
reported in the studies by Chattergoon et al. (2012a), in which the hearts of TX fetal
sheep at 136dGA were lower in relative mass compared to controls and also had fewer
terminally differentiated cardiomyocytes. This suggests that, in the fetal heart, thyroid
hormones need to be maintained within a specific range near term to stimulate cell
proliferation and to promote the cardiomyocyte differentiation and maturation.
In the present study, the increase in circulating insulin may account, in part, for the
different growth patterns seen in the TX fetus as different adaptions may have occurred
in response to the deficit in thyroid hormones. This study has highlighted that
hypothyroid fetal sheep have an asymmetric pattern of growth and development. The
effects of thyroid hormone deficiency on organ mass can either be growth promoting or
growth retarding. Deficiency in thyroid hormones in utero affected overall body growth
and individual organs, and the findings demonstrate that thyroid hormones can exert
their effects in a tissue-specific manner. It can be proposed that the tissues from the TX
fetuses which are enlarged may demonstrate upregulation in key growth factors or
proteins involved in the insulin signalling pathway.
The absolute and relative mass of the pituitary gland was increased in the hypothyroid
fetuses at both 129 and 143dGA. This is likely to be due to an increase in the number of
pituitary thyrotrophs producing excess TSH, due to the lack of feedback from circulating
concentrations of T4 and T3. However, the endocrine cells and secretions of the pituitary
gland from thyroid hormone deficient fetuses should be examined to determine this. It
has been previously shown that the plasma concentrations of growth hormone,
produced by the anterior pituitary, is reduced in hypothyroid sheep fetuses (Richards et
al., 1993), although the mechanisms surrounding this suppression are unknown. The
pituitary gland also secretes adrenocorticotropic hormone (ACTH) to increase
production and release of cortisol from the adrenal gland (Bornstein et al., 2008). As the
plasma concentration of cortisol in the TX fetuses tended to be decreased (at 143dGA),
it can be postulated that the secretion and action of ACTH may be suppressed. This has
previously been reported after thyroidectomy in adult rats (Johnson et al., 2012).
The perirenal adipose tissue of the hypothyroid fetus was enlarged in the TX fetuses
compared to sham controls at both 129 and 143dGA. O’Connor et al. (2007) has
previously reported that TX sheep fetuses have increased adipose mass at 144dGA
compared to sham controls. The mechanisms of adipose overgrowth in hypothyroidism
in utero are largely unknown and will be examined in more detail in Chapter 5.
The kidneys, when relative to fetal body weight, were also larger in the TX fetuses
compared to sham controls at 143dGA. Overgrowth of the kidney has been seen
previously in hypothyroid fetal sheep (Chattergoon et al., 2012a) but the mechanisms
underlying these changes remain unknown. The circulating concentrations of thyroid
hormones are known to be reduced in IUGR in mammals (Jones et al., 1984; Kilby et al.,
1998) and previous studies in rats of IUGR induced by maternal protein restricted diet
have shown decreased kidney mass and nephron number in offspring at birth (Zimanyi
et al., 2000). Similarly, a fetal sheep model of natural IUGR from twinning also shows a
decrease in nephron number (Mitchell et al., 2004). In the present study, the increase
in renal mass that was only seen in the older fetuses could be associated with changes
in renal RAS activity which normally increase from 130-136dGA towards term (Chen et
al., 2005a). Thyroidectomy in fetal sheep leads to alterations in renin mRNA, total renin
and AT1R mRNA in the kidney (Forhead & Fowden, 2002; Chen et al., 2005b; 2007). It is
possible that the kidney may only be sensitive to the deficiency in thyroid hormones at
the later stages of gestation. To ascertain how the kidney has enlarged in the TX fetus,
renal structure was determined stereologically and will be discussed in Chapter 6.
This study has shown for the first time that the hypothyroid sheep fetus has an increased
without any change in the absolute or relative mass of the pancreas. However, a
approximately 7% of the total pancreas mass. This is the first report of increased
specific phenotype.
There is limited knowledge on the direct effects of fetal hypothyroidism on pancreatic
et al., 2011; 2014),
indicating that inactivation of local thyroid hormones by D3 during pancreas
findings, neonatal rats which are hypothyroid due to maternal hypothyroidism show no
et al., 2014). Furthermore,
mouse models of TR deletion do not show any morphological changes in the neonatal
pancreas (Mastracci & Evans-Molina, 2014). However, in vitro studies using islets
normal islet development and proliferation (Aguayo-Mazzucato et al., 2013).
due to the lack of the thyroid hormones and/or the increased circulating concentrations
of insulin and leptin. Fetal rat islets have been shown to express leptin receptors and
leptin is able to stimulate islet cell proliferation in vitro (Islam et al., 2000). In contrast
pancreas-specific knockout of the leptin receptor (Morioka et al., 2007). Therefore,
leptin on the development of the pancreas in fetal sheep are unknown.
It is possible that the increase in circulating insulin concentration in the TX fetus was due
cell mass was positively correlated with the plasma insulin concentration. Insulin may
act in a positive feedback loop, in which insulin stimulates pancreas growth and further
neonatal mice with upregulation of pancreatic mTOR, which was observed into
adulthood (Rachdi et al., 2008). This demonstrates that altering a component of the
insulin signalling pathway can have effects on pancreatic growth. Changes in plasma
3.5 Conclusions
Thyroidectomy in the ovine fetus in late gestation causes an asymmetric pattern of
growth and development with some tissues enlarged while others are growth retarded.
The tissue-specific changes in growth may be the result of increased circulating insulin
concentrations and altered insulin signalling. The increase in plasma insulin
mass. These findings are in contrast to the initial hypothesis that hypothyroidism in the
therefore decreased circulating insulin concentration. It remains unclear which factors
and mechanisms are responsible for driving the growth of the pancreas in the
hypothyroid fetus.
4 ENDOCRINE CONTROL OF FETAL PANCREATIC -CELL PROLIFERATION
IN VITRO
4.1 Introduction
and changes in plasma nutrients and hormones in utero can influence the development
of the pancreas (Holemans et al., 2003; Fernández et al., 2007). In the study reported
here, hypothyroidism in the sheep fetus during late gestation has been shown to
3). These effects may be a direct consequence of thyroid hormone deficiency and/or
due to other endocrine systems affected by hypothyroidism in utero.
(Bouwens & Rooman, 2005; Medina et al., 2011). In vitro
Falzacappa et al., 2007; Furuya et al.
mass seen in the TX sheep fetus may be due to an increase in cell proliferation and that
neogenesis in the late stages of gestation. Local thyroid hormone concentrations in the
developing pancreas are determined, in part, by the relative activites of D2 (conversion
of T3 from T4) and D3 (inactivation of T3 and T4). In the human pancreas, D2 expression
is at its highest at 8 weeks of gestation and then progressively decreases towards term
(Medina et al.
from 11 weeks onwards (Medina et al., 2011). The relative expression of D2 and D3 in
enable proliferation.
production and secretion of insulin, which in turn, may act on pancreatic islets as a
growth factor. Otani et al. (2004) created a transgenic mouse model in which the animals
cell mass and reduced pancreatic insulin content. A similar phenotype has been
described in 12 week old mice with deletion of Irs2 in the pancreas which shows a
et al., 2007). These studies, however, did not
age. This suggests that the insulin receptor and IRS2 are not essential for development
et al., 2002; Otani et al., 2004; Cantley et al., 2007) .
hypothyroidism in utero as plasma concentrations of leptin were increased in the TX
sheep fetus. Leptin receptor protein and mRNA are present in cultured insulinoma cells
in vitro and in fetal and adult rat islets in vivo (Kieffer et al., 1996; Islam et al., 1997;
Kulkarni et al., 1997). However, despite the presence of leptin receptors, there is
proliferation in vitro (Islam et al., 2000). In contrast to these findings, a two-fold increase
knockout of the leptin receptor (Covey et al., 2006; Morioka et al., 2007). The effect of
leptin on pancreatic development in fetal sheep remains to be established.
proliferation and glucose-stimulated insulin secretion using islets isolated from normal
proliferation will be inhibited by thyroid hormone and stimulated by insulin and leptin.
4.2 Methods
4.2.1 Animals
All of the proliferation studies were carried out in collaboration with Dr. Sean Limesand
at the Department of Animal Sciences, University of Arizona, Tucson, Arizona, USA. To
from untreated sheep fetuses aged between 133 and 142dGA and subjected to
proliferation assays in vitro. Islets were allocated to each treatment by equally
distributing islets from different aged fetuses.
Five Columbia-Rambouillet crossbred ewes carrying twin fetuses were purchased from
Nebeker Ranch (Lancaster, USA) and managed in compliance with the Institutional
Animal Care and Use Committee at the University of Arizona, which approved the study
and is accredited by the American Association for Accreditation of Laboratory Animal
Care. Ewes were fed Standard-Bread Alfalfa Pellets (Sacate Pellet Mills, Laveen Green,
USA) and provided with water ad libitum. The gestational age, body weight and sex of
each fetus are displayed in Table 4.1. The body weights were all within the normal range
for the breed and comparable to those of the sham control group in the previous study
(Chapter 3).
4.2.2 Surgical procedures
Ewes and fetuses were euthanized by maternal I.V. administration of pentobarbital
sodium (86mg/kg) and phenytoin sodium (11mg/kg; Euthasol, Virbac Animal Health,
Fort Worth, USA). After hysterectomy, each fetus was removed, blotted dry and
weighed. An incision was made down the length of the abdomen of the fetus. The
common bile duct was clamped at the proximal duodenum and the pancreas was
injected via the common bile duct with 20ml cold collagenase solution containing Krebs
Ringer Buffer (KRB; 118mM sodium chloride, 4.8mM potassium chloride, 1.2mM
magnesium sulphate, 1.2mM potassium phosphate, 2.5mM sodium bicarbonate,
Table 4.1. Gestational age, body weight and sex of twin fetuses used in proliferation
studies.
Sheep Gestational age(days)
Weight (kg) Sex
Twin A Twin B Twin A Twin B
1 133 2.83 2.52 Male Female
2 136 3.31 3.43 Male Female
3 139 3.29 2.90 Male Male
4 142 3.07 3.39 Female Female
5 136 4.00 4.47 Male Male
2.5mM calcium chloride), 0.425mg/ml collagenase V (Sigma) and 0.2% DNAse1 (Roche).
The perfused pancreas became distended and visible. The pancreas was dissected free
and divided from the common bile duct to the left of the portal vein. It was placed into
a tube containing 40ml cold collagenase solution.
4.2.3 Islet Isolation
Islets were isolated from the fetal pancreas as described previously (Limesand et al.,
2006; Rozance et al., 2006). The pancreas was minced with scissors and the tube
containing the pancreas in collagenase solution was heated in a water bath at 37°C to
digest for approximately 15-20 minutes, with vigorous shaking every 5 minutes. The
tissue was cooled on ice to stop the collagenase activity and washed with approximately
40ml cold quench buffer containing KRB and 5% BSA for 7 minutes on ice. The tissue was
filtered through a mesh filter (26 gauge) and the remaining solution was separated into
two 50ml tubes and washed again in cold quench buffer and incubated on ice for a
further 7 minutes. After a pellet had formed at the bottom of each tube, the supernatant
was removed and the pellets were resuspended in quench buffer and combined back
into one tube. To this tube, 40ml of quench buffer was added and the solution was
divided into four tubes equally. To each tube, 10ml of Histopaque (Sigma) was added.
Histopaque contains a solution of polysucrose and sodium diatrizoate, adjusted by
quench buffer to a density of 1.083g/ml to facilitate the recovery of islets. The tubes
were centrifuged for 20 minutes at 1600g at room temperature so that pancreatic acinar
cells collected at the bottom of the tube and the islets were suspended in the interphase
above the Histopaque. The interphase was removed from each tube, combined and
washed with 40ml quench buffer, and briefly centrifuged at 1600g. The pellet of islets
was resuspended in 10ml quench buffer and added to a 100mm Petri dish (Fisher
Scientific, Pittsburgh, USA). The islets were identified visually from acinar cells using a
dissecting microscope and were transferred using a pipette into a 100mm Petri dish
containing RPMI 1640 media (Sigma) with 10% fetal bovine serum (500U; EquaFetal,
Atlas Biologicals, Fort Collins, USA), penicillin-streptomycin (50μg and 100μg, Sigma) and
2.8mM glucose (D-glucose, Fisher Scientific). The islets were subjected to 95% O2/5%
CO2 gas for 5 minutes in a humidity chamber before incubation at 37°C for 24 hours
before treatment began.
4.2.4 EdU proliferation assay
To determine cell proliferation, the Click-iT EdU Imaging kit (Invitogen, Grand Island,
USA) was used to immunolabel and image isolated islets undergoing proliferation. The
most accurate method for assessing cell proliferation is by directly measuring DNA
synthesis. 5-ethynyl-2’-deoxyuride (EdU) is a nucleoside analogue of thymidine. It is
incorporated into DNA during active DNA synthesis in the S-phase of the cell cycle when
the DNA content doubles. The detection method is based on a copper-catalyzed
covalent reaction between the EdU which contains an alkyne and the fluorescent dye
which contains an azide.
Cell culture
Islets were picked randomly and placed into 100mm Petri dishes containing RPMI 1640
media with 10% fetal bovine serum, penicillin-streptomycin and 2.8mM glucose
supplemented with four different concentrations of each hormone treatment: 0, 0.1,
1.0 and 10ng/ml. A positive control treatment of 10ng/ml IGF-I was also used, as IGF-I
in vitro (Hogg et al., 1993;
Withers et al., 1999; Fernández et al., 2007). At least 50 islets were handpicked for each
treatment dish. The hormones used in each treatment group were as follows:
10ng/ml IGF-I (Sigma) 50μg IGF-I was resuspended in 1ml dH2O to make a stock solution
of 50μg/ml.
T3 (Sigma) T3 is insoluble in water, therefore 1mg T3 was dissolved in 1ml of 1M sodium
hydroxide and then added to 49ml RPMI media to make a 20μg/ml stock solution.
Insulin (Humulin R U-100, Lilly, Indianapolis, USA) Humulin R U-100 is synthetic insulin
synthesised by recombinant DNA technology using Escherichia coli bacteria. The
solution contained 100IU/ml, and there was 6nM insulin per IU. The molecular weight
of Humulin R is 5808g; therefore, a solution of 10ng/ml contained 2.86μl Humulin R U-
100.
Leptin (Abcam) Active sheep full length leptin protein was made into a 200μg/ml stock
by the addition of 0.5ml dH2O.
After 24 hours incubation, the islets were moved to smaller 35mm dishes (Cell Treat,
Shirley, USA) and the media was replaced with fresh media containing the appropriate
dose of hormone treatment. The media was spiked with EdU at a final concentration of
10μM. Again the islets were subjected to 95% O2/5% CO2 gas for 5 minutes in a humidity
chamber before incubation at 37°C for 24 hours.
Fixation, embedding and sectioning
After a total incubation period of 48 hours, the islets and media were transferred into
an Eppendorf tube and centrifuged until the islets had formed a pellet. The islets were
fixed in 4% paraformaldehyde. After fixation, the islets were resuspended and stored in
PBS. Embedding of islets was aided visually by the use of blue beads in order for the
islets to be visualised when sectioning. Approximately 100μl Affi-Gel 100-200 mesh
beads (Biorad) were washed twice in PBS. The islets were transferred in PBS to a 0.2μl
Eppendorf tube and approximately 10μl bead solution was added to the islets. After
mixing, the solution was spun for 10-20 seconds until a pellet of islets and beads had
formed at the bottom. The PBS was removed and 50μl warm Histogel (Thermo Scientific)
was added; the contents were mixed and spun for 1 minute at 1400g. The Histogel was
left to solidify at 4°C and was dislodged from the tube and placed in a cryomould (Tissue
Tek, Torrance, USA) containing optimum cutting temperature compound (Tissue Tek).
The block containing islets was frozen and stored at -80°C. The blocks were sectioned
on a cryostat kept at a constant temperature of -20°C. Sections were cut at a thickness
of 10μm at 100μm intervals and mounted onto glass microscope slides.
Immunocytochemistry
Using the EdU Click-iT kit, the slides were labelled for EdU positive cells. The slides were
heated for 30 minutes at 37°C, followed by a wash in dH2O. The cells were permeabilised
in PBS with 0.1% Triton X-100 (Sigma) for 15 minutes followed by two washes in PBS.
The cells were incubated with the Click-iT reaction cocktail mix (containing reaction
buffer (Tris buffered saline), 100mM copper sulphate, Alexa Fluor azide and a reducing
agent) for 30 minutes at room temperature in the dark. The cocktail was removed and
the slides washed with rinse buffer containing 3% BSA in PBS.
The slides were incubated with a blocking agent (0.5% BSA in Tris-sodium chloride-
Tween buffer) for 1 hour at room temperature in the dark. Insulin was identified in the
sections by incubation overnight at 4°C in the dark with a guinea pig polyclonal anti-
porcine insulin antibody (Dako, Carpinteria, USA) diluted to 1:500 in 1% BSA. Following
washes in PBS, immunocomplexes were detected by incubation for 1 hour at room
temperature with a polyclonal donkey anti-guinea pig IgG with Alexa Fluor 594
conjugate (Jackson Immunoresearch, West Grove, USA) diluted to 3μg/ml in 1% BSA.
The slides were incubated in 1mg/ml 4',6-diamidino-2-phenylindole (DAPI, Vector Labs)
as a nuclear counterstain for 3 minutes at room temperature in the dark. The slides were
rinsed in dH2O and mounted with 50% glycerol in 10mM Tris-hydrochloric acid and
coverslips (pH 8.0).
Morphometric analysis
Fluorescent images were visualised on a fluorescence microscope system (Leica
DM5500) and captured with a camera (Persuit 4 Megapixel CCD Camera, Diagnostic
Instruments, Sterling Heights, USA). Analysis was performed using ImageJ (US National
Institutes of Health, http://imagej.nih.gov/ij/). Approximately 2500-3000 insulin-
positive cells were counted over at least 6 sections for each treatment. Every EdU
positive cell also positive for insulin was counted to a minimum of 200 per treatment
group. The proportion of EdU/insulin positive cells was calculated relative to the total
number of insulin positive cells.
4.2.5 Glucose stimulated insulin secretion assay
Glucose stimulation
Preliminary studies were carried out to assess the functionality of isolated islets. A static
glucose stimulated insulin secretion (GSIS) assay was performed on islets incubated in
the different treatment groups as described by Rozance et al (2006). The GSIS was
carried out with Amy Kelly in the Department of Animal Sciences at the University of
Arizona.
Around 30 islets were picked randomly and placed into 35mm Petri dishes containing
RPMI 1640 media with 10% fetal bovine serum, penicillin-streptomycin and 2.8mM
glucose supplemented with 10ng/ml hormone. The islets were subjected to 95% O2/5%
CO2 gas for 5 minutes in a humidity chamber before incubation at 37°C. After 24 hours,
5-10 islets were transferred into 1.5ml tubes and there were 5 replicates per condition.
Islets were incubated in KRB-BSA at 37°C for 1 hour to equilibrate, followed by
stimulation with 1.1mM glucose for 1 hour. Supernatant was removed before
stimulating with 11mM glucose for 1 hour. A sample of incubation media was taken after
5 minutes to account for mechanical release of insulin and test islet incubations on ice
with 11mM glucose were carried out to control for cellular breakdown.
An assessment of insulin secretion was attempted in cells cultured with insulin, but it
became difficult to ascertain the extent to which the insulin detected in the media was
Furthermore, it has previously been reported that insulin potentiates GSIS in humans
and neonatal mice in vitro (Kulkarni et al., 1999; Bouche et al., 2010). For this reason,
the data were omitted and only the effects of leptin and T3 on GSIS were assessed.
Insulin concentration
After one hour, the islets were pelleted by centrifugation at 800g and the supernatent
was removed for analysis of insulin concentration. Total cellular insulin was extracted
from the fetal islets by acid-ethanol extraction with insulin content buffer containing
11.6M hydrochloric acid, 100% ethanol and dH2O at 20°C for 24 hours. Insulin
concentration was analysed by ELISA validated for ovine insulin (ALPCO, Salem, USA)
using dilutions of the incubation media (insulin released) and the acid-ethanol extract
(insulin content). The minimum detection level of the ELISA kit was 0.14ng/ml. Total
insulin content of the islets was determined by the addition of the amount insulin
released and the islet insulin content. Islet insulin secretion was quantified as the
fraction of total insulin content that was released into the incubation media.
4.2.6 Statistical analysis
All values are expressed as mean ± SEM unless otherwise indicated. The results obtained
in the proliferation assays were compared by one-way ANOVA followed by the post-hoc
Tukey test. The GSIS assay data was assessed using a two-way ANOVA using treatment
and glucose concentration as factors, followed by the Tukey test, or by a Student’s t-
test. Significance was accepted at P<0.05.
4.3 Results
4.3.1
T3
Visually, immunocytochemistry identified that islets cultured in the higher
concentrations of T3 showed a decrease in number of EdU/insulin positive cells (Figure
4.1).
In islets cultured in 1.0ng/ml and 10ng/ml T3, EdU positive cells appeared to aggregate
in the centre of the islets, where there was a distinct absence of insulin positive cells.
control at all T3 doses in a dose-dependent manner (Figure 4.2A, 0.1ng/ml: 4.6 ± 0.4%;
1.0ng/ml: 3.3 ± 0.3%; 10ng/ml: 2.5 ± 0.2%; P<0.05). The IGF-I positive control stimulated
proliferation to a rate of 8.2 ± 0.9%.
Figure 4.1. Immunofluorescence of fixed ovine fetal islets shows insulin labelling (red) and EdU
positive cells (green) with Dapi nuclei staining (blue). Islets were cultured in 10ng/ml IGF-I (positive
control) or 0, 0.1, 1.0 and 10ng/ml T3. Approximately 15-20 islets imaged for each treatment. Scale
bar 25μm, one islet per image.
Figure 4.2.
and 10ng/ml of (A) T3, (B) insulin and (C) leptin, compared to 10ng/ml IGF-I as a positive
control. Differing letters signify significance between treatment groups, 1-way ANOVA,
P<0.05, 200 cells in each treatment group.
Insulin
revealed no obvious change in the number of EdU/insulin positive cells, with the
exception of the highest concentration, 10ng/ml, which induced an increase in the
number of Edu/insulin positive cells (Figure 4.3).
The islets cultured in media without insulin had a proliferation rate of 4.5 ± 0.4% (Figure
4.2B). Insulin treatment at 0.1 and 1ng/ml had no significant effect on the number of
EdU/insulin-positive cells in fetal islets (0.1ng/ml: 5.2 ± 0.5%; 1.0ng/ml: 5.6 ± 0.5%,
proliferation was increased significantly compared to the basal condition and lower
doses of insulin (10ng/ml: 10.4 ± 0.9%, P<0.05; Figure 4.2B) and tended to be higher
than that induced by IGF-I at 10ng/ml (7.1 ± 0.7%; P=0.07, Figure 4.2B).
Leptin
Immunocytochemistry revealed a decrease in the number of EdU/insulin positive cells
at the lowest concentration of leptin (0.1ng/ml, Figure 4.4). However, at the highest
cells was more prominent.
The islets cultured in media without leptin had a proliferation rate of 6.6 ± 0.5%. The
rate of proliferation was significantly lower in cells cultured in 0.1ng/ml leptin (3.8 ±
0.8%; P
significantly higher than the other doses of leptin (P<0.05 in all cases) and equivalent to
the level of the IGF-I control group (10ng/ml: 10.3 ± 0.9%; IGF-I: 8.5 ± 0.8%; Figure 4.2C).
Figure 4.3. Immunofluorescence of fixed ovine fetal islets shows insulin labelled (red) and EdU
positive cells (green) with Dapi nuclei staining (blue). Islets were cultured in 10ng/ml IGF-I
(positive control) or 0, 0.1, 1.0 and 10ng/ml insulin. Approximately 15-20 islets imaged for each
treatment. Scale bar 25μm, one islet per image.
Figure 4.4. Immunofluorescence of fixed ovine fetal islets shows insulin labelling (red) and EdU
positive cells (green) with Dapi nuclei staining (blue). Islets were cultured in 10ng/ml IGF-I (positive
control) or 0, 0.1, 1.0 and 10ng/ml leptin. Approximately 15-20 islets were imaged for each treatment.
Scale bar 25μm, one islet per image.
4.3.2 GSIS
normal media without hormone, once normalised to total insulin content, was 5.7 ±
1.3pg/ml/ng and 7.8 ± 4.6pg/ml/ng, respectively (Figure 4.5). Using a two-way ANOVA
to compare the data between hormone treatment and concentration of glucose added,
the islets cultured in 10ng/ml T3 tended to increase insulin secretion when stimulated
by both 1.1mM and 11mM glucose compared to the control group (1.1mM glucose: 12.8
± 2.3pg/ml/ng; 11mM glucose: 14.8 ± 2.3pg/ml/ng, P=0.08, Figure 4.5). When the data
for the responses to 1.1 and 11mM glucose were combined, there was a significant
increase in GSIS in islets treated with T3 compared to those without hormone when
assessed by a Student’s t-test (P<0.05, Figure 4.5).
There was no significant change in the insulin secretion in the islets incubated in 10ng/ml
leptin when stimulated by either 1.1mM (6.6 ± 1.5pg/ml/ng) or 11mM glucose (7.7 ±
6.2pg/ml/ng) compared to the control group without hormone (Figure 4.5).
Figure 4.5. Mean ± SEM insulin secretion in response to 1.1 and 11mM glucose in islets
cultured in normal media without hormone (control) or with 10ng/ml T3 or 10ng/ml
no hormone, 2-way ANOVA, P=0.08. * Significantly different combined response from
the islets treated with no hormone, Student’s t-test, P<0.05. n= 3-4 in each group.
4.4 Discussion
during late gestation. Using EdU uptake as a measure of proliferation, it was identified
and studied in vitro. This is a novel finding and contrasts with previous reports in which
in vitro
and to reduce cell apoptosis (Verga Falzacappa et al., 2010). In a 5-bromo-2-
with T3 had an increase in BrdU uptake indicating a higher rate of proliferation. Another
cell proliferation (Furuya et al., 2010). In isolated islets from adult rats and in an
insulinoma cell line, Verga Falzacappa et al. (2007; 2009) have previously found T3 to act
proliferation. However, the previous studies have used isolated rat islets and rodent cell
lines, which used adult, rather than fetal, derived cells.
This study is the first to show an inhibitory dose-dependent effect of T3 on fetal
in vitro. The concentrations used in this study ranged from
the physiological to the supraphysiological in order to mimic circulating and tissue
concentrations that are seen in the normal and hyperthyroid fetus. It should be noted
that the pancreas has the ability to regulate local T3 production. Human fetal pancreas
has been shown to express mRNA for D2 from as early as 8 weeks and D3 mRNA from
11 weeks of gestation (Medina et al., 2011), both of which are important in the
regulation of active intracellular T3. An absence in the localisation of sulphotransferase
or sulphatase enzymes has been reported in the human fetal pancreas (Miki et al., 2002),
suggesting that the pancreas in utero may be unable to utilise sulphoconjugated T3
locally. The data from this study complement that from Chapter 3 in which the TX fetuses
in vivo and in vitro
sheep.
Preliminary data from the GSIS assay suggest that T3 increases insulin secretion from
isolated fetal ovine islets. Although there was a tendency for greater insulin secretion in
response to glucose from islets cultured in T3, these data were not significant. This is
most likely due to the low number of replicates (n=3-4) that were used in the
proliferation to switch from cell division to differentiation and thus promote maturation
decreases in insulin content and the expression of glucose sensing genes (Medina et al.,
2011), indicating that low T3 exposure is required for normal islet development and
maturation. The data in this study are consistent with studies on the role of T3 in
cardiomyocyte maturation in the sheep fetus by Chattergoon et al. (2012a; 2014).
Maturation of fetal ovine cardiomyocytes is characterised by a transition from
mononucleated to binucleated cells and suppression of mitosis near term.
Cardiomyoctyes from TX sheep fetuses show a lower rate of proliferation and a reduced
percentage of binucleated cells compared to controls (Chattergoon et al., 2012a). The
which T3 inhibits proliferation and stimulates maturation. In the TX fetus, the inhibitory
secretion and cellular morphology remains unknown, compared to that of the sham
controls. A recent study using human embryonic stem cell-derived pancreatic progenitor
cells grafted into mice found that chronic thyroid hormone deficiency results in impaired
et al.,
2016).
Genes involved in insulin production and secretion are found to be regulated by Mafa
and pancreatic MAFA protein levels in the mouse neonate increase with age (Aguayo-
Mazzucato et al., 2011). Expression levels of Mafa in pancreatic islets from rodent
fetuses increase coincident with T3 towards term and it is possible that T3 may regulate
Mafa
cell proliferation and the number of islet cells (Aguayo-Mazzucato et al., 2013). The islets
from T3-treated animals show increased islet gene expression of MAFA mRNA and
protein levels. It has been identified that the thyroid receptor may interact directly with
two putative TREs in theMafa gene (Aguayo-Mazzucato et al., 2013). Using a maturation
marker such as MAFA, future studies could analyse the maturity and functionality of the
Insulin has long been known to be a potent growth factor in utero (Hill & Milner, 1985)
and in the sheep fetus, growth rates and plasma insulin concentrations are positively
correlated (Fowden et al., 1989). Inhibition of components of the insulin signalling
pancreatic Irs2 and IgfIr et al.,
1998; Cantley et al., 2007). Furthermore, neonatal rats born to mildly diabetic mothers
compared to rats born to normal dams (Reusens-Billen et al., 1984). It is therefore
unsurprising in the present study that the highest concentration of insulin increased the
was associated with an increase in islet cell DNA synthesis (Duvillie et al., 2002).
Alterations in Akt, mTOR and pS6K have previously been shown to have detrimental
hypertrophy as well as hyperplasia (Bernal-Mizrachi et al., 2001; Tuttle et al., 2001). In
addition, neonatal mice with a conditional deletion of tuberous sclerosis complex 2 that
into adulthood (Rachdi et al., 2008). As Akt, mTOR and pS6K are all integral factors
within the insulin signalling pathway, it can be speculated that excess plasma insulin
The results in this study complement those in Chapter 3, as increased circulating insulin
sham controls. Although the plasma concentrations of insulin in the TX fetus were
between 0ng/ml and 1.0ng/ml, local pancreatic insulin concentrations are likely to be
in the TX fetus is likely to be due to the combined effects of increased insulin and loss of
thyroid hormone.
islets in vitro
proliferation, as it has been shown to be both inhibitory and stimulatory, depending on
proliferation in isolated fetal rat islets in vitro (Islam et al., 2000); however, an increase
receptor (Morioka et al., 2007). The contrasting data from previous investigations of the
used. Islam et al. (1997; 2000) reported stimulation of proliferation in rat fetal islets in
response to leptin in vitro, but used concentrations that were significantly higher (80 –
1600ng/ml) than the normal physiological range. Investigations by Morioka et al. (2007)
used a rat model with a leptin receptor deletion where the islets were totally insensitive
to leptin. The current study has used concentrations of leptin which are within the
physiological range and therefore, the bimodal response observed may be more
reflective of the normal response to leptin in vivo.
investigations have shown that leptin treatment suppresses insulin secretion in adult rat
islets (Kieffer et al., 1996) and transgenic neonatal mice which are leptin receptor
deficient are hyperinsulinaemic (Covey et al., 2006). Further investigations are required
4.5 Conclusions
in vitro in islets isolated from
the sheep fetus. These findings complement data from the previous study in vivo in
Preliminary data suggest that thyroid hormone may stimulate glucose-stimulated insulin
to exit the cell cycle and to start expressing maturational signals such as MAFA.
would be required to confirm this. Furthermore, it is still unclear whether the increase
division of existing cells. To identify neogenesis, the expression of progenitor markers
such as PDX1 and Ngn3 could be investigated in islets taken from TX and sham fetuses.
5 EFFECTS OF HYPOTHYROIDISM ON FETAL PERIRENAL ADIPOSE TISSUE
DEVELOPMENT
5.1 Introduction
Adipose tissue first appears in the sheep fetus around mid-gestation (~80dGA; Symonds
et al., 2012). As gestation progresses, total adipose mass increases and it comprises of
both white and brown adipocytes (Clarke et al., 1997; Symonds et al., 2003). In the fetus,
WAT is comprised of unilocular (UL) adipocytes, which secrete leptin, and its main
function is energy storage as a large single lipid droplet in each cell. Brown adipose tissue
contains adipocytes with many mitochondria and numerous smaller lipid droplets, and
is termed multilocular (ML). It is essential for thermoregulation after birth as it contains
the unique uncoupling protein, UCP1, which can generate rapid amounts of heat from
uncoupling oxidative phosphorylation from ATP production in the respiratory chain. This
is known as non-shivering thermogenesis (Nedergaard et al., 2001).
In late gestation, the proportion of BAT is greater compared to that of the WAT in the
sheep fetus (Devaskar & Anthony, 2002). The appearance of BAT may be regulated by
the thyroid hormones, as the rise in BAT mass coincides with the prepartum surge in
plasma T3 concentrations (Rabelo et al., 1995; Clarke et al., 1997). Thyroidectomy in the
sheep fetus has previously been shown to decrease rectal temperatures in neonates
(Polk et al., 1987), indicating a deficiency in either BAT mass and/or function at birth
induced by hypothyroidism. In contrast, hypothyroidism in the sheep fetus results in
overgrowth of perirenal adipose tissue in association with increased circulating levels of
insulin and leptin (Chapter 3).
Insulin is a potent growth factor for adipose tissue in utero (Saltiel & Kahn, 2001; Kamana
et al., 2015). Insulin receptors have been identified in isolated adipocytes from fetal rats
(Teruel et al., 1996) and insulin is able to influence fetal adiposity. Mice with an adipose-
specific deletion of InsR have decreased fat pad mass (Bluher et al., 2002) and fetal
sheep with IUGR have decreased plasma insulin concentrations which are correlated
with decreased PAT mass (Duffield et al., 2008). Maternal hyperglycaemia leads to
hyperinsulinaemia and hyperglycaemia in the sheep fetus (Stephens et al., 2001), and
the high circulating insulin levels in utero is posited to contribute to somatic overgrowth,
especially adipose tissue, of the fetus.
Thyroidectomised sheep fetuses have increased plasma leptin concentrations (Chapter
3) and adipose leptin mRNA abundance is associated with increased PAT mass in late
gestation (O'Connor et al., 2007). It has also been shown that birth weight and adiposity
correlate to the plasma leptin concentrations and mRNA abundance in fetal ovine
adipose tissue (Mühlhäusler et al., 2003). In fetuses of ewes over-nourished in late
gestation, leptin gene expression in adipose tissue is increased and adipose leptin mRNA
levels are positively correlated with plasma insulin concentrations (Mühlhäusler et al.,
2007). Furthermore, greater adipose tissue leptin mRNA levels are observed in fetal
sheep which have been intravenously infused with insulin (Devaskar & Anthony, 2002).
Growth of adipose tissue requires the differentiation of adipocytes and this is known to
et al.
causes the cells to undergo adipogenesis (Tontonoz et al., 1994; Wu et al., 1999). In fetal
the relative PAT mass (Duffield et al., 2009). The effects of thyroid hormone deficiency
in utero, however, on the development of adipose tissue, and the role of insulin
signalling in this process, are unknown.
The aims of the study were to examine the effects of hypothyroidism in utero on (1) the
relative proportions of UL and ML adipocytes, (2) the expression of proliferative and
adipogenic markers and (3) the insulin signalling pathway in perirenal adipose tissue.
These aims together will aid in the understanding of the mechanisms behind the
overgrowth of fetal adipose tissue observed during thyroid hormone deficiency.
It is hypothesized that the greater perirenal adipose tissue mass seen in the hypothyroid
sheep fetus is due to overgrowth of UL adipocytes. This is caused by increased levels of
In contrast, hypothyroidism in utero suppresses the development of ML adipocytes
which is responsible for impaired thermogenesis at birth.
5.2 Methods
5.2.1 Animals
All animals, treatments and post mortem procedures are described in Section 2.1. Four
treatment groups were analysed: TX at 129dGA (n=9), sham at 129dGA (n=9), TX at
143dGa (n=10) and sham at 143dGA (n=10). The perirenal adipose tissue collected from
each fetus was weighed and samples were either immersed in 4% formalin for paraffin
wax embedding or frozen immediately in liquid nitrogen before storage at -80°C.
5.2.2 Histology
All histology processing steps are described in detail in Section 2.3. Sections of wax
embedded adipose tissue were cut to a thickness of 7μm and left to dry overnight before
H&E staining, as described in section 2.3.3. Stained sections were scanned using a
NanoZoomer digital slide scanner (Hamamatsu Photonics) to create digital images for
analysis. All stereological measurements were performed and analysed blind to the
treatment group.
5.2.3 Percentage volume of adipocyte type
The percentage volumes of ML and UL adipocyte types were determined using NewCAST
stereological software (Visiopharm). A point counting grid containing 25 points was
applied over the adipose sections. Using meander sampling, adipocyte type was
classified using SURS (Figure 5.1).
The final magnification at analysis was x400. A total of 40 counting frames were used
per slide to provide at least 200 points per animal. An UL cell was defined as an adipocyte
containing a single lipid droplet with a diameter larger than 60μm, after shrinkage. The
fractional volume (Volfraction) was calculated using the equation:
Where P is the number of points falling on either UL or ML cells, and T is the total number
of sampling points counted in the adipose tissue.
Figure 5.1. H&E stained adipose section from fetal sheep. (A) Red circles indicate
multilocular adipocytes and blue circle shows a typical unilocular adipocyte. (B) Counting
grid used in meander sampling adipocytes. A multilocular or unilocular was counted when
underneath a black ‘+’.
Equation 5.1.
5.2.4 Relative adipose mass
The mass of each adipocyte component was calculated by multiplying the percentage
volume by the total PAT mass at post mortem. The relative mass of each cell type was
calculated by dividing the adipose mass by the fetal bodyweight (Equation 5.2):
( ) =
( ) )
5.2.5 Measurement of UL cell size
Unilocular adipocyte size was determined by measuring cell perimeter using a function
of the stereology software NDP.view (Hamamatsu Photonics, Figure 5.2).
Equation 5.2.
Figure 5.2. Methodology used to measure UL cell size. (A) Adjustment
for shrinkage by measurement of red blood cell diameter. (B)
Determination of UL cell perimeter.
Between 60 and 80 of the largest UL cells in the sections were measured and the average
cell perimeter was calculated for each treatment group. To account for tissue shrinkage,
the diameter of red blood cells was also determined. It is known that the average
diameter of a red blood cell in fetal sheep is 6μm (Karvonen, 1954) and this was used to
calculate the percentage shrinkage in the tissue which was then applied to adjust the
cell measurements (Equations 5.3 and 5.4). The amount of tissue shrinkage ranged from
40-50% and there was no difference in the shrinkage between the TX and sham groups.
5.2.6 Western blotting
Quantification of protein in fetal adipose tissue was determined using western blotting.
Adipose tissue from each fetus was homogenised (100mg) and its protein concentration
determined by a BCA protein assay (described in Section 2.5). The Western blotting
procedure is described in detail in Section 2.6.
nuclear antigen (PCNA) were analysed. In the nuclei of mitotic cells, PCNA is expressed
in high levels during the last 5% of the G1-phase and the first 35% of the S-phase of the
cell cycle (Bravo et al., 1984; Mathews et al., 1984). The protein, PCNA, is essential for
progression through the cell cycle and levels of PCNA indicate the extent of cell
proliferation in the tissue. The specific conditions for each antibody used are shown in
Table 5.1. The amount of protein loaded was 100μg, with the exception of the
measurements of Akt1, Akt2 and pAkt where 75μg protein was used. All samples were
heated to 70°C for 10 minutes with the exception of those for p-S6K quantification which
were heated to 99°C for 10 minutes.
Equation 5.3.
Equation 5.4.
After detection with ECL, the protein visualised in each sample was normalised to the
total protein content measured by Ponceau S. All of the samples were analysed across
four gels which were run and transferred together, to minimise variation. A single
control sample was run on each of the gels and the results of this control sample were
used to standardise the values obtained from all of the membranes. After densitometry
and normalisation to total protein, the results were standardised to the mean of the
sham group at 129dGA. Results are therefore expressed as fold changes in arbitrary units
(au).
Table 5.1. Antibodies used in Western blotting of adipose protein
Primary antibody Concentration Blocking
agent
Secondary antibody
Rabbit polyclonal anti-InsR (Santa
Cruz Biotechnologies, Heidelberg,
Germany)
10μg/ml 2% Non-fat
milk
Anti-rabbit 1:1750
(GE Healthcare)
Rabbit polyclonal anti-IGF-1R (Santa
Cruz Biotechnologies)
10μg/ml 2% Non-fat
milk
Anti-rabbit 1:1500
(GE Healthcare)
Rabbit polyclonal anti-leptin receptor
(LRL, Biorbyt, Cambridge, UK)
1μg/ml 2.5% Non-fat
milk
Anti-rabbit 1:2000
(GE Healthcare)
Rabbit polyclonal anti-p-Akt (Ser473,
Cell Signaling Technology, Hitchin, UK)
1:800 2.5% BSA Anti-rabbit 1:2500
(GE Healthcare)
Mouse monoclonal anti-Akt1 ( Cell
Signaling Technology)
1:1000 2.5% Non-fat
milk
Anti-mouse 1:2500
(GE Healthcare)
Rabbit monoclonal anti-Akt2 (Cell
Signaling Technology Technology)
1:1000 2.5% Non-fat
milk
Anti-rabbit 1:2500
(GE Healthcare)
Rabbit polyclonal anti-pmTOR (Ser
2448, Cell Signaling Technology)
1:800 2% BSA Anti-rabbit 1:2000
(GE Healthcare)
Rabbit polyclonal anti-pS6K (Thr 389,
Cell Signaling Technology)
1:1000 No blocking Anti-rabbit 1:1500
(GE Healthcare)
Rabbit polyclonal anti-GLUT4 (Abcam) 2.5μg/ml 2% Non-fat
milk
Anti-rabbit 1:2000
(GE Healthcare)
Mouse monoclonal anti-PCNA (Dako,
Cambridge UK)
2.0μg/ml No blocking Anti-mouse 1:1500
(GE Healthcare)
4.0 μg/ml 2.5% Non-fat
milk
Anti-rabbit 1:2000
(GE Healthcare)
receptor, Akt = protein kinase B, pAkt = phosphorylated protein kinase B, pmTOR = phosphorylated
mTOR, pS6K = phosphorylated S6 kinase
5.2.7 qRT-PCR
In order to further investigate the mechanism of increased adipose protein content of
by quantitative reverse transcription polymerase chain reaction (qRT-PCR). Following
the reverse transcription of RNA into cDNA, the amplification reaction is monitored in
real-time for quantitative analysis. The detection is based on a fluorescent signal and
the higher the starting copy number of the nucleic acid target, the sooner a significant
increase in fluorescence is seen (Bustin & Mueller, 2005). Quantification is based on
threshold cycle values (CT) and the CT is the point at which the PCR cycle reaches a fixed
fluorescent threshold.
TaqMan probes have gene-specific sequences which are labelled with a fluorescent
reporter dye at the 5’ end and a quencher dye at the 3’ end. When the probe is intact,
the quencher dye suppresses the fluorescence of the reporter dye. If the target
sequence is present, the probe anneals downstream of one of the primers and is
subsequently cleaved by the activity of Taq DNA polymerase. This cleavage separates
the reporter dye from the quencher dye, and thus increases the reporter signal.
Reporter dye is cleaved from the probe with every cycle resulting in an increase in
fluorescence which is proportional to the amount of amplicon.
Primer design
A and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) to be unsuitable in this
study, as CT values significantly changed with either treatment or gestational age (Figure
5.3). The genes, TATA-box binding protein (TBP) and ribosomal protein L13a (RPL13a),
showed no change with treatment or age and were therefore used as reference genes.
Ovine-specific TaqMan primers and probes were designed for the reference genes, TBP
spanned the exon-exon boundary were specifically designed to minimise amplification
of genomic DNA during PCR. Primers and probes for bovine GLUT4 were purchased
ready-made (Thermo Scientific), again, with a reporter sequence that spanned the exon-
exon boundary.
Figure 5.3. Mean ± SEM CT
GPADH in perirenal adipose tissue from sham and TX fetuses at 129 and 143dGA. * Significantly
treatment group at 129dGA, 2-way ANOVA, P<0.05. n = 4-6 in each group.
All the information for the qRT-PCR primers and probes is detailed in Table 5.2. All
probes were attached to a fluorescein (FAM) dye and were used at a concentration of
5μM.
RNA extraction
Extraction of adipose tissue RNA was carried out using the RNeasy Mini Kit (Qiagen,
Manchester, UK). Frozen adipose tissue was weighed at 30mg and homogenised in lysing
matrix tubes containing 600μl RLT lysis buffer using the SuperFastPrep-1 homogeniser
(MP Biomedicals) for 10 seconds at 400g. The RLT lysis buffer contained 2M DTT and a
high concentration of the protein denaturant guanidine isothiocycanate, which aids in
the binding of RNA to a silica membrane.
The samples were centrifuged at 17000g for 3 minutes at 4°C. Supernatant was
transferred to fresh tubes and an equal volume of 70% ethanol was added and mixed.
The samples were transferred to a RNeasy Mini spin column and centrifuged for 30
Table 5.2. Gene primers and probes for qRT-PCR in adipose tissue
Gene Forward Primer Reverse Primer Probe reporter
sequence
Probe
dye
Ovine
TBP
CTGGACTTCAAGATTCA
GAACATGGT
GGGTTAGCACAAGGCCTT
CTA
CACATCACAGCTC
CCC
FAM
Ovine
RPL13a
CCGGAAAAAGAAGCAG
CTCATG
GACCTCTGTGAATTTGCCA
ATTTTCT
CAGGCCGAAAAG
AACA
FAM
Bovine
GLUT4
Taqman(R) Gene Expression Assays. ID:
Bt03215316_m1; Part number: 4331182 (Thermo
Scientific)
TATGTGGCGGATG
CTATGGGTCCCT
FAM
Ovine CGATTCCAGAATGCCTT
GCT
GAGATCTCTGCTAACAGCT
TTTCCT
CCAAACCTGATGG
CATTAT
FAM
TBP = TATA-box binding protein, RPL13a = ribosomal protein L13a, GLUT4 = glucose transporter 4,
seconds at 8000g, after which the supernatant was discarded and the RNA was bound
to the silica membrane. Genomic DNA was removed by the addition of the enzyme
DNAse I (2.73U/μl; Roche); 10μl DNAse I and 70μl DNAse buffer (Roche) were added to
the silica membrane in the spin column. The column was left to incubate at room
temperature for 15 minutes.
Following incubation, 700μl Qiagen wash buffer was added, containing ethanol and
guanidine salt. The wash buffer removes proteins, fatty acids, carbohydrates and other
molecules that are not bound to the silica membrane. The column was centrifuged at
9000g for 30 seconds and the flow-through discarded. The column was washed twice
with 500μl Qiagen RPE wash buffer containing ethanol, and centrifuged at 14000g for 1
minute between each wash. The column was spun empty to remove any further traces
of ethanol. To elute the RNA, 50μl RNAse free water was added to the column which
was centrifuged for 1 minute at 9000g.
Determination of RNA concentration
The concentration of extracted RNA was determined using a NanoDrop
spectrophotometer (Thermo Scientific). The NanoDrop was calibrated with RNAse free
water before measurement of RNA. Surface tension holds 2μl of sample between two
optical fibres; a light is emitted and the spectrometer analyses the light passed through
the sample. Nucleotides such as RNA absorb light at 260nm and the 260/280nm ratio is
a measurement of RNA purity. A ratio of 2.0 is considered to be good quality RNA with
low DNA contamination. All samples had a 260/280nm ratio between 1.8 and 2.0.
Generation of cDNA
Complementary DNA is double stranded DNA synthesised from the extracted RNA and
this was achieved using the high capacity cDNA reverse transcription kit (Applied
Biosystems, Loughborough, UK). The kit uses random primers to initiate cDNA synthesis
and the enzyme reverse transcriptase to synthesise the cDNA. A reverse transcription
master mix was made by combining buffer, deoxynucleotide solution, random primers,
reverse transcriptase and water. To a 0.2μl PCR tube, 10μl master mix was added with
10μl 40ng/μl RNA sample. The samples were heated to 25°C for 10 minutes, 37°C for 2
hours, 85°C for 5 minutes, followed by cooling at 4°C. One sample from each treatment
group was treated without the addition of reverse transcriptase as a negative control.
qRT-PCR reaction
Samples were analysed for mRNA abundance using the CFX Connect Real Time PCR
detection system and data were acquired and processed with CFX Manager Software
(BioRad). Each sample was measured in triplicate and the CT value of the target gene was
normalised to the geometric mean of TBP and RPL13a. For each plate, a negative control
without cDNA was included to ensure that no amplicon contamination had occurred in
the reaction. In addition, cDNA from one sample was measured on each plate across all
assays as a quality control. To confirm the absence of genomic DNA, the reverse
transcriptase negative controls were also included. For all qRT-PCR reactions
(optimisation and experimental) the plates were incubated for 40 cycles at: 50°C for 2
minutes, 95°C for 10 minutes (polymerase activation), 95°C for 15 seconds
(denaturation) and 57°C for 1 minute (annealing).
In a reaction tube, 10μl TaqMan gene expression master mix with uracil-N-glycosylase
(Applied Biosystems) was added to 1μl primer/probe mix. In a white 96 well plate
(BioRad), 11μl master mix solution was added to each well followed by 9μl diluted cDNA
(1:10). The plate was sealed with an optical adhesive film (Applied Biosystems).
Standard curves
With test adipose cDNA, PCR reactions using reference and target genes were run to
obtain standard curves to determine the reaction efficiency. If the standard curves for
each gene are parallel, it indicates that the reactions have equal efficiency (Bustin et al.,
2009).
The cDNA was serially diluted seven times to a final dilution of 1 in 320. From the
measurements, the log of the dilution was plotted against the mean CT. The reaction
efficiency was determined from the slope using Equation 5.5 (Bustin et al., 2009). The
slopes for each gene were parallel and the linear relationships, denoted by R2, were all
over 0.98 (Figure 5.4).
Quantification of gene expression
As the standard curves for all assays were parallel, the geometric mean of the two
reference genes (Rf) was used to analyse the CT number of the genes of interest (GOI)
T method, which is summarised in Equation 5.6
(Vandesompele et al., 2002; Garcia-Crespo et al., 2005; Schmittgen & Livak, 2008). The
results were expressed as mean fold changes compared to sham fetuses at 129dGA.
( ) ( )
( ) ( )
2
Equation 5.6.
Equation 5.5.
Figure 5.4. Standard curves of average CT for genes of interest and reference genes
in fetal adipose tissue. TBP = TATA-box binding protein, RPL13a = ribosomal protein
5.2.8 Statistical analysis
All values are expressed as mean ± SEM unless otherwise indicated. The CV was
calculated for each stereological parameter using Equation 5.7, where S is the standard
deviation and x is the mean of the samples. All of the measurements had a CV of 15% or
less.
Statistical significance for comparisons between all parameters was assessed using a
three-way ANOVA using sex, treatment and gestational age as factors, followed by the
Tukey post hoc test. Once it was established that sex had no effect, parameters were
assessed using a two-way ANOVA with treatment and gestational age as factors,
followed by the post hoc Tukey test. For assessment of differences between the data
from two groups, a Student’s t-test was implemented. For correlation analysis, a linear
regression was used. In all cases, significance was accepted at P<0.05.
5.3 Results
5.3.1 Adipose tissue composition
From the H&E stained sections, it was clear that the structure of the adipose tissue in
the TX fetuses differed in the relative composition of UL and ML adipocytes, compared
to that of the sham controls at both 129 and 143dGA (Figure 5.5). The TX fetuses
appeared to have more UL and fewer ML adipocytes compared to the sham controls at
both 129 and 143dGA.
In the sham fetuses, there was a significantly greater proportion of ML relative to UL
adipocytes at both 129dGA (ML 69 ± 3% vs UL 31± 3%) and 143dGA (ML 68 ± 3% vs UL
32 ± 3%, Student’s t-test, P<0.001, Figure 5.6). In contrast, the proportions of ML and UL
adipocytes in the TX fetuses were similar at both 129dGA (ML 46 ± 4% vs UL 53 ± 4%)
and 143dGA (ML 49 ± 4% vs UL 51 ± 4%).
Equation 5.7.
A significant increase in the percentage of UL adipocytes, and a significant reduction in
ML adipocytes, were observed in the TX fetuses compared to the sham controls (P<0.05,
Figure 5.6). There was no effect of gestational age on the adipocyte proportions in either
treatment group.
Figure 5.5. H&E stained sections of perirenal adipose tissue in (A) sham 129dGA, (B) TX 129dGA, (C)
sham 143dGA and (D) TX 143dGA.
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When the percentages of ML and UL adipocytes were expressed as absolute and relative
adipocyte mass, significant increases in UL cell mass were observed in the TX fetuses
compared to sham fetuses at both 129 and 143dGA (P<0.05, Figure 5.7). The relative
mass of the UL cells in the TX fetuses was double that seen in the sham fetuses at both
129dGA (sham 1.2 ± 0.2g/kg vs. TX 2.4 ± 0.3g/kg) and 143dGA (sham 1.1 ± 0.2g/kg vs. TX
2.3 ± 0.3g/kg, P<0.05, Figure 5.7B). There was no effect of hypothyroidism on the
absolute or relative ML adipocyte mass (Figure 5.7). Gestational age had no effect on
the absolute or relative adipocyte mass in either treatment group (Figure 5.7).
Figure 5.6. Mean ± SEM ML and UL adipose cell proportion expressed as % of total
perirenal adipose tissue (PAT) volume, in sham and TX fetuses at 129 and 143dGA. *
Significantly different from sham fetuses at the same dGA, 2-way ANOVA, P<0.05. ‡
Significantly different from the UL cell type in same treatment group, Student’s t-test,
P<0.001, n = 9-10 in each group.
When all data were combined, significant positive correlations were observed between
the relative UL mass and plasma concentrations of both insulin (R=0.49, R2 = 0.24, n=37,
P 2 = 0.46 n=38, P
Figure 5.7. Mean ± SEM UL and ML adipocyte mass expressed as (A) absolute PAT mass
and (B) relative PAT mass in sham and TX fetuses at 129 and 143dGA. * Significantly
different from sham fetuses at the same dGA, 2-way ANOVA, P<0.05. ‡ Significantly
different from the UL cell type in same treatment group, Student’s t-Test, P<0.001. n =
9-10 in each group.
5.3.2 Unilocular adipocyte size
There was no difference in the average perimeter of the largest UL adipocytes between
the sham and TX fetuses at both 129 and 143dGA (Figure 5.9). In both treatment groups,
average UL cell size increased significantly with age between 129dGA and 143dGA
(P<0.05, Figure 5.9).
Figure 5.8. Correlation between relative UL cell mass and (A) plasma insulin concentrations,
n=37 and (B) plasma leptin concentrations in sham and TX fetuses at 129 and 143dGA, n=38.
5.3.3 Proliferative and adipogenic markers
PCNA
In PAT from hypothyroid fetuses PCNA protein content was significantly greater than
that in sham controls at both 129 and 143dGA (P<0.05, Figure 5.10), with no effect of
gestational age in either treatment group.
Figure 5.9. Mean ± SEM UL adipocyte perimeter, after correction for shrinkage, in PAT
the same treatment group at 129dGA. 2-way ANOVA, P<0.05. n = 9-10 in each group.
fetuses at both 129 and 143dGA, compared to the sham fetuses (P<0.05, Figure 5.11A).
group.
at both 129 and 143dGA, compared to sham controls (P<0.05, Figure 5.11B). In both the
mRNA between 129 to 143dGA (P=0.06, Figure 5.11B).
Figure 5.10. Mean ± SEM relative protein expression of PCNA in PAT from sham and
TX fetuses at 129 and 143dGA. Representative blot images from two fetuses in each
treatment group are shown. * Significantly different from sham fetuses at the same
dGA, 2-way ANOVA, P<0.05. n = 8-10 in each group.
Figure 5.11
PAT from sham and TX fetuses at 129 and 143dGA. * Significantly different from sham fetuses
at the same dGA, 2-way ANOVA, P<0.05. n = 8-10 in each group
5.3.4 Insulin signalling proteins
Receptors
controls at 129dGA (P<0.05, Figure 5.12A). At 143dGA, there was no significant
fetuses (P<0.05, Figure 5.12A).
compared to sham controls at 129dGA (P<0.05, Figure 5.12B). By 143dGA, however, the
P<0.05) and
to the same level seen in the sham controls (Figure 5.12B). There was no change in IGF-
The amount of long form leptin receptor in adipose tissue was unaffected by gestational
age or thyroidectomy (Figure 5.12C).
Figure 5.12
from sham and TX fetuses at 129 and 143dGA. * Significantly different from sham fetuses at the
ANOVA, P<0.05. n = 9-10 in each group.
Akt
Adipose protein levels of Akt1 were significantly increased, while Akt2 levels were
significantly decreased in TX fetuses compared to sham controls at both 129 and
143dGA (P<0.05, Figure 5.13A, B). In both treatment groups, there was no effect of
gestational age on adipose protein content of either Akt1 or Akt2.
The amount of pAkt was significantly decreased in the TX fetuses at 129dGA when
compared to sham controls (P<0.05, Figure 5.13C). In the hypothyroid fetuses, there was
a significant effect of gestational age, with the amount of pAkt increased between 129
and 143dGA (P<0.05, Figure 5.13C). At 143dGA, therefore, there was no difference in
the protein expression of pAkt between the TX and sham fetuses (Figure 5.13C).
Downstream targets
Protein expression levels of pmTOR tended to be lower in the TX fetuses at 129 and
143dGA compared to sham controls (2-way ANOVA, P=0.08, Figure 5.14A). When a
Student’s t-test was used to compare the data from TX and sham fetuses, there was a
significant decrease in pmTOR at 143dGA in response to hypothyroidism (P<0.05, Figure
5.14A). There was no effect of gestational age on pmTOR protein content in either
treatment group.
The adipose levels of pS6K were significantly increased in the TX fetuses at both 129 and
143dGA compared to the sham fetuses (P<0.05, Figure 5.14B). In the TX, but not sham
fetuses, a significant decrease in pS6K was observed between 129 and 143dGA (P<0.05,
Figure 5.14B).
In the hypothyroid fetuses, the protein expression of GLUT4 in PAT was significantly
increased by 60 and 80%, at 129 and 143dGA, respectively, compared to sham controls
(P<0.05, Figure 5.14C). There was no effect of gestational age on adipose GLUT4 levels
in either treatment group.
Figure 5.13. Mean ± SEM relative protein expression of (A) Akt1 (B) Akt2 and (C) pAkt in PAT
from sham and TX fetuses at 129 and 143dGA. * Significantly different from sham fetuses at
2-way ANOVA, P<0.05. n = 9-10 in each group.
Figure 5.14. Mean ± SEM relative protein expression of (A) pmTOR (B) pS6K and (C) GLUT4 in
PAT from sham and TX fetuses at 129 and 143dGA. * Significantly different from sham fetuses
at the same dGA, † significantly different from fetuses in the same treatment group at 129dGA,
2-way ANOVA, P
P<0.05. n = 8-10 in each group.
At 129dGA, adipose GLUT4 mRNA abundance was significantly increased by
approximately 25% in the TX fetuses, compared to sham controls (P<0.05, Figure 5.15).
A developmental increment in GLUT4 mRNA level was observed between 129 and
143dGA in the sham but not the TX fetuses (P<0.05, Figure 5.15). Adipose GLUT4 mRNA
abundance was similar in the TX and sham fetuses at 143dGA (Figure 5.15).
5.4 Discussion
5.4.1 Hypothyroidism induced unilocular cell hyperplasia
Development of adipose tissue in utero is vital for fat storage, energy provision and
metabolism, and thermoregulation in the offspring over the perinatal period. This study
has shown that thyroid hormone deficiency in the sheep fetus during late gestation
leads to enlargement of relative PAT mass, which was due to a specific increase in UL
Figure 5.15. Mean ± SEM relative mRNA abundance of GLUT4 in PAT from sham and TX
significantly different from fetuses in the same treatment group at 129dGA, 2-way ANOVA,
P<0.05, n = 8-10 in each group.
adipocyte mass. The relative mass of the ML adipocytes, however, was not altered in
the TX fetus. As there was no effect of gestational age on the adipocyte composition in
either treatment group, it is indicated that this phenotype was established prior to
129dGA and maintained to term.
To determine if the increase in UL adipocyte mass in response to hypothyroidism was
due to hypertrophy and/or hyperplasia, UL adipocyte size was measured by perimeter.
If the growth in PAT was due to adipocyte hypertrophy, the average cell perimeter would
be expected to be larger in the hypothyroid fetuses. As there was no apparent difference
in the UL adipocyte size between the TX and sham fetuses, it can be postulated that the
overgrowth of the adipose tissue in the TX fetus was due to adipocyte hyperplasia. This
was confirmed by the increase in the protein level of the mitotic marker, PCNA, in the
TX fetus at both 129 and 143dGA. In both treatment groups, the average UL cell size
increased with gestational age. This is to be expected as lipid deposition occurs in fetal
adipose tissue in preparation for energy availability after birth.
Hypothyroidism in the sheep fetus during late gestation may influence PAT mass by
changes in lipid metabolism. In human adults, hypothyroidism has previously been
shown to reduce catecholamine-stimulated lipolysis (Wahrenberg et al., 1986). Adult
of lipolytic enzymes in the liver compared to wild type controls (Liu et al., 2003).
Additionally, it has been reported in adult rats that hypothyroidism reduces expression
et al., 2000). Reduced sensitivity to
catecholamine in the TX fetus may result in an inability to utilise fat storage for energy
receptor expression in PAT and other tissues in the TX sheep fetus.
Although the relative proportion of ML adipocytes in PAT was decreased by
hypothyroidism in utero, the overall absolute and relative ML mass was unchanged.
However, the functionality of BAT as a thermoregulatory organ in the TX fetus remains
unknown. Polk et al. (1987) showed that thyroidectomy in the sheep fetus results in
hypothermia, impaired thermogenesis and a decrease in circulating free fatty acids in
the newborn lamb. Thermogenesis at birth is regulated, in part, by the expression of
UCP1 in BAT, and the UCP1 gene is known to contain a TRE (Rabelo et al., 1995). Adipose
UCP1 mRNA levels rise towards term, coincident with the abundance of D2 in fetal PAT,
indicating a local site for T3 production and activation of UCP1 (Clarke et al., 1997; Pope
et al., 2014). Therefore, adipose UCP1 may be downregulated in the TX fetuses due to
the prevention of the prepartum rise in thyroid hormones. The expression of UCP1 and
thermogenic capacity of BAT remains to be investigated in the TX sheep fetus.
adipocytes, indicating its importance in adipose growth (Rosen et al., 1999).
at both 129 and 143dGA compared to controls. This is the first report of increased
one month after birth compared to the fetus (Mühlhäusler et al., 2007) and, therefore
transition in adipose function from thermogenesis to lipid storage, which would
peroxisome proliferator response element on target genes (PPRE; Ying et al., 2007).
et al.
indicates that further knowledge is required to understand the regulation of
adipogenesis by thyroid hormones before and after birth.
5.4.3 Plasma insulin concentrations correlated with UL adipocyte mass
When all data were considered, there was a significant positive correlation between
circulating insulin concentrations and relative UL adipocyte mass, suggesting that the
rise in the population of UL adipocytes present in the TX fetus may be a direct result of
increased insulin action.
Insulin is known to promote growth of adipose tissue before birth (Teruel et al., 1996;
Kamana et al., 2015). Human offspring born to obese mothers have increased total fat
mass and a greater percentage adiposity which are associated with higher umbilical cord
concentrations of insulin, compared to offspring of lean mothers (Catalano et al.,
2009b). In adult humans, it has previously been reported that the circulating insulin
concentrations correlate with the number of adipocytes in subcutaneous adipose tissue
(Arner et al., 2010). Furthermore, in obese adult rats, adipocyte proliferative capacity
correlates with increased plasma insulin concentrations (Johnson et al., 1978).
Increased circulating insulin concentrations in the TX fetus may have contributed to UL
adipose growth through increased glucose uptake. Fetal thyroid hormone deficiency
increased the mRNA abundance of adipose GLUT4 at 129dGA and the protein expression
at both 129 and 143dGA. Elevated levels of adipose GLUT4 in the TX fetus may promote
glucose uptake which is stored as lipid, through the process of lipogenesis, thus
contributing to the increased unilocular adipocyte mass. Indeed, in adult mice with an
overexpression of adipose GLUT4, adipocyte number was increased two-fold, with no
change seen in adipocyte cell size (Shepherd et al., 1993). It is not known, however,
whether the increased adipose levels of GLUT4 seen in the TX fetus are representative
of cytoplasmic and/or membrane bound GLUT4. The trafficking of GLUT4 needs to be
assessed to ascertain whether there is simply an increase in the number of transporters
and whether this is translated to functional glucose uptake. Additionally, GLUT4 protein
was increased without any change in mRNA abundance in the TX fetus at 143dGA,
suggesting that there may be changes in post-transcriptional processes. This is the first
report of increased GLUT4 protein and mRNA in the adipose tissue of the thyroid
deficient sheep fetus and is consistent with previous studies in the neonatal rat, where
thyroidectomy induced adipose GLUT4 protein and mRNA (Castello et al., 1994).
Insulin may stimulate an increase in fetal UL adipose mass by a variety of mechanisms,
lipogenesis by an increase in the genes encoding acetyl-CoA carboxylase and fatty acid
synthase (Kersten, 2001). The transcription factor, SREBP-1, increases lipogenic gene
transcription and is stimulated by the insulin signalling pathway (Saltiel & Kahn, 2001).
80% compared to controls, and this is restored to normal levels after treatment with
insulin (Vidal-Puig et al., 1996). Additionally, in human adults, insulin infusion via
(Rieusset et al.
influence various components of the insulin signalling pathway to increase glucose
uptake and enhance lipid metabolism in skeletal muscle. In adult human subjects,
et al.
et al., 1999). It has been demonstrated that induction of
et al.
increase in GLUT4 protein expression in PAT to promote further growth of UL adipose
tissue.
5.4.4 Hypothyroidism altered insulin signalling in fetal adipose tissue
Insulin and IGF-I receptor expression
Thyroid hormone deficiency in the sheep fetus during late gestation altered normal
insulin signalling in PAT. Protein expression of both the insulin and IGF-I receptors was
decreased in the TX fetus at 129dGA compared to controls, indicating that
hypothyroidism altered adipose insulin sensitivity in the younger fetuses. This may be a
consequence of hyperinsulinaemia in the TX fetus which causes downregulation of the
insulin receptor by a homeostatic negative feedback mechanism in adipocytes. In the
term. This may be due to other hormonal influences during late gestation, such as
cortisol, possibly to reduce insulin signalling and limit adipose proliferation near term to
promote thermogenic function.
Downstream targets in insulin signalling
Previous studies have reported that Akt is essential in adipocyte development. Neonatal
mice which are deficient in both Akt1 and Akt2 are severely growth impaired with sparse
fat pads and no visible lipid droplets (Peng et al., 2003). In addition, it has previously
been established that Akt1 has a wide tissue distribution in adults and is important for
cell proliferation, whereas Akt2 is highly expressed in adipose tissue and skeletal muscle
and contributes to the regulation of insulin-mediated glucose uptake (Hers et al., 2011).
In this study, the adipose protein expression of Akt1 was increased, and Akt2 decreased,
in the TX fetuses compared to sham controls at both 129 and 143dGA. The rise in Akt1
may contribute to the mechanism whereby insulin promotes UL adipocyte proliferation.
The coincident decrease in Akt2, however, suggests that there may be a defect in insulin
signalling that could result in impaired insulin-mediated glucose uptake, although
adipose GLUT4 expression was elevated in the TX fetus. Alternatively, the reduction in
Akt2 seen in the TX fetuses may result from negative feedback to limit adipocyte glucose
uptake. Interestingly, Akt2 has also been shown to control cell cycle exit. Studies using
small interfering RNA in mouse and human fibroblasts in vitro identified that Akt2 had
no role with respect to cell cycle entry or cell proliferation, but was required for cell cycle
exit by targeting cell cycle inhibitors (Heron-Milhavet et al., 2006). These findings
support the data in this study in which adipose Akt2 was decreased in the TX sheep fetus.
As a consequence, fewer cells exit the cell cycle and continue to proliferate and
contribute to the increased UL adipocyte mass.
The activated phosphorylated form of total Akt, pAkt, was decreased in the hypothyroid
fetus at 129dGA, and was restored to normal levels by 143dGA. The Akt phosphorylation
site analysed in this study was Ser473, which is the dominant site of phosphorylation by
mTORC2 (Copp et al., 2009). This suggests that there may be suppression of adipose
mTORC2 levels in response to hypothyroidism in utero (Figure 5.16). Once activated, Akt
phosphorylates mTOR at Ser2448, which predominately activates mTORC1 (Copp et al.,
2009). The mTORC1 complex regulates cell growth and translation, in part, by
phosphorylation of the downstream target, S6K (Hara et al., 2002). A recent study has
identified a negative feedback mechanism regulating the downstream targets of the
insulin pathway. In an epithelial tissue cell line, mTORC2 is negatively regulated by S6K
through the phosphorylation of Sin1, a component of the mTORC2 complex (Liu et al.,
2013). It is possible that the increased pS6K in the adipocytes of the TX fetus inhibits
mTORC2 (Figure 5.16).
Figure 5.16. A diagram of the insulin signalling pathway including the two Akt isoforms and
mTOR complexes. During hypothyroidism in utero, stimulation of mTORC1 by elevated Akt1
may be responsible for the rise in pS6K. However, the inhibitory actions of S6K on mTORC2
may account for the overall lack of effect of hypothyroidism on pmTOR. Red dots signify
phosphorylation sites.
The protein level of the activated pmTOR (Ser2448) tended to decrease in the TX fetus
but this represents the combined level of both mTOR complexes. Indeed, the lack of
change in adipose pmTOR in the TX fetus may be a consequence of increased mTORC1
and decreased mTORC2 levels. Further characterisation of the distinct roles of mTORC1
and mTORC2, and their response to hypothyroidism in utero, is required to fully
understand their contribution to adipocyte growth before and after birth.
Although there are no reports of a TRE present in the enhancer regions of insulin
signalling genes, thyroid hormone has previously been shown to stimulate Akt1
endothelial cells in vitro (Hiroi et al., 2006). Additionally, in a human insulinoma cell line,
(Verga Falzacappa et al., 2007). In adipose tissue, the primary outcomes of the insulin
signalling pathway are cell proliferation by activation of S6K and glucose uptake by
GLUT4 translocation. As both adipose pS6K and GLUT4 were upregulated in the TX fetus,
it can be postulated that UL adipocyte proliferation originated from hyperinsulinaemia
in thyroid hormones.
5.4.5 Plasma leptin concentrations correlate with UL cell mass
In the present study, the increase in plasma leptin in the TX fetus was likely to be due to
the larger proportion of UL adipocytes as these cells are characteristic of WAT which
secretes and synthesises leptin. Indeed, a positive correlation was observed between
plasma leptin concentration and UL cell mass in all fetuses. This correlation has been
reported previously in the fetuses of well-fed ewes (Mühlhäusler et al., 2002). Thyroid
hormone deficiency in the sheep fetus has also previously been shown to increase
adipose leptin mRNA levels (O'Connor et al., 2007). The increase in circulating leptin
concentrations seen in the TX fetus, therefore, may be due to the greater UL adipose
mass and/or secretory capacity of the adipocytes; these changes may be secondary to
hypothyroidism and/or hyperinsulinaemia in utero. Adult rat adipocytes in vitro
produce and secrete leptin in response to insulin (Barr et al., 1997). In addition, adipose
leptin mRNA abundance is increased in sheep fetuses infused with insulin (Devaskar &
Anthony, 2002).
In the TX sheep fetus, it is possible insulin and leptin interact in a positive feedback
Elevated insulin concentrations in the TX fetus may be responsible for UL adipocyte
proliferation and increased leptin secretion. The high circulating leptin concentrations
insulin.
Mechanisms by which insulin promotes UL adipocyte mass
5.5 Conclusions
Hypothyroidism in the sheep fetus during late gestation was associated with increased
PAT mass which appeared to be due to UL adipocyte hyperplasia. The greater deposition
of WAT in the TX fetus may be secondary to increased mRNA and protein expression of
Figure 5.17. Proposed feedback model responsible for increased UL adipocyte mass and
the TX sheep fetus.
the concomitant increases in plasma concentrations of insulin and leptin. There was no
change in the ML adipocyte mass in response to hypothyroidism in utero, however,
further studies on adipocyte function are required to determine adipose thermogenic
capacity in the TX fetus.
Thyroid hormone deficiency was associated with altered insulin signalling in the PAT of
fetuses in late gestation. Expression of the insulin and IGF type 1 receptors decreased,
which is characteristic of PAT insulin resistance and could have consequences for
neonatal and adult metabolism. Furthermore, alterations in downstream factors, such
as the Akt1 and 2 and mTOR, may have short and long-term effects on normal glucose
and lipid metabolism. Further work is needed to characterise the role of signalling
protein isoforms, and the consequences of hypothyroidism for adipose metabolic
function before and after birth.
6 EFFECTS OF HYPOTHYROIDISM ON FETAL KIDNEY DEVELOPMENT
6.1 Introduction
In precocious mammals, like the sheep and human, development of the kidneys begins
early in gestation with nephrogenesis completed just before birth. This means that the
final number of nephrons generated will persist into adulthood and no further nephrons
can be generated after birth (Gimonet et al., 1998; Wintour et al., 2003; Figueroa et al.,
2005). Nephrogenesis is, in part, regulated by the fetal renin-angiotensin system, which
in turn, is sensitive to changes in thyroid hormones (Kobori et al., 2001; Chen et al.,
2007). Since nephron number is determined before birth, any alterations in thyroid
hormones in utero have the potential to have a significant impact on renal function in
neonatal and adult life.
The adult kidney is essential in blood filtration and fluid homeostasis, while before birth,
these functions are mediated by the placenta. In fetal sheep and rats, there is an
increase in the expression of the sodium transporters, ENaC and Na+/K+ ATPase pump
towards term, with abundance at its highest shortly before birth (Watanabe et al., 1999;
Keller-Wood et al., 2008). The maturational changes in renal transporters in preparation
for neonatal life are known to be influenced by changes in circulating glucocorticoid and
insulin concentrations (Wang et al., 2001; Song et al., 2006; Keller-Wood et al., 2008).
The role of thyroid hormones, however, in the control of renal development is unknown.
It has been demonstrated that hypothyroidism in the sheep fetus leads to an increase
in relative kidney mass during late gestation (Chapter 3; Chattergoon et al., 2012a). The
high plasma insulin concentration observed in the thyroid hormone deficient fetus
(Chapter 3) may contribute to changes in kidney growth. In neonatal mice, kidney size
was reduced by deletion of the irs2 gene (Carew et al., 2010), suggesting that the insulin
signalling pathway has an important role in kidney development.
The aims of the study were (1) to identify structural changes in the fetal kidney which
may account for the greater relative kidney weight induced by hypothyroidism, (2) to
elucidate if renal overgrowth is associated with any changes in the insulin signalling
pathway in the fetal kidney, and (3) to investigate whether tubular ion channel protein
expression is affected by hypothyroidism in utero.
It was hypothesised that enhanced renal growth in the hypothyroid sheep fetus is due
to greater number of glomeruli and tubules in the kidney cortex which is secondary to
insulin signalling in the fetal kidney. Furthermore, the expression of the transporter
proteins in the fetal kidney will be downregulated by thyroid hormone deficiency in
utero and prevention of the prepartum surge in T3 concentration.
6.2 Methods
6.2.1 Animals
All animals, treatments and post mortem procedures are described fully in Section 2.1.
As reported in Chapter 3, an increase in kidney mass was only seen in the TX fetuses
compared to the sham controls at 143dGA and therefore only these fetuses were used
in the study (sham n=10, TX n=10). One kidney portion was collected from each fetus
and immersed in 4% formalin for paraffin wax embedding, as described in Section 2.3.
The second kidney was frozen at -80°C until required for analysis.
6.2.2 Histology
The sectioning, staining and stereological measurements of the glomerulus were
undertaken by Mona Hasim, an undergraduate student at Oxford Brookes University, as
part of her final-year project while under my supervision.
All histology processing steps are described in detail in Section 2.3. Serial sections of wax
embedded kidney were cut to a thickness of 5μm and left to dry overnight before H&E
staining. Stained sections were scanned using a NanoZoomer digital slide scanner
(Hamamatsu Photonics) to create digital images for analysis. All stereological
measurements were performed blind to the treatment group.
6.2.3 Glomerulus size
Using the stereology software NDP.view (Hamamatsu Photonics), the diameters of the
largest glomeruli in the outer renal cortex were determined using a ruler function
(Figure 6.1). Large glomeruli were defined to have a diameter of at least 45μm at the
widest axis, before shrinkage, to ensure as far as possible that glomeruli measured were
in transverse mid-line section. At least 25 glomeruli were analysed per animal. To adjust
measurements for tissue shrinkage in processing, the diameters of red blood cells in the
sections were measured and used to calculate shrinkage (6μm; Karvonen, 1954;
Equations 5.3 and 5.4, Chapter 5). The percentage of tissue shrinkage ranged from 45 to
60% and there was no significant difference in shrinkage between treatment groups.
The CV for glomerular diameter within each fetus was calculated using Equation 5.7
(Chapter 5) and all fetuses had a CV of less than 12%.
Figure 6.1. Analysis of glomerular diameter in kidney from sham
and TX sheep fetuses at 143dGA.
6.2.4 Fractional glomerular and tubular volume
The fractional volumes of glomeruli and tubules were determined using NewCAST
stereological software (Visiopharm). Only the renal cortex was used as the region of
interest and a point counting grid containing 64 points was applied over the sections.
Using meander sampling, kidney tissue was investigated using SURS (Figure 6.2).
Figure 6.2. H&E stained kidney section from fetal sheep. (A) ‘G’ indicate glomeruli
and circled structures labelled ‘T’ indicate tubules. (B) Counting grid used in
meander sampling of glomeruli and tubules. A structure would be counted when
underneath a green ‘+’.
The final magnification at analysis was x400. Between 40 and 50 counting frames per
slide were used to provide at least 200 counts per animal for each variable. The
fractional volumes of glomeruli and tubules (Volfraction) were calculated using equation
6.1:
Where P is the number of points falling on either glomeruli or tubules, and T is the total
number of sampling points.
6.2.5 Glomerular density and volume
The physical dissector method was used to measure the density of glomeruli in the renal
cortex. The physical dissector is a stereological technique used to count particles in a
virtual 3D volume generated by two sections separated by a known distance. Only
transects which are partially or completely inside a counting frame are counted in pairs
of serial sections (the reference and the ‘look-up’ sections). The only particles that are
counted are the ones which appear on the reference section but not on the lookup
section (Kaplan et al., 2012). These are known as the dissector particles, Q-. The number
of particles in a unit volume (numerical density) was calculated by dividing the counted
number of particles by the dissector volume (Gundersen & Jensen, 1987; Howard &
Reed, 2010; Kaplan et al., 2012).
The stereological software NewCAST (Figure 6.3, Hamamatsu Photonics) was used to
implement the dissector. The distance between the pair of slides should be less than
one third of the average height of the particle examined (Howard & Reed, 2010). Using
the mean diameter of the glomerulus in the ovine fetal kidney as approximately 150μm,
the 1st and 5th sections were used, separated by a distance of 20μm between the pair.
Between 55 and 60 counting frames were assessed and the area of the counting frame
was 0.13mm2.
Equation 6.1.
The number of dissector frames was measured by counting the corner points of the
counting frame. Glomerular density (Numden) was calculated using Equation 6.2:
([ ] )
Q- P is the total number of corner
points, and a and h are the frame area and dissector height, respectively. The whole
equation was divided by two to account for the counting taking place in two directions.
The mean glomerular volume was calculated by dividing the fractional glomerular
volume (Section 6.2.3) by the numerical density. The CV for the mean glomerular volume
for each individual animal was under 9%.
6.2.6 Glomerular proliferation
In order to identify cells undergoing proliferation, sections were immunolabelled using
a mouse monoclonal anti-PCNA antibody at a concentration of 4.1μg/ml (Dako) and
visualised using the Vectastain Elite ABC kit (anti-mouse secondary antibody; Vector
Laboratories, Section 2.4). Counterstaining of cells was carried out using the nuclear
Figure 6.3. The physical dissector used to measure glomeruli density in kidney cortex from a
sheep fetus at 143dGA. Section pairs 20μm apart were analysed for glomerular structures in
the counting frame in the reference (left) and look-up (right) sections.
Equation 6.2.
stain methyl green (Vector Laboratories, Section 2.4). Slides were scanned into digital
images using a NanoZoomer (Hamamatsu Photonics). In glomeruli judged to be
sectioned approximately mid-line, the expression of PCNA was scored using the
following criteria: 0 = absent PCNA labelling, 1 = 1-10 PCNA-positive cells, 2 = 11-20
PCNA-positive cells, 3 = 21 or more PCNA-positive cells. The scoring reflected the
number of positively labelled cells and not the intensity of the labelling (Figure 6.4).
Between 40 and 50 glomeruli from the outer cortex were sampled for each animal. The
glomerulus diameter was also measured.
6.2.7 Tubule length density
Tubule length density is a measure of renal tubule length in a reference volume. In order
to analyse the length density of proximal and distal tubules in the renal cortex, a
counting frame was used within the NewCAST stereological software (Figure 6.5). The
stereological method assumes that the length of the structure is larger than the width
(Howard & Reed, 2010). Only fully cross-sectioned tubules with a visible lumen were
counted by meander sampling and tubules were only counted if they were within the
0.017mm2 counting frame.
Figure 6.4. Scoring of PCNA immunolabelling in the kidney glomerulus of a sheep fetus at 143dGA.
(A) Absence of PCNA labelling and scored 0, (B) scored 1 for 1-10 labelled cells, (C) scored 2 for the
presence of 11-20 labelled cells and (D) scored 3, due to the presence of more than 20 positively
labelled cells. Scale bar: 25μm.
Tubule length density (Lengthden) was calculated using Equation 6.3:
= 2 ×
Where Q is the total number of tubules counted, is the area of the counting frame
and P is the total number of counting frames per section (Noorafshan, 2014). At least
200 tubules were counted over 30 fields of view per section at a final magnification of
x400. The CV for tubule length density was 7% or less for each fetus.
6.2.8 Tubule surface area density
Tubule surface area density is the measure of tubule surface (internal and external) per
length of tubule in a reference volume. Surface area density of proximal and distal
tubules in the renal cortex was determined using the NewCAST stereological software
Figure 6.5. The counting frame used to analyse tubule length density in the kidney cortex of a
sheep fetus at 143dGA. A tubule should be counted if it lies within the frame. It will be excluded
if it touches a red line, but included if it touches a green line. The green ‘A’ indicates a counted
tubule.
Equation 6.3.
and a set of isotropic linear test line probes. Lines of a fixed length were superimposed
onto each section in a random orientation and intersections were counted where the
line probe crossed a tubule surface (Figure 6.6). End-points associated with each line
were also counted to determine a reference volume.
Surface area density (Sv) was calculated as:
Where is the number of intersection points per test line in a reference space; this was
determined by Equation 6.5:
Equation 6.4.
Figure 6.6. Isotropic linear test lines used to determine tubule surface area density in kidney
cortex from a sheep fetus at 143dGA. The green ‘A’ indicate where a tubule has crossed the
isotropic line and the blue ‘P’ are the end-points of the line counted to determine reference
volume.
=
×
Where is the sum of the tubule intersections, is the length of the test line and
is the total number of line end-points (Noorafshan, 2014). At least 200 intersections
were counted per kidney in over 30 fields of view at a final magnification of x400. The
CV for tubule surface area density was calculated using Equation 5.7 (chapter 5) and was
7% or less for each fetus.
6.2.9 Western blotting
The kidney was divided into the cortex and the medulla for quantification of proteins by
western blotting. Cortical and medullary tissue from the kidney of each fetus (100mg)
was homogenised in lysis buffer and the protein concentration was determined using a
BCA protein assay (Section 2.5). The western blotting procedure is described in detail in
Section 2.6.
Components of the insulin signalling pathway, as well as protein content of PCNA and
+/K+
specific conditions for each antibody used are shown in Table 6.1. The amount of protein
100μg protein was used. All samples were heated to 70°C for 10 minutes with the
exception of those used for p-S6K quantification, which were heated to 99°C for 10
minutes. After detection, the protein visualised in each sample was normalised to the
total protein content assessed by Ponceau S staining. The samples of cortex and medulla
from all animals were loaded across four gels which were separated and transferred
together to minimise variation. A control sample was loaded on each of the gels and the
results of the control were used to normalise the values across all membranes. After
densitometry and normalisation to total protein content, the results were standardised
to the mean value of the sham group. Results are therefore expressed as fold changes
in arbitrary units.
Equation 6.5.
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6.2.10 Kidney wet and dry weights
In a separate cohort of fetal sheep, hypothyroidism was induced as described previously
(Section 2.1) and tissues were collected at 129 and 143dGA (n=6 in each sham and TX
group). One kidney from each fetus was weighed as wet after dissection and was
dehydrated in a freeze-dryer for 48 hours and weighed again to determine kidney water
content. Wet and dry kidney weights were expressed relative to the fetal body weight
and the water content was calculated as a percentage.
6.2.11 Statistical analysis
All values are expressed as mean ± SEM unless otherwise indicated. Statistical
differences were assessed using a two-way ANOVA with treatment and fetal sex as
factors. If it was established that sex had no effect, parameters were assessed using a
Student’s t-test. Wet and dry kidney weights were assessed by three-way ANOVA with
treatment, age and fetal sex as factors. Similarly, if it was established that fetal sex had
no effect, a two-way ANOVA was used to assess these parameters. Distribution of
glomerular PCNA scoring between the sham and TX fetuses was also assessed by two-
way ANOVA, using PCNA score and treatment as factors. Linear regression was used to
examine relationships between variables. To determine significant differences between
the correlations of glomerular PCNA counts, a Fisher’s z-transformation test was
performed. In all cases, significance was accepted at P<0.05.
6.3 Results
6.3.1 Glomerulus size and fractional glomerular volume and density
The average glomerulus diameter in the TX fetuses (148.1 ± 6.0μm) was not significantly
different from that seen in the sham fetuses (151.1 ± 4.9μm).
There was no significant difference in the percentage glomerular volume between the
sham (5.5 ± 0.2%) and TX (5.4 ± 0.3%) fetuses. Additionally, there were no significant
differences in glomerular density (Figure 6.7A) or mean glomerular volume between the
sham and TX fetuses (Figure 6.7B).
6.3.2 Glomerular proliferation
There was no significant difference in the distribution of glomerular PCNA scoring
between the sham and TX fetuses (Figure 6.8).
There was a positive correlation between glomerulus diameter and PCNA score in the
sham fetuses (R=0.58, R2=0.34, n=10, P<0.001) and that was not seen in the TX fetuses
(R=0.25, R2=0.06, n=9). The correlations between sham and TX fetuses were not
significantly different to each other (Fisher’s z-transformation test, P=0.56, Figure 6.9).
Figure 6.7. Mean ± SEM (A) glomerular density and (B) glomerular volume in the renal
cortex of sham and TX fetuses at 143dGA. n = 10 fetuses in each group.
Figure 6.9. Correlations between glomerulus diameter and scored PCNA-positive
cells in kidney cortex from sham and TX fetuses at 143dGA. Sham: n=10, R= 0.58,
R2=0.34, p<0.001; TX: n=9, R=0.24, R2=0.06.
Figure 6.8.Mean ± SEM glomeruli per PCNA score in sham and TX fetuses at 143dGA.
n = 10 fetuses in each group.
6.3.3 Tubule length density and surface area density
There was no effect of thyroid hormone deficiency on the tubule length density in the
kidney cortex (sham 215 ± 21cm/mm3 vs TX 212 ± 15cm/mm3, Figure 6.10A).
Thyroidectomy had no effect on tubule surface area density in the kidney cortex; tubule
surface area density in the TX fetuses (1.7 ± 0.1cm2/mm3) was similar to that observed
in the sham fetuses (sham 1.6 ± 0.2cm2/mm3, Figure 6.10B).
6.3.4 Insulin signalling proteins
Receptors
There were no significant differences in the relative protein contents of the insulin, IGF
type 1 and leptin long-form receptors in the renal cortex or medulla in the TX fetuses
compared to sham controls (Figure 6.11). In addition, there was no effect of sex on the
relative levels of any of the receptor proteins measured.
Figure 6.10. Mean ± SEM (A) tubule length density and (B) tubule surface area density in
kidney cortex from sham and TX fetuses at 143dGA. n=10 fetuses in each group.
Figure 6.11.
kidney cortex and medulla from sham and TX fetuses at 143dGA. n=9-10 in each group.
Akt
In the cortex, there was an effect of fetal sex on Akt1 content (P<0.05); greater Akt1
expression was observed in the female fetuses compared to the male fetuses, regardless
of treatment group (P<0.05; Figure 6.12A). There was no significant effect of
thyroidectomy or fetal sex on the relative protein expression of Akt1 in the renal medulla
(Figure 6.12B).
Figure 6.12. Mean ± SEM relative protein expression of (A) Akt1 in male and female
fetuses in the kidney cortex from sham and TX fetuses at 143dGA, normalised to sham
male fetuses and (B) Akt1 in the kidney medulla. † Significantly different from male
fetuses in the same treatment group, 2-way ANOVA, P<0.05. n=9-10 in each group,
balanced by sex (n=4-6 in each group).
There was no significant change in the relative levels of either Akt2 or pAkt in the
medulla or cortex in the TX fetuses compared to the sham fetuses (Figure 6.13). There
was no significant effect of fetal sex on either Akt2 or pAkt expression.
Downstream targets
Protein expression levels of pmTOR and pS6K in the renal cortex and medulla were
unchanged in the TX fetuses compared to sham controls (Figure 6.14A, B).
Figure 6.13. Mean ± SEM relative protein expression of (A) Akt2 and (B) pAkt in
kidney cortex and medulla from sham and TX fetuses at 143dGA. n=9-10 in each
group.
In the renal cortex, there was a significant interaction between the effects of treatment
and fetal sex on GLUT4 protein content (P<0.05). Although hypothyroidism had no effect
on GLUT4 expression in the male fetuses, a decrease in GLUT4 protein was observed in
the female TX fetuses compared to female sham controls (P<0.05; Figure 6.15A). In
addition, cortical GLUT4 content was higher in the sham female fetuses compared to
the sham male fetuses (P<0.05, Figure 6.15A). There was no effect of fetal
Figure 6.14. Mean ± SEM relative protein expression of (A) p-mTOR and (B) pS6K in
kidney cortex and medulla from sham and TX fetuses at 143dGA. n=9-10 in each group.
hypothyroidism on the relative expression of GLUT4 in the renal medulla; however,
significantly lower GLUT4 content was seen in the female fetuses compared to the male,
regardless of treatment (P<0.05; Figure 6.15B).
Figure 6.15. Mean ± SEM relative protein expression of GLUT4 in the (A) kidney cortex and (B)
from male fetuses in the same treatment group, *significantly different from sham fetuses of
the same sex, 2-way ANOVA, p<0.05. n=9-10 in each group, balanced by sex (n=4-6 in each
group).
6.3.5 Cell proliferation
There were no significant changes in the protein expression of PCNA in either the renal
cortex or medulla in TX fetuses compared to sham controls (Figure 6.16). Relative PCNA
content in the kidney was not affected by fetal sex.
6.3.6 Sodium channels and transporters
+/K+
+/K+
6.17). There was no effect of sex on any of the transporter proteins measured.
Figure 6.16. Mean ± SEM relative protein expression of PCNA in the kidney cortex and
medulla from sham and TX fetuses at 143dGA. n=9-10 in each group.
6.3.7 Kidney wet and dry weights
There was no significant difference in the absolute kidney wet weight in the TX fetuses
compared to sham controls at 129 (sham 6.5 ± 0.5g vs TX 6.4 ± 0.6g) or 143dGA (sham
7.0 ± 0.6 vs TX 8.1 ± 0.5g; Figure 6.18A). There was no effect of gestational age on
absolute kidney wet weight in either treatment group. There was no significant change
in the absolute dry weight of kidneys from TX fetuses compared to sham controls at
either age group, however, there was a significant increase in absolute dry weight in the
older fetuses compared to those at 129dGA, in both treatment groups (P<0.05, Figure
6.18B).
Figure 6.17 +/K+
Na+/K+
n=9-10 in each group.
Relative kidney wet weights were significantly greater in the TX fetuses compared to the
sham controls at 143dGA only (P<0.05, Figure 6.19A), which is consistent with previous
data in this study (Chapter 3). In the sham, but not TX, fetuses, there was a significant
decrease in relative wet weight between 129 and 143dGA (P<0.05, Figure 6.19A).
Relative dry weight tended to decrease at 143dGA compared to 129dGA (Student’s t-
test, P=0.06, Figure 6.19B). There was no significant difference in relative kidney dry
weights between the TX and sham fetuses at either 129 or 143dGA (Figure 6.19B).
Figure 6.18 Mean ± SEM (A) absolute kidney wet weight and (B) absolute kidney dry weight
treatment group at 129dGA, P<0.05, 2-way ANOVA. n = 6 fetuses in each group.
There was no effect of thyroidectomy on the kidney water content at 129dGA (Figure
6.20). At 143dGA, the kidneys from the TX fetuses had a significantly higher water
content of 86.5 ± 0.2% compared to 84.4 ± 0.2% in the sham fetuses (P , Figure
6.20). In the sham, but not TX, fetuses, kidney water content was significantly lower at
143dGA compared to 129dGA (P , Figure 6.20).
Figure 6.19 Mean ± SEM (A) kidney wet weight and (B) kidney dry weight, relative to fetal
body weight, from sham and TX fetuses at 129 and 143dGA. * Significantly different from
group at 129dGA, P
group at 129dGA, P=0.06, Student’s t-test. n = 6 fetuses in each group.
6.4 Discussion
6.4.1 Fetal hypothyroidism had no effect on renal glomerular or tubular growth
At 143dGA, the relative mass of the kidney was increased in TX fetuses compared to
sham controls (Chapter 3) and contrary to the original hypothesis, this did not appear to
be associated with alterations in glomerular and tubule density or size. There were no
differences in glomerular diameter, volume or number of PCNA-positive cells between
the sham and TX fetuses. Analysis of tubule length and surface area densities
demonstrated that the overgrowth of the kidney in the TX fetuses was not associated
with any apparent structural changes in the tubules. Overall, the stereological data
suggest that there did not appear to be structural changes in the renal cortex that
accounted for the increase in relative kidney mass in response to fetal hypothyroidism.
It should be noted, however, that all stereological analyses used only the cortex of the
kidney and the medulla was not examined. This was because the tubular and vascular
structures in the medulla are more difficult to distinguish from one another.
Figure 6.20 Mean ± SEM kidney water content, expressed as a percentage of wet kidney
weight in sham and TX fetuses at 129 and 143dGA. * Significantly different from sham
at 129dGA, P<0.05, 2-way ANOVA. n=6 in each group.
Furthermore, the study did not distinguish between the proximal and distal tubules in
the renal cortex and these were analysed together. The study was somewhat restricted
by the sample collection and preparation. Whole kidney stereology could not be
performed as the entire kidney was not wax embedded; therefore all stereological
measurements were expressed relative to the reference volume studied.
It may be possible that there was no change in renal development during
hypothyroidism in utero as local T3 synthesis in the kidney may have been maintained
by the actions of sulphatase and/or deiodinase enzymes. Currently there are no reports
on the localisation of sulphatases in the fetal kidney and this requires further
investigation. Previous studies in fetal sheep have shown that developmental changes
in renal structure coincide with changes in renal RAS activity, and that the RAS in the
fetal kidney is known to be sensitive to thyroid hormones in utero (Chen et al., 2005a).
Thyroidectomy in fetal sheep has been demonstrated to reduce renal levels of renin
mRNA and protein, ACE and AT1R and AT2R mRNA (Forhead & Fowden, 2002; Chen et
al., 2005b; 2007). Additionally, hypothyroid sheep fetuses show lower renal protein
adrenergic stimulation (Liu et al., 2005). It was surprising, therefore, that measurements
of glomerular and tubular structure were unaffected by fetal thyroidectomy.
Alternatively, it is possible that changes in plasma insulin and leptin seen in the TX fetus
may have normalised aspects of renal development.
Insulin has previously been shown to be important in fetal kidney growth. Fetal mice
express insulin receptor mRNA and protein from 60% gestation onwards, and insulin
causes hyperplasia in a dose-dependent manner in metanephroi isolated from fetal mice
(Liu et al., 1997). However, there was no evidence of changes in components of the
insulin-IGF signalling pathway in the kidneys of TX compared to sham fetuses which
suggests that the fetal kidney is relatively unresponsive to the increased plasma insulin
concentration observed during hypothyroidism in utero.
There was no change in the protein content of the leptin receptor in the cortex or
medulla in the TX fetuses. In neonatal rats, leptin appears to be required for normal
glomeruli development as leptin antagonism leads to the development of small and
immature glomeruli (Attig et al., 2011). Further studies are necessary to determine the
specific effects of the endocrine environment on the development of the kidney in the
TX fetus.
6.4.2 Insulin signalling components exhibited sexual dimorphism in the fetal sheep
Interestingly, there was an effect of fetal sex on the protein expression of various
components of the insulin signalling pathway in the fetal ovine kidney. Renal cortical
Akt1 levels were two-fold higher in the female, compared to male fetuses, regardless of
treatment. There has been no previous report of a sex difference in Akt1 in the fetal
kidney. However, greater Akt1 in cardiomyocytes has been reported in female
compared to male adult mice; in these cells, oestrogen receptors mediate anti-
apoptotic protection through activation of PI3K and Akt1 (Wang et al., 2009). Sexual
dimorphism in oestrogen receptors has been reported in the kidneys of adult rats
(Sharma & Thakur, 2004). Oestrogen receptors are present in the kidneys of fetal mice,
human and pigs (Brandenberger et al., 1997; Lemmen et al., 2002; Knapczyk et al.,
2008), although there is no difference in serum oestrogen levels in males and females in
utero in humans and sheep (Hickey et al., 2014; Reddy et al., 2014).
The renal levels of GLUT4 protein were also affected by fetal sex. In the renal cortex,
higher levels of GLUT4 were observed in the female sham fetuses compared to the male
sham fetuses. In contrast, in the medulla, the female fetuses of both treatment groups
had lower GLUT4 protein expression compared to the male fetuses. Furthermore, renal
cortical GLUT4 protein was decreased by hypothyroidism in the female, but not male,
fetuses. The reduction in cortical GLUT4 observed in the female TX fetuses was
surprising, as previously it has been demonstrated in dogs and humans that insulin
infusion increases renal glucose uptake (Cersosimo et al., 1994; Meyer et al., 1998).
However, it is also known glucose uptake and utilisation occurs predominately in the
medulla (Gerich et al., 2001), where there was no change in GLUT4 expression in the TX
fetuses, suggesting that renal glucose uptake is unaffected in hypothyroid fetuses. The
significance of differences in the renal components of the insulin signalling pathway
between male and female sheep fetuses remains to be established.
6.4.3 Fetal hypothyroidism increased kidney water content
Near term, the kidney of the hypothyroid sheep fetuses was composed of a higher water
content compared to sham controls, and this may contribute to the greater renal mass.
The increase in water content could be due to changes in fluid retention in the organ,
which may be a result of altered blood volume and vascular structure and/or nephron
filtration and reabsorption rates. Hypothyroidism in adult humans induces an increase
in sodium reabsorption in the distal tubule and a decrease in water excretion (Allon et
al., 1990). Additionally, in adult rabbits with congenital hypothyroidism, osmotic water
permeability in the renal tubules is increased, which means that they retain more water
compared to controls (Mulder et al., 2003).
It has previously been shown that capillary density is elevated in both the cortex and
medulla of hypothyroid adult rats (Rodríguez-Gómez et al., 2013). To study the vascular
structure of the fetal kidney, it would need to be perfused at dissection to ensure that
the blood vessels remain distended under perfusion pressure; capillary density could
then be measured by use of endothelial markers. Protein content of angiogenic growth
factors, such as vascular endothelial growth factor A, angiopoietin 1 and their receptors,
could also be determined in the fetal kidney (Dunford et al., 2014). Three dimensional
representations of blood vessels could also be obtained to quantify volume and surface
area using vascular corrosion casting, as described by Dunford et al., (2014).
Additionally, renal function should be examined in vivo in the TX fetuses by measuring
arterial blood pressure, renal blood flow, and glomerular filtration and urine flow rates.
Furthermore, the extent to which the effects of hypothyroidism on water content are
specific to the kidney or occur in other fetal tissues more globally remains to be
established. Interestingly, other tissues from the same cohort of TX fetal sheep also
demonstrate a higher water content, such as the biceps femoris and the liver
(unpublished data), suggesting that that this may not be an organ specific phenotype.
6.4.4 Fetal hypothyroidism had no effect on sodium transporter protein expression
Western blotting analysis identified similar protein expression of the subunits of ENaC
and Na+/K+ ATPase in the TX and sham fetuses. However, this method of protein analysis
provides limited knowledge on the activity of the sodium channels and transporters.
Furthermore, it has previously been reported in fetal sheep that mRNA abundance of
these sodium transporters increases towards term, with no change seen in the protein
expression (Keller-Wood et al., 2008). To investigate transporter and channel activities
in vivo, the responses to natriuretic agents could be analysed, such as sodium excretion
and transepithelial currents.
While it is well known that glucocorticoids and insulin can regulate ENaC mRNA
expression in the fetal ovine kidney towards term (Keller-Wood et al., 2008), it remains
unclear whether thyroid hormones also have a role in the maturation of renal ENaC
expression. It was surprising, however, that there was no alteration in the protein levels
of the Na+/K+ ATPase subunits, as it is known that the pump is regulated by thyroid
hormones in adult tissues. Previous studies have shown increased mRNA abundance of
Na+/K+ ATPase in the kidneys of hypothyroid rats injected with T3 (McDonough et al.,
et al., 1993).
In contrast, however, other reports have shown that hypothyroidism in rats has no
effect on renal mRNA levels of either Na+/K+ ATPase subunit (Horowitz et al., 1990).
It was also surprising that the protein expression of the sodium transporters in the fetal
kidney did not respond to the hyperinsulinaemia seen in the TX fetus. Adult rats
chronically infused with insulin showed a greater response in sodium excretion when
treated with natriuretic agents although there was no change in ENaC protein
expression in either the whole kidney or renal cortex (Song et al., 2006). In renal tubules
isolated from adult rats, insulin incubation causes increased phosphorylation of the
Na+/K+ et al., 1999). It may be that while there was no change
in the protein content of sodium transporters present in the TX fetuses, the amount of
trafficking to the apical and basolateral membranes may be altered and in future this
may be detected by electron microscopy. It has previously been reported that chronic
insulin infusion in adult rats leads to increased apical membrane localisation of ENaC,
and this is also demonstrated after acute insulin treatment in the mouse (Tiwari et al.,
2007). It may be possible that while the development of glomerular and tubular
structure in the fetal kidney is relatively unresponsive to the increased circulating insulin
concentrations seen in the TX fetus, there may be changes in the expression of apical
sodium transporters, enhancing their reabsorptive function to contribute to the
increased kidney water content. It is possible that hypothyroidism decreases sodium
transporter protein that would normally increase towards term, but hyperinsulinaemia
leads to an upregulation in transporter expression, so there is no net effect.
6.5 Conclusions
It has been shown that relative fetal kidney mass was increased in the hypothyroid
sheep fetus during late gestation. However, this was not associated with altered
glomerular or tubular growth or with any changes in the insulin signalling pathway. It
may be possible that there was no change in renal development during hypothyroidism
in utero due to local T3 synthesis by the actions of sulphatase and/or deiodinase
enzymes. Alternatively, it is possible that changes in plasma insulin seen in the TX fetus
may have normalised aspects of renal development
Enlargement of the kidney in the TX fetus may be due, in part, to increased water
content. Further research is necessary to examine the effects of thyroid hormones on
renal function and the vascular structure of the kidney. The protein expression of the
ion transporters was also unaffected by fetal hypothyroidism, however more
experimental work is needed to identify the role thyroid hormones in regulating renal
sodium transporters in late gestation. The extent to which the effects of fetal
hypothyroidism on water content are specific to the kidney or occur more globally
remains to be established.
7 GENERAL DISCUSSION
In many mammalian species, including humans and sheep, the fetal thyroid gland is
functional from mid-gestation. Thyroid hormones influence growth, metabolism and
development in utero, especially close to term when T3 levels rise in the fetal circulation
(Forhead & Fowden, 2014). The aim of the thesis was to examine the effects of
hypothyroidism on the growth and development of the sheep fetus during late
gestation. Specifically, the research in this study sought to determine the consequences
of fetal thyroid hormone deficiency on pancreatic islet development and the extent to
which the effects of hypothyroidism on fetal growth may be mediated by changes in
insulin signalling pathways.
The data of the thesis contradict that of the initial hypothesis, in which it was speculated
that growth retardation in the hypothyroid sheep fetus was due to low circulating insulin
upregulated the insulin signalling pathway in PAT to contribute to an overgrowth of
unilocular adipocytes. Enlargement of the fetal kidney in response to hypothyroidism in
utero, however, was not associated with changes in insulin signalling, or glomerular or
tubular structure, and may have resulted from greater tissue water content (Figure 7.1).
7.1 Role of thyroid hormones in the control of body and organ growth
Thyroidectomy in fetal sheep resulted in an asymmetric pattern of growth,
demonstrating that the thyroid hormones exert their effects in a tissue-specific manner.
Organs such as the lungs and heart were reduced in mass relative to body weight,
whereas organs such as the adipose tissue and kidneys were enlarged. Overall, there
was no change in the body weight of the TX fetuses, which may be because the
alterations in organ mass balanced to a comparable mass seen in the sham fetuses.
Additionally, there was no change in crown-rump length in TX fetuses compared to sham
controls, although fore and hind-leg limbs were growth retarded, indicating that there
may be differences in the effects of hypothyroidism in utero on regions of the developing
skeleton.
Figure 7.1. Thyroid hormone deficiency in utero
proliferation. In perirenal adipose tissue, increased cellular insulin signalling promoted
unilocular adipocyte growth, leading to a greater plasma concentration of leptin, which could
the markers of the insulin signalling pathway in fetal kidneys, with no alterations in kidney
structure. Fetal kidneys had a greater water content which may be a consequence of increased
sodium transporter functionality.
The tissue-specific effects of thyroid hormone deficiency suggest that there may be
differences in thyroid hormone sensitivity between fetal organs. This may be, in part,
due to variation in expression of transporters, receptors and metabolic enzymes
between tissues, which determine the local tissue-specific concentrations of thyroid
hormones. These factors controlling thyroid hormone metabolism alter in response to
thyroid hormone deficiency before birth. For example, in hypothyroid fetal sheep D2 is
upregulated in the brain, to maintain the local concentration of T3, which is important
for normal brain growth and development (Polk et al., 1988). The asymmetric pattern
of growth in the hypothyroid fetuses may also be due to sensitivities to other growth
factors such as insulin and the insulin-IGF signalling pathway.
7.2 Role of thyroid hormones in development of fetal tissues
This study reported for the first time that hypothyroidism in the ovine fetus caused a
concentration in utero
cell proliferation in a dose-dependent manner in isolated fetal ovine islets studied in
vitro
secretion, remains unknown. It is possible that the prepartum surge in T3 in the ovine
and growth to maturation, in a manner similar to that seen in fetal cardiomyocytes near
term (Chattergoon et al., 2012a; 2014). Therefore, in the sheep fetus, removal of the
thyroid gland and prevention of the normal rise in T3 near term may maintain
maturation of glucose-stimulated insulin secretion. Indeed, the findings from
preliminary experiments suggested that T3 promotes glucose-stimulated insulin
secretion in isolated fetal ovine pancreatic islets in vitro. In fetal sheep, isolated
cardiomyocytes exposed to T3 have an increased expression of the cell cycle inhibitor
p21 and a decrease in the cell cycle promotor, cyclin D1, suggesting that T3 initiates cell
cycle exiting (Chattergoon et al., 2012b). Hypothyroidism in the neonatal mouse has
been shown to downregulate expression of cell cycle inhibitors in developing testis
(Holsberger et al.
Pancreatic islets isolated from thyroid deficient fetal sheep should be used in the future
to assess the expression patterns of transcription factors involved in neogenesis and
proliferation in the islets of hypothyroid and sham fetuses, by either PCNA protein
determination or proliferation assays in vitro. Additionally, future studies may
determine the effects of thyroid hormone deficiency on the expression of signalling
pancreatic islets from fetal sheep. To identify the molecular mechanisms by which
effects of receptor deletions on fetal and postnatal growth could be examined
individually and/or as a double knock-out to assess specific receptor function. In
addition, glucose homeostasis and insulin secretion could be examined in vivo in
postnatal animals using glucose tolerance tests and the morphology and secretory
function of the developing pancreas may be examined in wild-type and mutant mice in
fetal, neonatal and adult life. Fetal islet structure and function could be further
examined in sheep fetuses infused with varying concentrations of T3.
In a novel finding, thyroidectomy in the sheep fetus resulted in an increase in the relative
UL adipocyte mass with no change in the ML adipocyte mass. The role of the thyroid
hormones in UL adipose development before birth is still relatively unknown. Perirenal
adipose tissue from TX fetuses could be assessed for markers of adipogenic pathways,
responsive element-binding protein, to determine how thyroid hormone deficiency in
utero has specifically affected UL adipocyte proliferation. Hypothyroidism in human
adults has previously been shown to reduce catecholamine-stimulated lipolysis
(Wahrenberg et al.
assessed alongside lipolytic enzymes such as adipose hormone-sensitive lipase to
ascertain if these processes are downregulated in adipose tissue from TX sheep fetuses.
It is possible that thyroid hormones act to limit UL adipose growth in the sheep fetus
adipocytes for thermogenic function. Although there was no change in the ML adipose
mass, the functionality of the ML adipocytes in the TX fetus remains unknown. It would
therefore be necessary to determine UCP1 expression in the BAT of hypothyroid fetuses.
in normal thermoregulatory control of BAT in the thyroid deficient fetus. In these
studies, it would be necessary to isolate UL and ML adipocytes from PAT in order to
the elevated levels of adipose proteins measured in PAT taken from TX sheep fetuses in
the present study, may have been a consequence of the greater proportion of UL,
relative to ML, adipocytes.
The increase in kidney mass observed in the TX sheep fetus did not appear to be
associated with a greater number or growth of glomeruli or cortical tubules. Further to
this, there was no difference in the dry kidney weights between sham and TX fetuses.
The percentage of water content in the kidney of the TX fetus was increased compared
to sham controls, suggesting that thyroid hormones influence renal water content which
may be composed of blood volume and/or tubular filtrate. Fetal urine is a major
component of amniotic fluid, which suggests that the thyroid hormones may have a role
in renal water excretion and amniotic fluid production which could be investigated
further. It is possible that other tissues in the TX fetus may vary their water content;
therefore, it would be interesting to measure the dry weights of other organs in the
hypothyroid fetus to establish if this effect is specific to the kidney or a more global
consequence of thyroid hormone deficiency before birth. It is possible that the higher
water content in the TX fetuses may be due to increased function of renal sodium
transporters. Although no changes in ENaC or Na+/K+ ATPase were observed in response
to hypothyroidism in utero, the amount of transporter trafficked to and expressed in
apical plasma membrane of renal tubules should be determined in the TX fetuses.
Upregulation of ENaC at the cellular apical membrane may lead to greater retention of
sodium, which in turn would cause increased uptake of water. It will also be necessary
to investigate renal function in vivo by measuring arterial blood pressure, renal blood
flow, glomerular filtration rates and urine production rates to determine if
hypothyroidism affects haemodynamic and fluid homeostasis. In addition, assessment
of renal vascular structure may establish if changes in blood volume account for the
greater fluid content and mass of the fetal kidney during thyroid hormone deficiency.
The future studies required in this research, highlight a limitation in the use of the sheep
model. The whole of the whole pancreas was used for stereological studies, providing
no additional tissue for maturational or mechanistic analysis. More thyroid deficient
fetal sheep would be needed to fully investigate the role of the thyroid hormones on the
pancreas, adipose and kidney. However, sheep are not as readily available as rodent
models, such as mice. The experimental design has also limited some of the research in
this project. The vessel structure of the kidney could not be assessed as the kidney was
not pressure perfused at collection. Additionally, the results obtained in this thesis only
provide a snapshot of the physiology of the TX fetuses, as tissue collection occurred after
fetal euthanasia.
7.3 Interactions between thyroid hormones and insulin signalling in utero
The effects of hypothyroidism in the sheep fetus may have been mediated by
interactions with the insulin signalling pathway. It was speculated that growth
retardation in the thyroid hormone deficient fetus was due to downregulation of insulin
signalling. Although insulin signalling in the smaller tissues was not investigated in this
project, the hypothesis could still be valid as the enlarged adipose tissue of the TX fetus
was associated with, in part, an upregulation of several insulin signalling proteins. The
insulin signalling pathway could be assessed in the growth retarded organs, such as the
heart and lungs, to determine if this has been altered by hypothyroidism in utero.
The overgrowth of UL adipocytes seen in the TX fetuses may be due to the concomitant
increase in plasma concentrations of insulin as insulin promotes local adipose expression
proliferation may have been due to an upregulation of the insulin signalling pathway.
The enhanced UL adipocyte mass in the TX fetus was likely to be responsible for the
increased circulating concentrations of leptin and, in turn, leptin may have promoted
to separate the effects of higher insulin and leptin concentrations from the effects of
hypothyroidism on insulin signalling and other molecules. To determine the specific
roles of thyroid hormones on tissue development and insulin signalling pathways, tissue-
create a hypothyroid environment in specific organs without alterations in circulating
insulin concentrations, and as such, the effects of thyroid hormone deficiency alone on
the development of fetal tissues can be investigated.
7.4 Short-term consequences of hypothyroidism in utero
Hypothyroidism in utero has consequences for maturation of the neonate. Little is
known about the physiology of human neonates born with congenital hypothyroidism
as they are treated with T4 soon after birth (LaFranchi, 2011). Furthermore, human
neonates with congenital hypothyroidism may have a less severe phenotype to that
seen in the TX ovine fetus due to the significant placental transfer of maternal thyroid
hormones. The impact of thyroid hormone deficiency before birth on the functioning of
organ systems in the neonate has, therefore, not been fully investigated.
Hypothyroid neonates may be unable to maintain stable blood glucose levels. Previous
studies have demonstrated that thyroidectomy in the sheep fetus results in decreased
hepatic glycogen content and decreased hepatic activity of gluconeogenic enzymes in
late gestation (Forhead et al., 2003; 2009). Additionally, the hypothyroid fetus has a
higher circulating concentration of insulin, which could further exacerbate neonatal
changes that lead to pancreatic dysfunction. In sheep fetuses of obese ewes
increased at mid-gestation and yet reduced near term, to below that seen in control
et al., 2000). Further studies should examine pancreatic islet development and insulin
secretion in neonates and young animals exposed to hypothyroidism before birth. The
hypothyroid fetus may have impaired tissue sensitivity to insulin at birth, which may, in
turn, promote further hyperinsulinaemia in neonatal life. The high insulin and leptin
concentrations in the TX fetus are similar to that seen in offspring born of mothers with
diabetes and/or obesity (Catalano et al., 2009b; Kamana et al., 2015). The offspring have
increased adiposity which increases independently of body weight and is positively
correlated with insulin resistance at birth (Catalano et al., 2003; 2009b). A decrease in
InsR protein was observed in adipose tissue of the TX fetuses and the higher circulating
insulin may have affected insulin receptor sensitivity in other peripheral tissues.
Increased water content in the kidney of the TX fetus may alter haemodynamics in utero
and early in postnatal life. Previous studies examining the effects of thyroidectomy on
blood pressure in fetal sheep have reported conflicting results. Walker and Schuijers
(1989) reported that thyroidectomy in fetal sheep at 80dGA results in significantly lower
arterial blood pressure in TX fetuses studied at 120dGA. In contrast, no change in arterial
pressure was observed in sheep fetuses thyroidectomised at 100dGA and studied at
term (Ayromlooi et al., 1983). The data from the previous studies may be variable due
to the timing of thyroidectomy and measurement of arterial blood pressure. It has also
been shown that hypothyroidism in the sheep fetus causes alterations in plasma
noradrenaline concentrations depending on the timing of thyroidectomy (Walker &
Schuijers, 1989; Fowden et al., 2001) and highlights the need for further characterisation
of the functioning of the sympathetic nervous system and catecholamine receptor
expression and tissue sensitivity in the TX sheep fetus. Thyroid hormone deficiency in
utero may also have a consequence for thermogenesis after birth, such that neonates
may fail to maintain body temperature due to abnormal ML adipocyte function and
decreased responses to catecholamine stimulation.
7.5 Long-term consequences of hypothyroidism in utero
Extensive studies have shown that hormonal and environmental insults early in
development have long-term programming effects on hormonal and metabolic
homeostasis in later life (Barker, 2007; Lisboa et al., 2015). The adult offspring of rats
hypothyroid during pregnancy show reduced glucose tolerance and lower glucose-
stimulated insulin secretion from isolated pancreatic islets (Farahani et al., 2010;
Karbalaei et al., 2014). Although these offspring are euthyroid in adult life, the
pancreatic islets are less sensitive to glucose with decreased insulin output per islet
(Karbalaei et al.
or in adult life, and there may be dynamic changes in islet morphology and function over
the perinatal period and into adulthood.
Offspring born to diabetic mothers, which are hyperinsulinaemic in utero, show a
positive correlation between percentage body fat as a neonate and as a child (Catalano
et al., 2009a). Adolescents born to mothers with gestational diabetes are also
hyperinsulinaemic at birth and have increased body weight, greater waist circumference
and increased fat storage (Crume et al., 2011; Kamana et al., 2015). Moreover, these
offspring are more susceptible to the onset of metabolic diseases, such as high blood
pressure, abnormal cholesterol levels and obesity, all of which are risk factors for
diseases such as type 2 diabetes and coronary heart disease (Kamana et al., 2015). The
increased adipose tissue mass of the hypothyroid fetus may have an intergenerational
effect. A recent study of maternal obesity in mice highlighted that hyperinsulinaemia,
increased insulin resistance and enlarged islet mass persisted in both F1 and F2 progeny,
even after the diet was corrected in the offspring (Graus-Nunes et al., 2015). This
suggests that the developmental programming of pancreatic structure and function can
persist, although the mechanisms responsible are unknown.
It has been previously been established that changes in cardiovascular development in
the prenatal environment can programme adult blood pressure (Barker et al., 1989;
Langley & Jackson, 1994; Manning & Vehaskari, 2001; Vehaskari et al., 2001). In humans,
offspring of mothers who were hypothyroid during the last 10 weeks of gestation have
elevated systolic blood pressure when measured at 20 years of age (Rytter et al., 2016).
The hypothyroid sheep fetus had increased renal water content and in the fetal rat, it
has previously been shown that increased sodium and fluid retention in the kidney
suppresses plasma renin activity and that reduced renin activity prenatally programmes
hypertension (Vehaskari et al., 2001; Manning et al., 2002).
Human neonates are screened for thyroid status shortly after birth and in the case of
hypothyroidism, synthetic T4 is prescribed as life-long treatment. Although this
treatment has been shown to normalise circulating thyroid hormone levels, and prevent
cognitive impairment (Arnold et al., 1990), it is unknown whether other physiological
changes that have occurred in utero have long term consequences. This requires
longitudinal studies in experimental animal models to determine if altered fetal growth
and development in response to changes in thyroid hormones in utero will affect health
in the life course of an individual.
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